Technology - Investor's Business Daily04:35 Текст источника в новой вкладке

 
 
1. Apple's Self-Driving Bet Pits It Against Tesla, With Big AutoЧт., 23 нояб.[−]

Apple ( AAPL) is working on using a light-based technology to make it easier for self-driving cars to identify pedestrians and cyclists, putting it in the camp of several big-name proponents of the tech but against Tesla ( TSLA).

A new Apple research paper discusses an object detection method for self-driving systems that is based purely on LiDAR, or simply Lidar. Lidar is a method to gauge distance by illuminating a target with a pulsed laser light, and measuring how long it takes to return.

The technology is being implemented in self-driving cars and systems to create an accurate, 3D picture of a physical environment that is then harvested and capitalized on by machine learning software.

Big Three automakers such as General Motors ( GM) and Ford Motor ( F), along with Alphabet's ( GOOGL) Waymo unit, are backing Lidar. Meanwhile, Tesla is throwing its weight behind radar instead.

In October, General Motors announced the acquisition of a California-based company, called Strobe, to beef up its Lidar efforts in self-driving technologies.

GM at that time described Strobe as "a company that has quietly been building the leading next-generation Lidar sensors" that will significantly enhance the capabilities of its self-driving cars and drive down the costs of implementing the technology.


Tesla Chief Executive Elon Musk once tweeted that radar, unlike Lidar, "can see through rain, snow, fog and dust." The Tesla Autopilot system is said to rely on radars and cameras for object detection.

While GM complements its Lidar technology with cameras and radar sensors, a GM executive has said that getting to the highest levels of autonomous driving "with just cameras and radars is not physically possible."

The research by Apple computer scientists Yin Zhou and Oncel Tuzel was submitted to the online journal arXiv Nov. 17.


IBD'S TAKE: General Motors earns a solid Relative Strength Rating of 88, which is high among automakers. Learn which top stocks are showing superior relative price strength.


While Apple is famously secretive about its autonomous driving efforts, it has a permit from Californian authorities to test self-driving cars. Recently, CEO Tim Cook called self-driving systems the "mother of all AI projects."

Shares of GM lost 1.5% to close at 44.29 on the stock market today. Apple rose 1.1% to 174.96. Ford dipped 0.4% to 12.07, while Tesla ended the regular trading day down 1.6% to 312.60.

RELATED:

Tesla's Electric Truck Arrives Amid 'Production Hell,' Hot Competition


2. New Facebook Portal Will Tell If You Were Misinformed By RussiansЧт., 23 нояб.[−]

Facebook ( FB), under congressional scrutiny for the role its social network played in the 2016 U.S. election, took a step Wednesday to inform users if they were fooled by misinformation from Russian operatives.

XAutoplay: On | OffFacebook said it will soon create a portal to enable people on Facebook to learn which Facebook pages or Instagram accounts they may have liked or followed created by Russian actors between January 2015 and August 2017. The new tool will be available for use by the end of this year in the Facebook Help Center.

"It is important that people understand how foreign actors tried to sow division and mistrust using Facebook before and after the 2016 U.S. election," Facebook said in a post on its website. "That's why, as we have discovered information, we have continually come forward to share it publicly and have provided it to congressional investigators."

In September, Facebook announced it found more than 3,000 ads addressing social and political issues that ran in the U.S. between 2015 and 2017 and that appear to have come from accounts associated with an entity known as the Internet Research Agency — a Russian company that engaged in an online operation on behalf of the Russian government. The ads were shared with congressional investigators.

Russia's campaign to meddle in the U.S. election reached 126 million people through 80,000 posts on Facebook.


IBD'S TAKE: Facebook is an IBD Leaderboard stock with an IBD Composite Rating of 99 out of a possible 99 and remains in buy range from a 175.59 buy point. Here's a simple routine to help you understand how to invest in the stock market.


Facebook had said the ads and accounts "appeared to focus on amplifying divisive social and political messages across the ideological spectrum — touching on topics from LGBT matters to race issues to immigration to gun rights."

Facebook shares dipped 0.5% to close at 180.87 on the stock market today. Facebook shares are up 56% this year.

Facebook scored multiple price-target hikes on Nov. 2 following its quarterly earnings report that blew past estimates.

RELATED:

Facebook Shares Higher As Third-Quarter Results Crush Estimates


3. HP Inc. Stock Tumbles On In-Line Earnings And OutlookЧт., 23 нояб.[−]

Shares of HP Inc. ( HPQ) fell Wednesday, a day after the PC and printer maker delivered in-line earnings for its fiscal fourth quarter and gave earnings guidance for the current quarter that matched Wall Street's views.

XAutoplay: On | OffHP fell 5% to close at 21.34 on the stock market today. Intraday Tuesday, HP stock hit a seven-year high of 22.68.

Wall Street analysts had mixed responses to HP's quarterly report.

"HP posted another quarter of revenue upside, but EPS was in line as lower margins prevented revenue from dropping to the bottom line," UBS analyst Steven Milunovich said in a report. "The glass-half-empty view is disappointment with the printer margin in the quarter and again early in fiscal 2018 as (HP's acquisition of the printer business from) Samsung is integrated."

HP likely is being more aggressive on printer prices to increase its installed base so it can sell more higher-margin supplies later, he said.

"We see unit placements as critical to maintaining supplies growth," Milunovich said.

Milunovich reiterated his buy rating on HP and upped his price target to 24 from 22.


IBD'S TAKE: HP stock has a middling IBD Composite Rating of 62 out of 99. For more analysis on HP and its peers, visit the IBD Stock Checkup.


HP's results marked its third consecutive quarter with growth in both its PC and printer businesses, Morgan Stanley analyst Katy Huberty said in a report.

HP is taking market share in personal computers and has stabilized its printer and supplies business, she said.

Guggenheim analyst Robert Cihra kept his neutral rating on HP, saying the company will face difficult year-over-year comparisons in the near term.

RELATED:

HP Inc. Disappoints With In-Line Earnings And Guidance


4. Analog Devices Gets Price-Target Hikes On Upbeat Earnings ReportЧт., 23 нояб.[−]

Chipmaker Analog Devices ( ADI) received at least six price-target increases to its stock after delivering a beat-and-raise quarterly report on Tuesday.

XAutoplay: On | OffAnalog Devices earned an adjusted $1.45 a share, up 38% year over year, on sales of $1.54 billion, up 54%, in its fiscal fourth quarter ended Oct. 28. Analysts expected $1.37 and $1.5 billion.

For the current quarter, Analog Devices expects to earn an adjusted $1.28 a share on sales of $1.49 billion, based on the midpoint of its guidance. Wall Street was modeling earnings of $1.17 a share on sales of $1.46 billion.

Analog Devices scored price-target hikes from B. Riley FBR, CFRA, Jefferies, KeyBanc, Morgan Stanley and Stifel, all of which have buy ratings on the stock.

The most bullish of the bunch was B. Riley FBR analyst Craig Ellis who upped his price target to 113 from 110.

Analog Devices shares fell 1.7% to close at 88.65 on the stock market today.


IBD'S TAKE: Analog Devices stock has an IBD Composite Rating of 97 out of 99, but it ranks No. 2 in IBD's Electronics-Semiconductor Manufacturing industry group. To see which company leads the group, visit the IBD Stock Checkup.


"Communications base station strength led (the fourth quarter's) positive sales surprise followed by Industrial," Ellis said. The company's fiscal first-quarter guidance could be conservative, he said.

Longer term, Analog Devices is poised to benefit from strong demand for industrial, automotive and wireless infrastructure chips, he said.

Investors likely are disappointed by the magnitude of the quarterly beat by Analog Devices, Morgan Stanley analyst Craig Hettenbach said in a report. He noted that Microchip Technology ( MCHP) and Texas Instruments ( TXN) also traded down despite solid earnings reports recently.

"Clearly, the bar is quite high and the magnitude of beats is shrinking as growth shifts from above seasonal to seasonal," Hettenbach said. He reiterated his overweight rating on Analog Devices stock and upped his price target to 103 from 98.

RELATED:

Analog Devices Posts Beat-And-Raise Quarterly Results


5. Why This Biotech Could Prosper On Back Of Roche Cancer TrialЧт., 23 нояб.[−]

Five Prime Therapeutics ( FPRX) could benefit from Roche's ( RHHBY) recent lung cancer trial, an analyst suggested Wednesday — about two weeks after Five Prime lost nearly 41% of its value on a pancreatic cancer study.

XAutoplay: On | OffThe mechanism of Five Prime's drug, known as cabiralizumab, means it could potentially have some success in treating advanced lung and other cancers, Instinet analyst Christopher Marai said in a note to clients.

Marai's report follows Roche's release Monday of data from a trial combining immuno-oncology drug Tecentriq with cancer drug Avastin and chemotherapy in lung cancer. The regimen hit its key goals in a Phase 3 trial.

Roche's Tecentriq is a checkpoint inhibitor, meaning it blocks a specific interaction that would otherwise prevent an immune response. Avastin inhibits a growth-factor protein, called VEGF-A, that has been correlated with tumor growth.

Although Tecentriq plus Avastin and chemo hit its goals in lung cancer patients, a late-stage study in 2010 showed a regimen of Avastin and chemo had no impact in patients with pancreatic cancer. Pancreatic cancer is notoriously difficult to treat.


IBD'S TAKE: Small-cap biotechs outperformed their larger brethren in the quarter with some beating sales expectations by more than $20 million. Head to the Industry Snapshot for a closer look at what this could mean for the group.


Five Prime earlier this month unveiled data showing a combo of cabiralizumab and Bristol-Myers Squibb's ( BMY) Opdivo had an impact as a treatment in pancreatic cancer. Still, the benefit wasn't as big as some wanted, and Five Prime toppled nearly 41%.

Cabiralizumab targets what are known as tumor-associated macrophages, or TAMs. These are cells found in close proximity to or within tumor masses. Cabiralizumab is programmed to find these cells by seeking out a receptor on their surface called CSF1R.

Marai notes TAMs suppress immune cells, preventing them from destroying tumor cells. They are also resistant to checkpoint inhibitors like Roche's Tecentriq and Bristol's Opdivo.

TAMs are also known to promote angiogenesis, the formation of new blood vessels, a key to the survival and spread of tumor cells. They do this by secreting growth proteins like VEGF-A, which is targeted by Avastin.

Data from Five Prime and Bristol support the theory that TAMs promote angiogenesis by secreting more than just VEGF-A, which is likely why Avastin plus chemotherapy had no impact on overall survival in the 2010 study, he said.

But Five Prime and Bristol managed a 13% overall response rate in patients with advanced pancreatic cancer. The take-away, Marai says, is that drugs like cabiralizumab may be more potent in preventing angiogenesis than drugs like Avastin.

"Consequently, anti-CSF1R therapies (like cabiralizumab) may provide better antiangiogenesis effect or synergistic effects with current antiangiogenesis therapies given the broad role of TAMs in this process," he said.

"Given data from Bristol and Five Prime presented for cabiralizumab plus Opdivo that support clinical benefit in pancreatic cancer, we hypothesized that TAMs may play a role in angiogenesis beyond VEGF-A activity alone and that other TAM-mediate mechanisms may be important to the antiangiogenesis effect of cabiralizumab (and anti-CSF1R)."

As a result, Marai sees a potential role for cabiralizumab in treating tumors that have a high number of TAMs like advanced lung, ovarian and head and neck cancers.

By the closing bell on the stock market today, Five Prime ticked down 2 cents to 26.97.

RELATED:

Why Roche Cancer Trial Is Kick In The Teeth For Dow Stock Merck

Biotech Spikes After Settling Debate Over Its Seizure Medicine

Medtronic Surges After Topping Quarterly Earnings Views


6. Adobe Systems Called 'Cloud And AI All-Star' In Bullish ReportЧт., 23 нояб.[−]

Shares of digital media and marketing software firm Adobe Systems ( ADBE) are trading in record-high territory, but have room to climb higher, a Wall Street analyst said in a report Wednesday.

KeyBanc Capital Markets analyst Brent Bracelin reiterated his overweight rating on Adobe stock and raised his price target to 216 from 178.

Adobe shares dipped 0.7% to close at 182.90 on the stock market today. Adobe hit an all-time high of 185.55 intraday on Tuesday.

Adobe is an "all-star" company in cloud computing and artificial intelligence and should perform well in 2018, Bracelin said.

"We have increasing confidence in the upside levers to Adobe's cloud growth and profit margins next year, in part driven by price increases and an expanding portfolio of 20-plus Creative Cloud products that account for 60% of sales, up from 45% in 2015," Bracelin said. "(Adobe) remains one of the core cloud software platforms to own for 2017 and 2018."


IBD'S TAKE: Adobe Systems stock is currently ranked No. 32 on the IBD 50 list of top-performing growth stocks.


Adobe's internet cloud software business is "best in class" and its advancements in artificial intelligence such as Sensei are "underappreciated," Bracelin said.

"Adobe stands out as one of the better-positioned cloud software leaders entering 2018, uniquely positioned to deliver 20%-plus revenue growth," he said.

RELATED:

Adobe Gets Fresh Buy Rating; UBS Names Top Picks In Software

Adobe Systems Rockets On 2018 Outlook, Price-Target Hikes


7. Broadcom Might Raise Its Bid For Qualcomm: ReportЧт., 23 нояб.[−]

Chipmaker Broadcom ( AVGO) is considering raising its takeover bid for Qualcomm ( QCOM) to avoid a proxy battle, Reuters reported late Wednesday.

Qualcomm rejected Broadcom's unsolicited bid on Nov. 13, saying it undervalued the company. Broadcom offered to pay $70 in cash and stock for each share of Qualcomm. The deal would consist of $60 in cash and $10 per share in Broadcom shares.

After consulting with several of Qualcomm's top shareholders, Broadcom is considering sweetening the deal by offering more of its stock, sources told Reuters.

Qualcomm's shareholders indicated to Broadcom they expect at least $80 per share for Qualcomm to be sold, Reuters said.


IBD'S TAKE: Broadcom stock has a best-possible IBD Composite Rating of 99. For more analysis on Broadcom and its peers, visit the IBD Stock Checkup.


Qualcomm reportedly has refused several meeting requests by Broadcom officials since the buyout offer was announced Nov. 6.

Broadcom stock fell 0.4% to 275.37 on the stock market today. Qualcomm shares rose 2.2% to 68.13.

RELATED:

Broadcom Gets Price-Target Hikes After Closing Brocade Deal

Qualcomm Rejects Broadcom's Buyout Offer, Says It's Undervalued


8. Alphabet (GOOGL) Stock Quotes, Company News And Chart AnalysisСр., 22 нояб.[−]

XAutoplay: On | Off


View GOOGL Stock Quote Page
| View GOOGL Ratings

Google-Parent Alphabet Stock News & Analysis

Apple HomePod Speaker Delayed, Will Miss Holiday Shopping SeasonVoice-activated smart speakers are expected to be hot sellers this holiday shopping season, but Apple is going to miss out on the action. Apple revealed Friday that its HomePod speaker is being... Read More
Creativity Helps Yelp Defend Against Facebook, Google OnslaughtLooking to avoid the competitive wrath of Facebook and Alphabet that target its core market with various ventures, Yelp has been busy adjusting business models and creating new ones to boost growth.... Read More
S&P 500 Futures Fall Amid GE, China Internet News; FANGs Are Still BuysS&P 500 futures fell modestly Monday morning as Chinese internet giants rallied on earnings and the 11.11 sales event, while General Electric slashed its dividend in half. Meanwhile, Facebook, Amazon, Netflix and Google-parent Alphabet... Read More
Recent IPO Roku Soars Late On Third-Quarter Earnings BeatStreaming video firm Roku saw its shares rocket in late trading Wednesday after the company reported much better-than-expected results for the third quarter, its first as a publicly traded company. Roku reported an adjusted... Read More
These Five 95+ Composite Rating Stocks Are Moving On Earnings, Deals; S&P 500 FuturesFutures for the S&P 500 index were little changed Tuesday morning. Apple-supplier Skyworks Solutions, Microchip Technology and Supernus Pharmaceuticals fell late Monday despite beating earnings views. Alphabet-unit Google and Salesforce rose on... Read More

More Technology Stocks Coverage

FANG Stocks News: Facebook, Amazon, Netflix, Google

Apple (AAPL) Stock Quotes And Company News

Tesla (TSLA) Stock Quotes And Company News

View More Tech Stocks


9. FANG Stocks News & Quotes: Facebook, Amazon, Netflix, GoogleСр., 22 нояб.[−]

Collectively known as the FANG stocks, Facebook ( FB), Amazon ( AMZN), Netflix ( NFLX) and Google parent Alphabet ( GOOGL) are among the tech titans of our time.

XAutoplay: On | OffFacebook and Google alone capture the lion's share of all global online advertising, including in the fast-growing mobile format, while Amazon dominates e-commerce and cloud services with its Amazon Web Services business.

And although Netflix is facing increasing competition from Hulu and fellow FANG stocks — particularly Amazon and YouTube owner Google — its original programming and massive global expansion in 2016 have cemented its leadership in the streaming industry.

Check this page regularly for ongoing coverage of the latest FANG news and investing insight.

FANG Stocks News & Quotes

Amazon, Google, Wal-Mart Fight For The Key To Your Smart HomeThe hottest smart-home purchase this holiday season is likely to be a smart video doorbell. As many as 14% of U.S. households with broadband access say they're pretty likely to buy the... Read More
Technology Stocks Lead Market To Record Highs; What Else Did, Too?The main indexes got back to making new highs Tuesday, a day that saw technology stocks underscore their market leadership. The Nasdaq composite — a technology gauge because of its heavy 47% weighting... Read More
Stocks Up Big As Apple Leads Dow; Is It Time To Buy This Top Internet Play?Apple paced a hearty gain for the Dow Jones industrial average at midday Tuesday, rising more than 2% to 173.49, amid a broad stock market rally. Apple is now extended past a... Read More
Google Aims Cloud Price Cuts At Artificial Intelligence, NvidiaAlphabet's Google has cut prices on cloud-computing services — including those that use superfast number-crunching processors from Nvidia — a week ahead of Amazon.com's annual conference for software developers. Google's cloud platform unit announced... Read More
How Hulu Live, YouTube TV Are Helping AT&T, Dish StreamingNeither Google nor Hulu's owners have disclosed subscriber numbers for their live TV streaming services, but Morgan Stanley says their success is helping give media companies a lift amid cable TV "cord-cutting."... Read More
Apple HomePod Speaker Delayed, Will Miss Holiday Shopping SeasonVoice-activated smart speakers are expected to be hot sellers this holiday shopping season, but Apple is going to miss out on the action. Apple revealed Friday that its HomePod speaker is being... Read More
Small Caps Up Big On Tax Plan; Can Cisco Follow Apple As A New Turnaround Play?U.S. stocks continued to hold strong gains in late afternoon trading Thursday following a passage of a Republican-led overhaul of the tax code in the House of Representatives. The Tax Cuts and... Read More

RELATED:

Apple Stock Quotes & News

Tesla Stock Quotes & News

More Tech Stock News

Best Stocks To Buy And Watch


10. Amazon (AMZN) Stock Quotes, Company News And Chart AnalysisСр., 22 нояб.[−]

XAutoplay: On | Off


View AMZN Stock Quote Page
| View AMZN Ratings

Amazon Stock News & Analysis

Amazon, Google, Wal-Mart Fight For The Key To Your Smart HomeThe hottest smart-home purchase this holiday season is likely to be a smart video doorbell. As many as 14% of U.S. households with broadband access say they're pretty likely to buy the... Read More
Amazon Scores Two Price-Target Hikes As Business Optimism GrowsE-commerce leader Amazon.com received two price-target hikes Monday on expectations of a strong holiday sales season and increased optimism about its competitive position. Nomura analyst Simeon Siegel raised his price target on... Read More
Why Amazon.com Deserved Exceptional Treatment On LeaderboardThe longer a stock climbs, the less likely it is to start a big new advance. That's the basic premise of separating and counting the bases that a winning stock makes over... Read More
Apple HomePod Speaker Delayed, Will Miss Holiday Shopping SeasonVoice-activated smart speakers are expected to be hot sellers this holiday shopping season, but Apple is going to miss out on the action. Apple revealed Friday that its HomePod speaker is being... Read More
Why Wal-Mart, Cisco And GM Are The New 'Growth' Stocks; S&P 500 FuturesFutures for the S&P 500 index and Dow industrials fell slightly vs. fair value Friday morning. Nasdaq 100 futures were fractionally higher. The S&P 500 index and other major averages soared Thursday... Read More

More Technology Stocks Coverage

FANG Stocks News: Facebook, Amazon, Netflix, Google

Apple (AAPL) Stock Quotes And Company News

Tesla (TSLA) Stock Quotes And Company News

View More Tech Stocks


11. Why FCC Net-Neutrality Reversal Could Later Be Reversed AgainСр., 22 нояб.[−]

The Republican-led Federal Communications Commission may overreach in dismantling Obama administration net-neutrality rules, thereby fueling a future counter-reversal by a Democratic majority agency, says a longtime cable TV industry analyst.

XAutoplay: On | OffCraig Moffett, analyst at MoffettNathanson, says FCC Chairman Ajit Pai jettisoned some pre-Obama existing internet rules, such as equal treatment of web content, that could go beyond the pale.

"To judge by the public commentary, even the (service providers) themselves seem to suspect that this seeming good fortune will prove transitory. A more limited reversal might have stood a better chance of standing for a while," Moffett said in a note to clients.

"One obvious problem with anything out of the FCC on what has become such a hyperpartisan topic is that it can so easily be reversed by the next (Democratic) FCC," he added.

Most observers had expected Pai would eliminate so-called "Title 2" regulations brought by the FCC under President Obama that put internet service providers in the same camp as public utilities. Few expected Pai to reach beyond Obama-era enforcement.

The FCC will vote on Pai's proposal at its Dec. 14 meeting. Pai says the changes will encourage more broadband investment by service providers.

Net-neutrality rules have been a political hot potato for over a decade. They've focused on consumer access to websites, the speed of web connections, and whether internet service providers can charge content firms or business partners for superior network performance.

Back-and-forth regulatory shifts may not be what investors or broadband service providers need, says Moffett.

"One can't imagine that there are any broadband providers who would be eager to test the limits of what is now allowable under this regulatory regime, given the enormous risk of popular and/or regulatory or legislative backlash," he said.

Comcast ( CMCSA), in a statement on Tuesday, noted: "Independent of any FCC action, Comcast's commitment to our customers remains the same: We do not and will not block, throttle, or discriminate against lawful content."


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


Under Pai's proposal, service providers may be able to charge content providers or business partners fees for "prioritized" services. Some regulatory authority on consumer protection would shift to the Federal Trade Commission.

Pai says new "transparency" rules requiring policy disclosures by service providers will protect consumers.

Moffett says it is unlikely Congress will step in to deal with net-neutrality issues on a bipartisan basis.

RELATED:

Why AT&T's Antitrust Battle May Quash Other Media Megamergers

How Hulu Live, YouTube TV Are Helping AT&T, Dish Streaming

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting


12. Hewlett Packard Enterprise's Whitman To Step Down; Shares SlideСр., 22 нояб.[−]

Hewlett Packard Enterprise ( HPE) offered a turbulent earnings report Tuesday as it announced that Chief Executive Meg Whitman will step down on Feb. 1 and forecast current quarter earnings that would fall below views — all amid a company restructuring.

XAutoplay: On | OffThe company said Antonio Neri, who was named company president in June, will replace Whitman. For the January quarter, HPE forecast adjusted earnings of 22 cents a share at its midpoint of guidance vs. estimates of 28 cents.

The result was that shares in the maker of servers, networking and data storage hardware fell 6% to 13.25 in after-hours trading on the stock market today.

Whitman will remain on HPE's board of directors, the company said. Before running HPE, Whitman won kudos as the CEO of eBay ( EBAY). Whitman had been in the running to be Uber's new CEO until the ride-sharing service named Expedia's ( EXPE) Dara Khosrowshahi. Even before the Uber position opened up, there had been speculation that Whitman could leave in a few quarters.

HPE is battling Cisco Systems ( CSCO) and Dell Technologies ( DVMT), which acquired data storage systems maker EMC last year, as corporate spending on information technology infrastructure slows down.


IBD'S TAKE: Hewlett Packard Enterprise has done little to boost its shares since going public in November 2015. It engaged in a series of cup bases before working two flat bases, the second of which it's in now. HPE ranks 32nd among companies in IBD's Computer-Tech Services Group with Epam Systems ( EPAM) at the top of the list.


HPE reported fiscal fourth-quarter adjusted earnings of 31 cents a share, above estimates. Earnings fell 49% from a year ago. Revenue fell 37% to $7.8 billion but still beat expectations.

A year earlier, HPE earned 61 cents a share on sales of $12.48 billion. Analysts expected HPE to report earnings of 28 cents on sales of $7.75 billion for the period ended Oct. 31.

HPE in August completed the sale of its software business to U.K.-based Micro Focus International. HPE earlier spun off its enterprise services business, which merged with Computer Sciences to create DXC Technology ( DXC).


13. Baozun Third-Quarter Results Beat Estimates On Sales, EarningsСр., 22 нояб.[−]

Chinese e-commerce services provider Baozun ( BZUN) reported third-quarter results after the market close Tuesday that beat consensus estimates on the top and bottom line.

XAutoplay: On | OffBaozun reported adjusted earnings of 9 cents per share, beating analyst views for 8 cents, as polled by Thomson Reuters. It reported revenue of $133.8 million, beating the estimate of $132.1 million and up 19% from the year-ago period.

Baozun shares were down 4%, near 34 during after-hours trading in the stock market today. The company held its initial public offering in May 2015, pricing shares at 10.


IBD'S TAKE: There are plenty of places on Investors.com to research and find top stocks, such as IBD'S reporting on the best Chinese stocks to buy and watch.


Shanghai-based Baozun was founded in 2007. It offers services such as information technology, digital marketing, customer services, warehousing and fulfillment that enable companies to sell goods online.

RELATED:

Tencent Third-Quarter Results Top Estimates For Sales, Profits

Alibaba Pushes Deeper Into Retail With $2.88 Billion Investment


14. Salesforce.com Earnings Beat, But Guidance Light As Stock SlidesСр., 22 нояб.[−]

Salesforce.com ( CRM) late Tuesday reported adjusted third-quarter profit and revenue that topped expectations, but it offered a profit outlook for the current quarter that was slightly disappointing to investors.

XAutoplay: On | Off Shares in the leader of software-as-a-service cloud computing were down a fraction to 108.10 in after-hours trading on the stock market today.

Salesforce.com said third-quarter earnings were 39 cents a share, up 62% from a year ago, with revenue rising 25% to $2.68 billion, topping consensus estimates. A year earlier, Salesforce.com earned 24 cents a share on sales of $2.14 billion. Analysts expected Salesforce.com to report earnings of 37 cents on sales of $2.65 billion for the period ended Oct. 31.

For the current quarter that ends in January, Salesforce.com forecast adjusted earnings of 32 cents to 33 cents a share vs. estimates of 34 cents a share.

Salesforce.com also forecast billings, a sales growth metric, below views, noted Abhey Lamba, a Mizuho Securities analyst, in a note to clients. He says guidance could be conservative.

"Management had guided the Q3 billings growth rate to be in the 7% to 10% range but it eventually delivered results in the mid-20s," Lamba said in a note.

Salesforce.com said it expects revenue to grow 23% to a range of $2.801 billion to $2.811 billion. Analysts had projected sales of $2.79 billion.

The company's cloud software helps businesses organize and handle sales operations and customer relationships. Salesforce.com earlier this month forecast 20%-plus organic revenue growth through 2022 annual Dreamforce customer conference.

Shares rose 1.3% to 108.80 on Tuesday's regular session. Salesforce.com shares have shot up nearly 58% in 2017.


15. Biotech Spikes After Settling Debate Over Its Seizure MedicineСр., 22 нояб.[−]

GW Pharmaceuticals ( GWPH) settled a debate Tuesday on whether its cannabinoid seizure drug, Epidiolex, is only effective in a combination — prodding shares to an eight-month high on successful data.

XAutoplay: On | OffBy the closing bell on the stock market today, GW soared by 11.1% to 127.54.

The firm is testing Epidiolex in patients with what's known as Lennox-Gastaut syndrome, a type of epilepsy that affects children. Prior tests were in patients already receiving an approved drug called clobazam.

Late Monday, GW posted an abstract, or data, ahead of the American Epilepsy Society meeting in December. Of those on Epidiolex and clobazam, 45% responded vs. 19% on a placebo. In patients on Epidiolex alone, 35% responded vs. 13% for the placebo group.

"The importance of the abstract stems from a Wall Street debate regarding how much of Epidiolex's efficacy is driven by a potentiation of another anti-epileptic, clobazam," Leerink analyst Paul Matteis said in a note to clients.

Epidiolex is known as a cannabinoid, meaning it's derived from the cannabis plant. The Food and Drug Administration hasn't approved any drug containing or derived from the whole cannabis plant, though it has approved several cannabinoid-based medicines derived from synthetics that operate similar to cannabis.

Matteis noted the difference between patients who responded to Epidiolex and placebo responders is clinically meaningful. Various other drugs show the Food and Drug Administration sees a 10% drug-placebo difference as clinically meaningful.

"As for physicians in a commercial setting, we think the results clearly justify the use of Epidiolex whether or not clobazam is present as a background therapy," he said.


IBD'S TAKE: GW has an IBD Composite Rating of 29, meaning it performs in the bottom third of all stocks in terms of key growth metrics. Better-rated biotechs have CRs closer to 99, the top rating. Head to IBD Stock Checkup for a look at stronger stocks.


GW also presented a long-term safety study for Epidiolex in patients with Dravet syndrome, a type of epilepsy that begins around six months of age. The study had 264 patients who rolled over from Phase 3 studies.

At the time of the analysis — 16 months into the study — 75 patients had withdrawn, but only 17 due to adverse events. Monthly convulsive and total seizure reductions from baseline deepened to 57%-59% at week 60 from 37%-39% at week 12.

In patients with Lennox-Gastaut, 366 patients were rolled into long-term studies. Of those, 67 total had withdrawn at 16 months. There was no color on why those patients withdrew. Monthly and total seizures declined 62%-70% from baseline at week 60, from 47%-48% at week 12.

"While the efficacy results should be interpreted with some caution due to their single-arm nature, the data, alone with the relatively high retention rate out past one year, are both encouraging," Matteis said.

He has an outperform rating on GW stock.

RELATED:

This Beer-And-Wine Giant Is Buying A Little Bit Of WEED

Zogenix Stock Nears 7-Year High On Excitement Over Epilepsy Drug

Biotech Nearly Triples On Seizure Drug, Hitting Rival GW Pharma


16. Tesla Could Rocket To New Highs, Then Collapse: Morgan StanleyСр., 22 нояб.[−]

Expect Tesla ( TSLA) shares to be extremely volatile in 2018, as shares could hit a record high of 400 before facing headwinds and collapsing, a Morgan Stanley analyst said Tuesday.

XAutoplay: On | OffIn a note to clients, analyst Adam Jonas maintained an equal weight rating on Tesla with a price target of 379. But it came with a warning.

"From a shorter-term trading perspective, we anticipate Tesla's stock price may reach highs in the range of $400 or more over the next few months before facing some more serious headwinds later in the year that could take the stock significantly below current levels," Jonas wrote.

Tesla shares gained 2.9% to close at 317.81 on the stock market today. Tesla's record high of 386.99 was set on June 23.

Jonas estimates Tesla shares could rise to 400 as it resolves battery production issues and alleviates other bottlenecks that have slowed production of the Model 3. But shares could fall to 200 due to mounting concerns that Tesla might lose its competitive position, he wrote.

Tesla shares rose Friday following the splashy debut Thursday evening of a futuristic big-rig truck and a new sports car, at a time when the company is burning cash and hasn't met delivery schedules for its new Model 3.

Equity analysts who follow Tesla seemed impressed by the splashy product announcements overall but also expressed concerns about production on the Model 3 and the way Tesla used the event as a cash-raising opportunity.


IBD'S TAKE: Despite skeptics and safety questions, the era of electric cars and trucks and self-driving vehicles is clearly underway. Automakers and tech companies are plowing billions of dollars into research and forging alliances in a rush for the inside lane on the automobile's most revolutionary track since the Model T.


Taking a more optimistic view on Tesla was Nomura analyst Romit Shah who, on Monday, reiterated a buy rating on Tesla and price target of 500.

"Ultimately, we believe Thursday's event will only further strengthen Tesla's brand and luxury appeal," Shah wrote in a research note to clients. "And while the business model and operations still need figuring out, we believe that Tesla has expanded its addressable opportunity by tens of billions of dollars, thus, paving the way for exponential revenue growth potential for at least the next five years," Shah wrote.

Tesla reported third-quarter results on Nov. 1 that missed earnings expectations by a wide margin and revealed that production woes with its new Model 3 continue.

RELATED:

Tesla's Electric Truck Arrives Amid 'Production Hell,' Hot Competition

Tesla Stock Quotes, Company News And Chart Analysis


17. Medtronic Surges After Topping Quarterly Earnings ViewsСр., 22 нояб.[−]

Medtronic ( MDT) surged to a three-month high Tuesday after the No. 1 medical devices-maker topped fiscal second-quarter earnings views and reported revenue from heart valve replacements grew by more than a third.

XAutoplay: On | OffBy the closing bell on the stock market today, Medtronic surged 4.8% to close at 82.66. Meanwhile, shares of Edwards Lifesciences ( EW) — Medtronic's key rival in what's known as transcatheter aortic heart-valve replacements — lifted 2.2% to finish the regular trading day at 109.52.

For its fiscal second quarter, Medtronic reported adjusted income of $1.07 per share on $7.05 billion in sales. Revenue was in line with Medtronic's pre-announcement and beat views for $6.96 billion. Earnings crushed the consensus for 99 cents.

On a year-over-year basis, both metrics declined 4%, Medtronic said in a release. Adjusting for foreign exchange rates, divestitures and the impact of Hurricane Maria, revenue and earnings would have climbed 4% and 5%, respectively.

The firm's cardiac and vascular group posted $2.77 billion in sales, up 7%. This was helped by sales of transcatheter aortic heart valves, or TAVR, which grew by a "high-thirties" percentage. TAVR is a method of repairing a damaged heart valve without resorting to open-heart surgery.


IBD'S TAKE: In the biotech sector, large-caps struggled during the quarter as smaller firms led the way, outperforming expectations. Head to the Industry Snapshot for a breakdown on the quarter.


Edwards rivals Medtronic in TAVR. Boston Scientific ( BSX) doesn't have a product approved in the U.S., but is expected to re-enter the European market in early 2018 after recalling its product due to problems with its locking mechanism.

Minimally invasive and restorative therapies groups split a $55 million to $65 million impact from Hurricane Maria, which bashed Puerto Rico during the quarter. On a comparable basis, sales from those groups grew 2% apiece.

The firm reiterated its guidance for constant-currency sales growth of 4%-5% in fiscal 2018, and adjusted profit per share growth of 9%-10%.

RELATED:

How These Rivals Could Take A Chunk Of Medtronic's Heart-Unit Sales

How Electricity Could Replace Opioids In Treating Chronic Pain

Edwards Lifesciences Crashes After Heart Valve Sales Miss Lofty Views


18. Apple iPhone X Supply Catching Up With Demand; Some Balk At PriceСр., 22 нояб.[−]

Apple's ( AAPL) production of the iPhone X smartphone is starting to catch up with demand — as evidenced by shorter delivery wait times — but the high price of the premium handset also could be repelling some consumers, one investment bank says.

XAutoplay: On | OffExpected delivery dates for the iPhone X when ordered from Apple's website have shrunk to 2-3 weeks from 3-4 weeks recently, Rosenblatt Securities analyst Jun Zhang said in a note to clients on Tuesday. He chalked that up to Apple ramping up production as well as consumer pushback to the device's price tag, which starts at $999.

"We continue to believe that the high price points remain a significant concern with consumers," Zhang said.

He believes Apple might bring down the cost of the iPhone X by offering a version with an LCD screen instead of an OLED screen next year. That LCD-screen handset could be called the iPhone 8S, he said.

Consumers also appear to be skipping the company's midrange iPhone 8 series handsets in favor of less expensive, year-old iPhone 7 series handsets, Zhang said.


IBD'S TAKE: Apple stock has an IBD Composite Rating of 89, meaning it has outperformed 89% of stocks in key metrics over the past 12 months. For more analysis on Apple, visit the IBD Stock Checkup.


"Our research suggests Apple increased iPhone 7/7 Plus production before the holiday season by 3 to 4 million units but also cut iPhone 8 production by the same amount for December," Zhang said. "In our view the average, mid-end consumer is choosing an iPhone 7 over the iPhone 8, whereas high-end consumers are more likely to choose an iPhone X."

Zhang reiterated his buy rating on Apple stock with a price target of 180.

Apple shares gained 1.9% to close at 173.14 on the stock market today.

RELATED:

Apple HomePod Speaker Delayed, Will Miss Holiday Shopping Season

Apple Could Reach $1 Trillion Market Cap In 2018, Analyst Says


19. Shares Of Chinese Online Credit Providers Crash Over Crackdown FearsСр., 22 нояб.[−]

Shares of Qudian ( QD), Yirendai ( YRD) and other China-based providers of online credit plunged Tuesday on reports that China's Internet Financial Risk Management Group had ordered a suspension of online small-loan approvals, but some stemmed their losses by session's end and others even gained ground.

In addition to Qudian and Yirendai, also falling were China Rapid Finance ( XRF) and PPDAI Group ( PPDF).

XAutoplay: On | OffShares of Qudian, which is backed by Alibaba Group ( BABA) affiliate Ant Financial, lost 3.8% to close at 19.31 on the stock market today. Qudian says it's the largest online provider of small-cash credit products in China in terms of active borrowers and transactions. Qudian held its initial public offering in October with American depositary receipts priced at 24.

Yirendai, which facilitates loans on a peer-to-peer platform, dipped 0.4% to close at 44.90%. Consumer lending company China Rapid Finance, which was down 8% at one point, came all the way back to gain 3.3% and close at 9.43. It came public in April with shares priced at 6.


IBD'S TAKE: There are plenty of places on Investors.com to research and find top stocks, but when you're looking to get a broader idea on top tech stocks, IBD's Tech Leaders feature is worth reviewing.


PPDAI, however, plunged, losing 14% to close at 10.80. It came public on Nov. 10, with shares priced at 13. The company provides a peer-to-peer online lending platform.

In January, Chinese authorities said they were planning to tighten regulation of its fast-growing internet finance industry and crack down on illicit transactions, said a report from Reuters. The rapid expansion of consumer loans, especially small loans available through online microloan platforms, has raised concerns among financial regulators.

RELATED:

Best Chinese Stocks To Buy And Watch


20. Analog Devices Posts Beat-And-Raise Quarterly ResultsСр., 22 нояб.[−]

Chipmaker Analog Devices ( ADI) early Tuesday beat Wall Street's targets for its fiscal fourth quarter and guided higher for the current quarter.

XAutoplay: On | Off

Analog Devices earned an adjusted $1.45 a share, up 38% year over year, on sales of $1.54 billion, up 54%, in the quarter ended Oct. 28. Analysts expected $1.37 and $1.5 billion.

For the current quarter, Analog Devices expects to earn an adjusted $1.28 a share on sales of $1.49 billion, based on the midpoint of its guidance. Wall Street was modeling $1.17 and $1.46 billion.

Analog Devices shares fell 3.1% to close at 90.19 on the stock market today. On Monday, Analog Devices stock reached a 17-year high of 93.99.

"The fourth quarter of 2017 drove a strong finish to the fiscal year, with high-quality revenue growth and operational execution that expanded gross and operating margins, and delivered stellar earnings per share growth," Analog Devices Chief Executive Vincent Roche said in a news release.

The Norwood, Mass.-based company makes mixed signal and digital signal processing chips.

RELATED:

Broadcom Gets Price-Target Hikes After Closing Brocade Deal

Marvell To Buy Cavium For $6 Billion, Creating Chip Powerhouse


21. HP Inc. Disappoints With In-Line Earnings And GuidanceСр., 22 нояб.[−]

Personal computer and printer maker HP Inc. ( HPQ) late Tuesday posted in-line earnings on better-than-expected sales for its fiscal fourth quarter and offered an outlook for the current quarter that met Wall Street views.

HP earned an adjusted 44 cents a share, up 22% year over year, on sales of $13.9 billion, up 11%, in the quarter ended Oct. 31. Analysts expected earnings of 44 cents a share on sales of $13.25 billion, according to Zacks Investment Research.

For the current quarter, HP expects to earn an adjusted 42 cents a share, up 11%, based on the midpoint of its guidance. It did not give a revenue target. Wall Street was modeling HP to earn an adjusted 42 cents a share on sales of $12.85 billion in its fiscal first quarter.


IBD'S TAKE: HP stock has a middling IBD Composite Rating of 59 out of 99. For more analysis on HP and its peers, visit the IBD Stock Checkup.


HP shares were down 5.5% in after-hours trading on the stock market today. During the regular session, HP rose 1.5% to 22.46.

"Our results demonstrate that HP is strong and getting stronger" HP Chief Executive Dion Weisler said in a news release. "We posted top-line growth across both Personal Systems and Print, with broad-based, double-digit growth in all three regions, while also growing operating profit and non-GAAP EPS year-over-year."


22. Chipmakers Marvell, Cavium Continue To Soar On Merger NewsСр., 22 нояб.[−]

Chipmakers Marvell Technology Group ( MRVL) and Cavium ( CAVM) continued to see their stocks climb on Tuesday, a day after Marvell announced a cash-and-stock deal to buy Cavium.

Marvell jumped 7.8% to close at 23.28 on the stock market today. Cavium climbed 3.8% to finish at 87.20 on Tuesday. On Monday, after the deal was announced, Marvell rose 6.4% and Cavium jumped 10.8%.

Marvell agreed to pay $40 per share in cash and 2.1757 Marvell common shares for each Cavium share. The rising value of Marvell's stock has upped the purchase price to about $90.65 per Cavium share, vs. the $80 per share value Marvell first announced.

The deal now values Cavium at $6.27 billion, up from $6 billion initially.


IBD'S TAKE: Cavium is currently ranked No. 20 on the IBD 50 list of top-performing growth stocks.


Wall Street analysts applauded the deal. Marvell received three stock rating upgrades to buy from hold, plus at least three price-target hikes from other analysts.

Oppenheimer analyst Rick Schafer was among the most bullish of the group. He reiterated his outperform rating and raised his price target to 30 from 23.

"Strategically, acquiring Cavium increases Marvell's exposure to the data-center/networking markets, creating a robust portfolio to better compete against powerhouse Broadcom ( AVGO)," he said in a note to clients. "Financially, we see the deal as a strategic use of Marvell's $1.6 billion in cash."

RELATED:

Marvell To Buy Cavium For $6 Billion, Creating Chip Powerhouse


23. Will FCC Net Neutrality Reversal Open Door To Internet Fast Lanes?Ср., 22 нояб.[−]

Internet service providers such as AT&T ( T), Comcast ( CMCSA) and Verizon Communications ( VZ) could get a bigger-than-expected lift from overhauled net neutrality rules under a preliminary proposal from Ajit Pai, chairman of the Federal Communications Commission.

Pai let trickle some key elements of his proposal via a commentary piece he wrote that appeared in The Wall Street Journal on Tuesday. As expected, Pai proposed that the telecom agency eliminate public-utility-type Title 2 regulations that were foisted on internet service providers by the Obama administration. The Title 2 rules are part of the Communications Act of 1934.

Pai may in principle retain rules that bar ISPs from blocking or slowing web content, although they won't be enforced under Title 2 authority.

"I look forward to returning to the light-touch, market-based framework that unleashed the digital revolution and benefited consumers here and around the world," Pai said in a news release.

The Republican-led FCC will vote on Pai's proposal at its Dec. 14 meeting.

There's speculation Pai's proposal could open the door to these service providers to seek fees from content producers or business partners for internet "fast lanes" or "paid prioritization." That could be a significant revenue stream for companies like Comcast, Charter Communications ( CHTR), AT&T and Verizon.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


The details of Pai's proposal, which may include paid prioritization, are expected to be posted on the FCC's website Wednesday morning.

Pai is expected to propose getting rid of the Obama-era "general conduct" rule that gives the FCC broad power to police all broadband activity by internet service providers.

And, Pai proposed that the Federal Trade Commission re-asset its authority to protect consumer privacy in broadband services.

Comcast, in a statement released on Tuesday said: "(Pai's) proposal is not the end of net neutrality rules. With the FCC transparency requirement and the restoration of the FTC's role in overseeing information services, the agencies together will have the authority to take action against any (service provider) which does not make its open internet practices clearly known to consumers, and if needed enforce against any anti-competitive or deceptive practices."

RELATED:

Why AT&T's Antitrust Battle May Quash Other Media Megamergers

How Hulu Live, YouTube TV Are Helping AT&T, Dish Streaming

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting


24. Why AT&T's Antitrust Battle May Quash Other Media MegamergersВт., 21 нояб.[−]

The Department of Justice's antitrust battle with AT&T ( T) likely will quash near-term megamergers involving media companies, such as 21st Century Fox Entertainment ( FOXA), analysts say.

XAutoplay: On | OffOn the other hand, if AT&T winds up acquiring Time Warner ( TWX) as planned, more so-called vertical mergers involving media, telecom or internet companies might quickly follow in a new competitive landscape, they add.

The Trump administration's crackdown on AT&T will make other companies leery of making media acquisitions, says Andy Hargreaves, analyst at KeyBanc Capital Markets.

"The DOJ's lawsuit significantly increases uncertainty around the application of antitrust law. This is likely to dramatically slow the pace of M&A in media, and possibly other industries," Hargreaves said in a note to clients.

The Department of Justice announced Monday it is suing to block AT&T's merger with media giant Time Warner. The DOJ says the megamerger would be harmful to consumers because the combined company might extract higher prices for Time Warner content from other video distributors such as Dish Network ( DISH) or Charter Communications ( CHTR).

AT&T could also try to withhold content from emerging internet video rivals, such as Amazon.com ( AMZN) or Apple ( AAPL), asserts the DOJ.

Rupert Murdoch's 21st Century Fox has reportedly engaged in talks with Walt Disney ( DIS), Comcast ( CMCSA), Amazon, and Verizon Communications ( VZ), according to reports.

John Hodulik, a UBS analyst says Fox is unlikely to made a deal until the AT&T case is resolved.

"We expect the industry to be in a holding pattern pending final determination but continue to believe secular shifts will drive further M&A over the long-term," Hodulik said in his report.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


AT&T agreed to buy Time Warner for $85 billion in October 2016. AT&T has raised significant debt to finance the deal, notes a Wells Fargo report. AT&T aims for an expedited trial, with a court decision in 4 to 6 months.

The DOJ has asked AT&T to sell off Turner Broadcasting or its DirecTV satellite business to gain approval. AT&T says no divestitures are required by law. The DOJ says it's not interested in placing conditions on AT&T as it did on Comcast in 2011, when the cable TV firm bought NBCUniversal. The conditions on Comcast expire in 2018.

Craig Moffett, analyst at MoffettNathanson, in a report says the lawsuit's outcome will shape future M&A. If AT&T wins and no programming access conditions are placed on the deal, Moffett said: "The only feasible alternative for distribution competitors would be to acquire their own content, either to differentiate their services from AT&T's or, alternatively, to threaten mutually assured destruction if AT&T's (Time Warner) content were to be withheld."

RELATED:

AT&T Calls Out CNN Issue As DOJ Moves To Block Time Warner Deal

AT&T, Time Warner Deal In Distress? Video Market Analysis May Be Key

Could Softbank Take Sprint Private If T-Mobile Deal Is Dead?

Telecom Mergers: A 'Game Of Thrones' Without The Dragons


25. AT&T Calls Out CNN Issue As DOJ Moves To Block Time Warner DealВт., 21 нояб.[−]

AT&T ( T) CEO Randall Stephenson signaled late Monday that AT&T's legal battle vs. the Department of Justice will utilize comments made by President Trump directed at cable news channel CNN.

The Department of Justice announced Monday that it is suing to block AT&T's merger with media giant Time Warner ( TWX). The DOJ says the megamerger would be harmful to consumers.

President Trump has often complained on Twitter ( TWTR) about CNN's political coverage, raising questions over the Justice Department's actions.

Stephenson said the telecom will not sell CNN to win approval of the deal.

"Let me address the elephant in the room," Stephenson said on a conference call. "There's been a lot of speculation that this is all about CNN and frankly I don't know. But nobody should be surprised that the questions keep coming up because we've witnessed such as abrupt change in the application of antitrust law."

The DOJ has asked AT&T to sell off Turner Broadcasting or its DirecTV satellite business to gain approval.

Time Warner owns HBO, a movie studio, a stake in online video streamer Hulu, and several cable TV networks. Turner Broadcasting holds valuable sports broadcasting rights in addition to news channel CNN.

Stephenson said the DOJ is overestimating AT&T's market clout compared to internet giants such as Netflix ( NFLX), Amazon.com ( AMZN) and Alphabet's ( GOOGL) Google.

Makan Delrahim, head of the department's antitrust division, says U.S. consumers would be harmed by the merger.

"It would mean higher monthly television bills and fewer of the new, emerging innovative options that consumers are beginning to enjoy," said Delrahim, according to a Bloomberg report.

Delrahim had stated last year, prior to joining the DOJ, that he saw no issues big enough to halt the deal. But the DOJ's staff could have influenced Delrahim with fresh data, some analysts contend.

AT&T lashed back, calling the department's lawsuit to block the Time Warner purchase a "radical" departure from recent antitrust policy.

AT&T's position is that so-called "vertical" deals do not raise basic antitrust concerns. AT&T says its pay TV and wireless businesses do not compete with Time Warner's entertainment offerings. AT&T agreed to buy Time Warner for $85.5 billion in October 2016.

"Today's DOJ lawsuit is a radical and inexplicable departure from decades of antitrust precedent," David McAtee, AT&T senior executive vice president said in a prepared statement. "Fortunately, the Department of Justice doesn't have the final say in this matter. Rather, it bears the burden of proving to the U.S. District Court that the transaction violates the law. We are confident that the court will reject the government's claims and permit this merger under long-standing legal precedent."

The DOJ has said it's not interested in putting conditions on the deal, as it did in Comcast's ( CMCSA) acquisition in 2011 of NBCUniversal from General Electric ( GE).

Time Warner owns HBO, a movie studio, a stake in online video streamer Hulu, and several cable TV networks. Turner Broadcasting holds valuable sports broadcasting rights in addition to news channel CNN.

With Time Warner, AT&T aims to gain content that it can distribute over wireless networks. With AT&T's subscriber data, it had planned to provide targeted advertising.

AT&T shares, which closed up 0.4% to 34.64 on the stock market today, edged lower in late trading. Time Warner, which finished the regular session off 1.1% at 87.11, moved modestly higher after hours.


26. Amazon Scores Two Price-Target Hikes As Business Optimism GrowsВт., 21 нояб.[−]

E-commerce leader Amazon.com ( AMZN) received two price-target hikes Monday on expectations of a strong holiday sales season and increased optimism about its competitive position.

XAutoplay: On | OffNomura analyst Simeon Siegel raised his price target on Amazon to 1,360 from 1,000 and maintained a buy rating, while GBH Insights analyst Daniel Ives raised his target to 1,270 from 1,185.

Amazon shares finished the trading day down 0.3% to close at 1,126.31 on the stock market today. The shares are up 50% this year.

"Our retail checks on Amazon heading into holiday season have been incrementally stronger, based on our survey work, which lead us to believe the company could be on a trajectory to handily exceed Wall Street estimates in the fourth quarter," Ives wrote in a note to clients.

"While shares have had an eye-popping run to date, we believe there is more fuel left in the tank as Amazon only appears to be in the middle innings of an unprecedented growth cycle across both the consumer and enterprise segments," Ives wrote. He also based his price-target increase on expectations the integration of Whole Foods Market will provide significant growth opportunities.


IBD'S TAKE: Amazon is an IBD Leaderboard stock holding near highs as it sits virtually at the top of a buy range from a 1,083.41 buy point. The stock has been a big winner after a breakout from a 104.67 cup-with-handle buy point. Here's an analysis on why Amazon.com deserved exceptional treatment on leaderboard.


Siegel raised his price target on Amazon after re-evaluating the various Amazon businesses and investments, with expectations of stronger profits down the road.

"With nearly all retailers playing defense, the few willing and able to go on the offensive have been digging ever-increasing moats to take ever-increasing share," he wrote, in regards to Amazon.

RELATED:

Retail And E-Commerce News And Stocks To Watch

Wal-Mart Earnings Top As E-Commerce Sales Soar 50%


27. Alibaba Pushes Deeper Into Retail With $2.88 Billion InvestmentВт., 21 нояб.[−]

China e-commerce leader Alibaba ( BABA) on Monday said it will invest $2.88 billion for a 36.16% stake in Hong Kong-based Sun Art Retail as part of a strategic alliance to expand opportunities in the nation's food and grocery retailing sector.

XAutoplay: On | OffSun Art Retail operates 446 "hypermarket complexes" in 224 cities across 29 provinces, regions and municipalities in China, under the RT-Mart and Auchan banners. As part of the deal, Alibaba formed a strategic alliance with Auchan Retail and Ruentex Group.

France-based Auchan Retail is an international food retailer that operates in 17 countries. Auchan will hold a 36.18% stake in the venture while Ruentex will hold a 4.67% stake. Alibaba's 36.16% stake in the venture was acquired from Ruentex.

Ruentex Group is led by billionaire Samuel Yin and owns a wide range of businesses in the retail, property development, textile, insurance and biomedical industries.

Alibaba said the partnership is part of its " New Retail" strategy that integrates online and brick-and-mortar retailing into a cohesive strategy to boost sales and convenience. Two years ago, Alibaba decided to start its own chain of supermarkets called Hema, of which there are now 18. Hema is a chain of digitized physical supermarkets where shoppers use a mobile app for online orders and in-store purchases of groceries or freshly prepared foods, as well as to research products while shopping, and to pay digitally or with facial recognition.

Alibaba shares climbed 1.6% to close at 188 on the stock market today, near its record high of 191.22 set on Nov. 2. Alibaba shares have more than doubled in price this year.


IBD'S TAKE: Alibaba is on the IBD Leaderboard list of top-performing stocks, with an IBD Composite Rating of 99 out of a possible 99. The stock is getting solid buying support at the 50-day moving average.


In June, Alibaba agreed to purchase an 18% stake in Hong Kong-listed Lianhua Supermarket with the aim of boosting business efficiencies and enhancing customer experience. Alibaba also led a $300 million, D-round investment in Yiguo.com, China's largest online provider of fresh produce, in August.

In September, Alibaba announced plans to invest $15.2 billion over the next five years to strengthen and expand its global logistics and delivery network.

RELATED:

Alibaba Kicks Off Festival Leading To Biggest Shopping Day Of Year

Best Chinese Stocks To Buy And Watch


28. Galapagos Pops To Vertex's Detriment — But Can It Compete?Вт., 21 нояб.[−]

Galapagos ( GLPG) stock popped Monday to Vertex Pharmaceuticals' ( VRTX) detriment after it figured out "one piece of its triple-combination puzzle" in treating cystic fibrosis, an analyst said.

XAutoplay: On | OffStill, Galapagos still has a long road to truly challenging Vertex in treating cystic fibrosis, according to Leerink analyst Geoffrey Porges. Vertex already has four potential triple-pill combos in midstage testing, whereas Galapagos just has one potential piece of its triple.

Late Sunday, Galapagos said its drug known as GLPG2222 was safe and tolerable in a group of patients with cystic fibrosis. The drug also helped reduce chloride in patients' sweat — a test of cystic fibrosis — and increased patients' ability to forcefully expel air.

But the lung function results were inferior to Vertex's results of tezacaftor plus ivacaftor in a failed Phase 3 trial, Porges said. On sweat chloride, GLPG2222 was inferior to Vertex's tezacaftor alone in a Phase 2 trial in the same patient population.

"There is a vast amount of work in front of Galapagos and its potential partner AbbVie ( ABBV) to challenge Vertex in this category," he said. "These results do not yet compel us to alter our cystic fibrosis market."


IBD'S TAKE: Vertex started out in hepatitis C, but its efforts were dampened by Gilead Sciences' massive hepatitis C franchise. So it moved onto cystic fibrosis. See what transitioned the firm from its "crisis" by visiting The New America.


Porges currently forecasts Galapagos having a 25% chance of success in cystic fibrosis, and maintained an outperform rating and 179 price target on Vertex. Vertex is planning to use its drugs tezacaftor and ivacaftor as a backbone for its triple.

By the closing bell on the stock market today, Galapagos lifted 2.8% to end the trading day at 93.39. Vertex dipped 1.9% to finish at 144.64.

RELATED:

Why Roche Cancer Trial Is Kick In The Teeth For Dow Stock Merck

Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'

Three Biotech Firms Top Third-Quarter Views — But Only One Pops


29. Broadcom Gets Price-Target Hikes After Closing Brocade DealВт., 21 нояб.[−]

Chipmaker Broadcom ( AVGO) received a pair of bullish reports after closing its acquisition of Brocade Communications Systems on Friday.

XAutoplay: On | OffBMO Capital Markets on Monday resumed coverage of Broadcom with an outperform rating and a price target of 330. RBC Capital Markets reiterated its "top pick" buy rating on Broadcom and raised its price target to 315 from 300.

BMO analyst Ambrish Srivastava is upbeat about Broadcom's next planned acquisition, the proposed takeover of Qualcomm ( QCOM). On Nov. 13, Qualcomm rejected Broadcom's initial bid as too low.

"We see Broadcom continuing on its path of translating acquisitions into meaningful accretion to free cash flow and earnings," Srivastava said in a report. "We are positive on Broadcom's audacious bid for Qualcomm. We see Broadcom stock worth in the range of $410-450 if the proposed acquisition were to go through."


IBD'S TAKE: For the latest news on chip stocks, visit IBD's news page Chip Stocks To Watch And Semiconductor Industry News.


Broadcom's just-closed acquisition of Brocade will add $1.4 billion in annual revenue and $900 million in earnings before interest, taxes, depreciation and amortization, he said. Broadcom announced its $5.9 billion purchase of Brocade in November 2016.

Broadcom's acquisition of Brocade removes an uncertainty hanging over the company as it pursues Qualcomm, RBC analyst Amit Daryanani said in a report.

Broadcom is likely to initiate a proxy battle to acquire Qualcomm, but there is still room for the two companies to negotiate a deal, Daryanani said. Broadcom offered to pay $70 in cash and stock for each share of Qualcomm.

Broadcom shares climbed 1.1% to close at 274.88 on the stock market today. Qualcomm lost 0.4% to finish at 66.47.

RELATED:

Marvell To Buy Cavium For $6 Billion, Creating Chip Powerhouse

Qualcomm Rejects Broadcom's Buyout Offer, Says It's Undervalued


30. Why Roche Cancer Trial Is Kick In The Teeth For Dow Stock MerckВт., 21 нояб.[−]

Roche ( RHHBY) is now a "real competitor" with a potential first treatment in advanced lung cancer, an analyst said Monday after the drugmaker's immuno-oncology regimen hit its goals in a Phase 3 trial.

XAutoplay: On | OffIn early trading on the stock market today, Roche jumped 5.9% to close at 30.82, running up to its highest point since mid-October. Meanwhile, shares of Dow component Merck ( MRK), which has a rival combination, dropped 2% to finish at 54.10.

Top-line data show Roche's Tecentriq combined with cancer drug Avastin and chemotherapy provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death compared with a regimen of Avastin plus chemo.

Further details will be provided during an upcoming medical conference in December, Roche said. Overall survival data aren't mature yet, but are encouraging and expected in the first half of 2018, the firm said.

The results are a mixed bag for Merck. Merck received accelerated approval in May to use its immuno-oncology drug Keytruda with chemo to treat advanced lung cancer.

Keytruda and Tecentriq are both immuno-oncology drugs, respectively, a PD-1 inhibitor and a PD-L1 inhibitor. Evidence has suggested these drugs could work better in a population of patients whose bodies make more of a protein called PD-L1.

In October, Merck pulled its application for its regimen in Europe and delayed a key study of the combination. This move led analysts to question whether there's an ongoing issue with the regimen. Merck stock dipped to a 17-month low on the worries.


IBD'S TAKE: Big biotech players struggled during the third quarter, but smaller caps enjoyed major sales beats led by Exelixis ( EXEL) and Neurocrine Biosciences ( NBIX), which topped views by $48.5 million and nearly $36 million, respectively. Read the Industry Snapshot for a deeper dive on the third quarter.


But Roche's trial helps to confirm the theory that an immuno-oncology plus chemo regimen can succeed in a broad population of patients with advanced lung cancer, regardless how much of that protein their bodies make, Leerink analyst Seamus Fernandez said.

It's not clear whether Avastin has any real benefit on the combination, Fernandez wrote in a note to clients. Avastin is approved as a first treatment in a form of advanced lung cancer, but isn't widely used and isn't well tolerated, he said.

Avastin-based regimens are used as first treatments in an estimated 10%-20% of lung cancer patients vs. Eli Lilly's ( LLY) drug Alimta, which is used in 50%-60%, he said. Merck discontinued pursuit of an Avastin-based regimen on safety concerns and, instead, gained approval with Lilly's drug.

"To us, this result is more a validation of the benefits of immuno-oncology plus chemo combinations and is most positive for Roche given Tecentriq's position in our model as the third or perhaps even fourth player in the PD-1/PD-L1 market by sales," he said.

Evercore analyst Umer Raffat agreed, noting the news solidifies Roche's regimen as a "real competitor" in treating advanced lung cancer.

RELATED:

This Biotech Just Neared A 17-Year High On Strong Cancer Regimen

How These Rivals Could Take A Chunk Of Medtronic's Heart-Unit Sales

Biotechs Sell Off In Droves — Are Investors Seeking Mergers?


31. BitAuto Third-Quarter Results Beat On Revenue, Miss On EarningsВт., 21 нояб.[−]

China-based BitAuto ( BITA) reported third quarter results before the market open Monday that beat revenue estimates but missed on the bottom line.

XAutoplay: On | OffBitAuto reported revenue of $352.4 million, beating the consensus estimate of $334 million and up 54% from the year-ago period.

It reported adjusted earnings of 23 cents, missing the consensus estimate of 33 cents, as polled by Zacks Investment Research.

BitAuto shares fell 3.9% to close at 37.61 on the stock market today. The shares are down 30% since hitting a record high of 54.42 on Oct. 17.

For the fourth quarter, BitAuto said it expects revenue in the range of $360.7 million to $368.2 million, above the Zacks consensus of $331 million.


IBD'S TAKE: BitAuto follows the strong earnings reports from JD.com ( JD) and Tencent Holdings ( TCEHY), which are among the best Chinese stocks to buy and watch.


Beijing-based BitAuto is a leading provider of online data and services for China's fast-growing automotive industry

RELATED:

JD.com Stock Jumps As Quarterly Earnings Beat Estimates

Tencent Third-Quarter Results Top Estimates For Sales, Profits


32. Verizon Upgraded On More Rational Wireless Outlook, DividendВт., 21 нояб.[−]

Verizon Communications ( VZ) will get a lift if wireless competition eases up, says one analyst who upgraded the phone company's shares and raised her price target.

XAutoplay: On | OffJennifer Fritzsche, a Wells Fargo analyst, raised her price target on Verizon to 50 from 48 and to outperform on its dividend outlook.

"In our view, much of the bad news is behind the stock in terms of wireless service revenue declines," Fritzsche said in a note to clients.

"A more rational environment in wireless most benefits Verizon," said Fritzsche because wireless is 68% of its total revenue.

Shares in Verizon climbed 1.7% to close at 46.20 on the stock market today. Dow component Verizon is down 14% in 2017. AT&T ( T) is down nearly 19%.


IBD'S TAKE: Verizon and AT&T both offer high dividends, but there are other options, such as real estate investment trusts (REITs) and banks. Check out IBD's Income Investor for high-dividend-paying stocks. The Federal Reserve is expected to continue hiking interest rates in 2018, a negative for dividend paying stocks.


While Sprint ( S) and T-Mobile US ( TMUS) have broken off merger negotiations, Fritzsche says Verizon could benefit if wireless firms hold back on aggressive promotions.

"We think Verizon is an attractive yield play, with its 5.3% dividend yield nearly 100 basis points above its long-term average," added Fritzsche. "We expect Verizon to grow free cash flow nearly 6% in 2018 as working capital headwinds from device purchases moderate, service revenue stabilizes and pension funding requirements drop."

RELATED:

T-Mobile Buyback Could Be Fallout From Sprint Deal Collapse

Why AT&T's Time Warner Woes Bode Poorly For Comcast Deal With Fox

Telecom Stocks To Watch And Industry News

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting


33. Financial Software Firm Intuit Beats Quarterly Estimates, Guides UpВт., 21 нояб.[−]

Accounting and tax software maker Intuit ( INTU) late Monday reported fiscal first-quarter results that beat Wall Street's targets and guided higher for the current quarter. But investors sold the news in extended trading.

XAutoplay: On | OffIntuit posted adjusted earnings per share of 11 cents, up 83% year over year, on sales of $886 million, up 14%, in its quarter ended Oct. 31. Analysts were expecting Intuit to report adjusted earnings of 5 cents a share on sales of $855 million, according to Zacks Investment Research.

For the current quarter, Intuit expects to earn an adjusted 33 cents a share on sales of $1.17 billion, based on the midpoint of its guidance. Wall Street was modeling for 31 cents and $1.12 billion.

Intuit shares fell 1.2% in after-hours trading on the stock market today. During the regular session, Intuit stock hit an all-time high of 158.90. It ended the session up 0.8% to 157.78.


IBD'S TAKE: Intuit stock has an IBD Composite Rating of 94, meaning it has outperformed 94% of stocks in key metrics over the past 12 months. For more analysis on Intuit, visit the IBD Stock Checkup.


Mountain View, Calif.-based Intuit makes financial software, including QuickBooks and TurboTax, for consumers, small businesses and tax professionals.

Intuit credited QuickBooks Online subscriber growth for the October-quarter beat. It ended the quarter with 2.55 million QuickBooks Online subscribers, up 56%.

"QuickBooks Online subscriber growth continues at a rapid pace and online ecosystem revenue is accelerating for small business and self-employed," Intuit Chief Executive Brad Smith said in a news release. "Gearing up for the tax season, we are focusing on delivering an outstanding end-to-end customer experience for the do-it-yourself taxpayers while rolling out new solutions to our customers."


34. Google Aims Cloud Price Cuts At Artificial Intelligence, NvidiaВт., 21 нояб.[−]

Alphabet's Google ( GOOGL) has cut prices on cloud-computing services — including those that use superfast number-crunching processors from Nvidia ( NVDA) — a week ahead of Amazon.com's ( AMZN) annual conference for software developers.

XAutoplay: On | OffGoogle's cloud platform unit announced the price cuts in a blog. According to website Tech Crunch, Google cut prices by as much as 36% for customers that rent Nvidia's superfast "GPU" processors. Using Nvidia's most advanced processors will cost $1.46 per minute, said Tech Crunch.

Cloud service providers are battling to provide superfast computer processing as artificial intelligence software proliferates. Google aims to help cloud customers become more competitive using data analytics and AI tools. Nvidia's electronic chips are well-suited for AI's need for parallel-processing, analysts say.

Amazon Web Services' conference kicks off on Nov. 27. AWS is by far the biggest provider of cloud computing services, where companies rent computing resources, followed by Microsoft ( MSFT) and Google.

Since 2006, AWS has consistently slashed prices for cloud services, aiming to attract new customers that normally process business workloads in their own data centers. Google, a latter entrant in the market, has cut prices aiming to grab share from AWS and Microsoft.

Customers pay cloud service providers as little as pennies an hour per server or as much as $1-$2 an hour, depending on the type of workload.


IBD'S TAKE: Alphabet stock has been consolidating after climbing above a technical buy point of 1008.71. The stock is trading above its 50-day moving average, a positive sign. Learn more at IBD Stock Checkup.


AI software needs computing power to find patterns and make inferences from large quantities of data. IBM ( IBM), also a cloud services provider, recently said it will rent its quantum computing machine to customers.

Google, meanwhile, has recently announced cloud partnerships with Salesforce.com ( CRM) and Cisco Systems ( CSCO).

RELATED:

Here's One More Thing Amazon May Be Killing

Google Plays Catch-Up In The Cloud With Amazon And Microsoft

Google Bid For Salesforce.com Despite Amazon Cloud Pact?

Why Cisco Is Good Fit For Google's Push In Cloud Computing


35. Cybersecurity Firm Palo Alto Networks Earnings, Revenue BeatВт., 21 нояб.[−]

Palo Alto Networks ( PANW) late Monday reported fiscal first-quarter profit and revenue that topped estimates and forecast December-quarter earnings and sales slightly above views, sending shares in the cybersecurity firm higher.

XAutoplay: On | OffPalo Alto Networks said that Q1 adjusted earnings were 74 cents a share, up 34% from a year ago, with revenue rising 27% to $505.5 million, topping consensus estimates. A year earlier, Palo Alto Networks earned 55 cents a share on sales of $398 million. Analysts expected Palo Alto Networks to report earnings of 69 cents on sales of $489 million for the period ended Sept. 30.

In the December quarter, Palo Alto Networks said it expects to earn 79 cents a share, with revenue rising 24% to $523 million at its midpoint of guidance vs. estimates of 77 cents and $520 million.

Shares in the maker of computer security software jumped 6.8% to 152 in after-hours trading on the stock market today. Shares were down a fraction to 142.53 in Monday's regular session. Palo Alto Networks has gained 14% in 2017 as of Monday's market close.

Palo Alto Networks competes in the corporate security firewall market vs. Cisco Systems ( CSCO), Check Point Software Technologies ( CHKP) and Fortinet ( FTNT). Firewalls block unauthorized traffic from entering a private network. IBD's Computer-Software Security group ranks No. 128 out of 197 industry groups.


36. How Hulu Live, YouTube TV Are Helping AT&T, Dish StreamingПн., 20 нояб.[−]

Neither Google nor Hulu's owners have disclosed subscriber numbers for their live TV streaming services, but Morgan Stanley says their success is helping give media companies a lift amid cable TV "cord-cutting."

XAutoplay: On | OffBenjamin Swinburne, a Morgan Stanley analyst, estimates in a note to clients that Hulu Live has some 250,000 online subscribers while YouTube TV has 400,000. Alphabet's ( GOOGL) Google launched YouTube TV on April 5; Hulu Live started on May 3.

But incumbent pay-TV companies AT&T ( T) and Dish Network ( DISH) have the most TV streaming subscribers and are adding to those numbers. Leichtman Research Group estimates that Dish's Sling-branded web streaming service has 1.68 million subscribers, including 240,000 added in the September quarter. AT&T's DirecTV Now service has 787,000 subscribers, including nearly 300,000 added in the third quarter.

"At the margin, new virtual (streaming) adoption is a growing offset to traditional declines," Swinburne said in the report.

AT&T has bundled its DirecTV Now streaming service with wireless products. Satellite TV broadcaster Dish also has not disclosed subscriber numbers.

Cord-cutting, a term for consumers that cancel monthly pay-TV subscriptions, is still growing. LRG says the top six cable companies lost about 290,000 video subscribers in the third quarter of 2017, compared with a loss of about 90,000 subscribers a year earlier. Satellite TV services lost 475,000 subscribers vs. a gain of about 5,000 subscribers a year earlier.

That's bad news for providers of content. Media companies such as Walt Disney ( DIS), Discovery Communications ( DISCA) and Time Warner ( TWX) garner per-subscriber fees from pay-TV providers.

Morgan Stanley's Swinburne, though, says media firms are getting a lift from the subscriber gains of Hulu Live, YouTube TV, Sling and DirecTV Now – even if per-subscriber revenue is lower than pay TV.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


Google on Oct. 30 launched a new TV app for YouTube's streaming service, which could boost subscriber growth, analysts say.

Hulu's parents are 21st Century Fox Entertainment ( FOXA), Disney, Comcast ( CMCSA) and Time Warner. AT&T is seeking regulators' approval to acquire Time Warner.

RELATED:

Why AT&T's Time Warner Woes Bode Poorly For Comcast Deal With Fox

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting

Hulu Names A Fox Executive As CEO For Second Straight Time

Can Google's YouTube TV Hit 2 Million Subscribers In A Year?


37. Opioid Crisis Is Six Times Larger Than Thought, Report SaysПн., 20 нояб.[−]

Taking a raft of new metrics into account, a new report from White House economists says the opioid epidemic sweeping the U.S. is far costlier than once thought, with the economic impact of the crisis exceeding half a trillion dollars.

XAutoplay: On | OffThe epidemic cost the American economy $504 billion in 2015, which was the equivalent of 2.8% of the gross domestic product that year, according to the report by the Council of Economic Advisers, or CEA. The White House's figures are more than six times larger than a previous study because it incorporates the value of lives lost to the epidemic.

The findings come less than a month after the Trump administration declared widespread opioid abuse a public health emergency while stopping short of freeing up federal disaster funds to tackle the problem.

A study released last year estimated the cost of the opioid crisis in 2013 at $79.9 billion, adjusted for 2015 dollars. The economists said prior research didn't capture the full impact because it at times only measured health care expenditures or earnings lost from those who die — which overlooks "other valuable activities in life besides work."

The CEA also said it made adjustments to more accurately measure the number of opioid-related deaths, which often go underreported, and focused on illicit opioids as well as prescription drugs.

"This is the first but not the last publication CEA plans to issue on the opioid crisis," according to the report. "A better understanding of the economic causes contributing to the crisis is crucial for evaluating the success of various interventions to combat it."


38. Chip Stocks To Watch And Semiconductor Industry NewsПн., 20 нояб.[−]

They range from giants like Intel ( INTC), Qualcomm ( QCOM) and Taiwan Semiconductor ( TSM) down to lesser-known names like Qorvo ( QRVO) and Microchip Technology ( MCHP), providing the underpinnings for all types of devices, from giant servers down to smartphones.

XAutoplay: On | Off They're the chipmakers that power much of the world's technology, making it possible for loved ones to talk face-to-face from across an ocean or for Wall Street to move billions of dollars in the blink of an eye.

Never has the sector been more competitive, with more than 750 companies vying globally to build the insides of the next hot device or power future megacomputers. Investors will find it tricky to navigate the sector.

Bookmark this page to stay on top of the latest news in chips.

Chip Stocks & Semiconductor Industry News And Analysis

Analog Devices Gets Price-Target Hikes On Upbeat Earnings ReportChipmaker Analog Devices received at least six price-target increases to its stock after delivering a beat-and-raise quarterly report on Tuesday. Analog Devices earned an adjusted $1.45 a share, up 38% year over... Read More
Broadcom Might Raise Its Bid For Qualcomm: ReportChipmaker Broadcom is considering raising its takeover bid for Qualcomm to avoid a proxy battle, Reuters reported late Wednesday. Qualcomm rejected Broadcom's unsolicited bid on Nov. 13, saying it undervalued the company.... Read More
Mellanox Technologies Scores Relative Strength Rating Upgrade; Hits Key BenchmarkMellanox Technologies saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 74 to 85. This proprietary rating identifies market leadership by using a 1 (worst) to 99... Read More
Stocks Showing Improved Relative Strength: Amkor TechnologyThe Relative Strength (RS) Rating for Amkor Technology headed into a higher percentile Wednesday, as it got a lift from 67 to 71. IBD's unique RS Rating measures technical performance by using... Read More
These 4 Tech Stocks Are All Up At Least 35% Since Jan. 1; Lock In Gains Now?Taking gains in stocks rising into new highs is not a bad strategy at all, especially when your gains are reaching 20% to 25%. If you buy top-rated stocks at the correct... Read More
Analog Devices Posts Beat-And-Raise Quarterly ResultsChipmaker Analog Devices early Tuesday beat Wall Street's targets for its fiscal fourth quarter and guided higher for the current quarter. Analog Devices earned an adjusted $1.45 a share, up 38% year... Read More
Chipmakers Marvell, Cavium Continue To Soar On Merger NewsChipmakers Marvell Technology Group and Cavium continued to see their stocks climb on Tuesday, a day after Marvell announced a cash-and-stock deal to buy Cavium. Marvell jumped 7.8% to close at 23.28... Read More

View More Chip Stock News

RELATED:

Best Stocks To Buy And Watch

View More Tech News & Analysis


39. SailPoint Technologies, SendGrid Deliver Strong IPO PerformancesСб., 18 нояб.[−]

SailPoint Technologies ( SAIL) raised $240 million in an initial public offering that priced late Thursday, and shares took flight on the first day of trading Friday.

XAutoplay: On | OffFounded in 2005, SailPoint Technologies says they've developed a new category of identity management solutions, offering a platform that provides organizations with a better view into who currently has access to which resources and how that access is being used.

SailPoint priced 20 million shares at 12, above the estimated range of 9 to 11. Shares opened at 14.90, for a 24% gain. At the close, SailPoint shares were up 8.3% to 13 on the stock market today,

"Our open identity platform provides a critical line of defense at the heart of modern cybersecurity strategies, and is growing in importance each day as enterprises embrace new technologies and build large, complex IT environments," SailPoint Chief Executive Mark McClain said in prepared remarks emailed to IBD.

For the nine month period ended Sept. 30, SailPoint reported revenue of $118.3 million, up 34% from the year-ago period, though it is not yet profitable.


IBD'S TAKE: The biggest stock market winners typically make their major price moves within a few months or years of their initial public offering. So it pays to identify and track companies that are ready to go or have recently gone public. Learn more at IBD's IPO page. IBD also focuses on the best-performing IPOs of the past three years in its IPO Leaders column.


Also coming in with a strong IPO this week was SendGrid ( SEND), which began trading Wednesday.

Founded in 2009, SendGrid provides a cloud-based platform for automated emails and marketing campaigns. It raised $131 million by offering 8.2 million shares at 16, above the estimated range of 13.50 to $15.50. The stock jumped 16% on its first day of trading Wednesday. On Friday, shares were up 2.7% to close at 18.61.

Third-quarter revenue for SendGrid rose 37% from the year-ago period to $28.3 million, as adjusted earnings doubled to 2 cents a share.

SendGrid says it delivers email to more than half the world's email addresses and has more than 58,000 customers.

RELATED:

Sogou Rises In Debut After China Search-Engine IPO Prices High


40. JA Solar To Take Itself Private In Deal Valued At $362 MillionСб., 18 нояб.[−]

Chinese Solar power company JA Solar ( JASO), said it has entered into a definitive agreement to be acquired by an investor consortium in an all-cash transaction valued at $362 million.

The investor group said it will pay $1.51 per share to holders of ordinary JA Solar shares, while holders of the American depositary receipts, which represent five ordinary shares, will receive $7.55.

JA Solar American depositary receipts surged 8.5% to close at 7.45 on the stock market today.

The buyer group is headed by JA Solar Chief Executive Baofang Jin, and Jinglong, a British Virgin Islands company of which Jin is the sole director, and other shareholders. The group intends to fund the merger with a combination of debt and equity. It's currently expected to close during the first quarter of 2018.


IBD'S TAKE: With thousands of publicly traded companies to choose from, how can you quickly find the best stocks to buy right now? A good starting point is to regularly review screens that highlight the top-rated equities.


JA Solar says it's the world's largest manufacturer of high-performance solar power products. The company reported third-quarter results Wednesday. It reported revenue of $652.6 million, an increase of 4.3% from the year-ago period and adjusted earnings of 14 cents per share, up 8%.

RELATED:

Ruling On Solar Tariff Case Could Create Harsh Reaction For Losers


41. Apple HomePod Speaker Delayed, Will Miss Holiday Shopping SeasonСб., 18 нояб.[−]

Voice-activated smart speakers are expected to be hot sellers this holiday shopping season, but Apple ( AAPL) is going to miss out on the action.

XAutoplay: On | OffApple revealed Friday that its HomePod speaker is being delayed until early 2018 from a planned December launch. The delay was first reported by CNBC.

"We can't wait for people to experience HomePod, Apple's breakthrough wireless speaker for the home, but we need a little more time before it's ready for our customers," Apple said in a prepared statement. "We'll start shipping in the U.S., U.K. and Australia in early 2018."

The $349 HomePod was unveiled in June and pitched as a premium music speaker with Siri voice controls. Owners of the device will be able to stream music from Apple Music, control connected appliances like lights and thermostats, and get audio responses to spoken questions about the weather, sports and other news.


IBD'S TAKE: Apple stock has an IBD Composite Rating of 90, meaning it has outperformed 90% of stocks in key metrics over the past 12 months. For more analysis on Apple, visit the IBD Stock Checkup.


The delay is good news for makers of rival devices such as Amazon's ( AMZN) Echo speakers with Alexa voice controls and Alphabet's ( GOOGL) Google Home speakers with Google Assistant voice controls.

Apple shares fell 0.6% to close at 170.15 on the stock market today.

RELATED:

Apple Could Reach $1 Trillion Market Cap In 2018, Analyst Says

Smart Speaker Sales To Spike This Holiday With Amazon Seen Leading

Why Apple Needed To Make A Smart Music Speaker


42. Tesla Shares Up On Semi Truck Unveiling, But Model 3 Problems SmolderСб., 18 нояб.[−]

Shares of Tesla ( TSLA) rose Friday following the splashy debut Thursday evening of a futuristic big-rig truck and a zippy new sports car, at a time when the company is burning cash and hasn't met delivery schedules for its new Model 3.

XAutoplay: On | OffTesla's new tractor-trailer truck, called Semi, is scheduled to go into production in 2019, though the company is notorious for missing production schedules and deliveries. Tesla says the electric truck has a range of 500 miles. Reservations can be made for $5,000.

Tesla Chief Executive Elon Musk also made a surprise announcement of a new Roadster, scheduled for production in 2020. It has a battery range of 620 miles and can accelerate from 0 to 60 in 1.9 seconds. The event took place at Musk's SpaceX headquarters in Los Angeles.

Equity analysts who follow Tesla seemed impressed by the splashy product announcements overall but also expressed concerns about production on the Model 3 and the way Tesla used the event as a cash-raising opportunity.

"While the specs for the Semi exceeded our expectations, given the current difficulty Tesla is having with Model 3 production and recent pricing dynamics on the models S and X, we remain on the sidelines looking for acceleration on Model 3 production and proof of Model S and X sales growth in 2018," Oppenheimer analyst Colin Rusch wrote in a note to clients.

"While we believe Tesla has the potential to become a transformative technology company and deliver outsized returns for investors, the company's pace of growth, recent questionable decisions around capital allocation, and lack of disclosure keep us on the sidelines," wrote Rusch.

Part Dazzled, Part Concerned

Jefferies analyst Philippe Houchois, in a research note titled "Part 'Blown Away', Part 'Blowin' in the Wind,' " wrote that important details about the Semi truck were missing, such as the longevity of the batteries, which is critical to the economics of trucking.

On the surprise announcement by Musk of a new Roadster, specs aside, what was more interesting to Houchois was how Tesla used it to raise capital. It offered to sell 1,000 limited-edition models, which could raise $250 million.

Tesla is asking for a $250,000 deposit on the first 1,000 Roadster vehicles. Beyond that, a $50,000 deposit is required for others who want a reservation. It will also collect cash on the Semi truck deposits. CNBC in a tweet said Wal-Mart ( WMT) has preordered five of Tesla's Semi trucks, which are scheduled to go into production in 2019. J.B. Hunt Transport Services ( JBHY) announced Friday that it placed a reservation for "multiple" Tesla Semi trucks.

"So, yes, Elon Musk just figured out a way to avoid banker fees for a several hundred million dollar capital raise," Houchois wrote in a research note to clients.

"While deposits could help liquidity, we think the stock's next move will depend on additional disclosure on Model 3 ramp-up and the size of incremental capital required," Houchois wrote .

He maintained an underperform rating on Tesla and price target of 240.

RBC Capital Markets analyst Joseph Spak said the specifications on the Semi truck exceeded expectations,.

"And while Tesla has had challenges meeting deadlines, it does eventually get there," Spak wrote in a research note to clients. He maintained a sector perform rating on Tesla and price target of 340.

'Production Hell'

The new Tesla vehicles come at a time when Tesla is struggling to get its new Model 3 out the door, during what Musk has called " production hell." Tesla twice delayed the launch of its semi-truck to give it more time to work through production bottlenecks on its mass-market Model 3 sedan.

Shares of Tesla were up more than 3% to 322.60 during morning trading in the stock market today, but lost some of their heat by the close. Shares ended the regular trading day up 0.8% to 315.05. Tesla shares are down about 19% from a record high of 389.61 set on Sept. 18, as concerns grew of production slips on the Model 3.


IBD'S TAKE: The Transportation-Trucking group on Friday ranked a strong No. 59 out of the 197 industry groups tracked by IBD. To search for stocks from this group that might qualify as leaders, check out IBD's Stock Lists.


Morgan Stanley analyst Ravi Shanker in a research note to clients last month said: "We believe Tesla's reveal of its autonomous, electric Class 8 semi-truck this month could be the biggest catalyst in trucking in decades and potentially set off separation between the technology leaders and the laggards among carriers, shippers, truck OEMs and suppliers."

Experts say electric vehicles could bring widespread disruption and dramatically shrink the number of auto manufacturers over the next couple of decades. But Tesla's Semi is not the first electric semitrailer truck to be announced.

The Japanese arm of German automotive giant Daimler ( DDAIF) stole some thunder from Tesla last month by introducing an all-electric, heavy-duty truck in what is becoming an increasingly competitive market. Daimler said the electric vehicle is part of a new product line dedicated to electric trucks and buses.

Volkswagen ( VLKAY) plans to roll out electric trucks and buses in a few years. Volkswagen and affiliated heavy-truck maker Navistar International ( NAV) are targeting the debut of a medium-duty electric truck in North America by late 2019 or early 2020. Volkswagen bought a stake in Navistar in 2016.

RELATED:

Musk's Latest Venture: Tunnel Through L.A.'s Traffic Problems


43. Why AT&T's Time Warner Woes Bode Poorly For Comcast Deal With FoxСб., 18 нояб.[−]

Comcast ( CMCSA) faces a tough regulatory climate if it acquires a sizable part of 21st Century Fox Entertainment ( FOXA), based on the trouble AT&T ( T) has had in winning approval for its Time Warner ( TWX) acquisition, says an analyst.

XAutoplay: On | Off

Comcast owns NBCUniversal, and regulatory conditions placed on that deal expire in 2018. The Department of Justice, meanwhile, reportedly wants AT&T to divest Turner Broadcasting, including CNN, to win approval of the Time Warner deal.

"It's hard to see how an attempt by Comcast to acquire more content assets wouldn't have a very tough row to hoe with the Department of Justice," Vijay Jayant, an analyst at Evercore ISI, said in a note to clients.

Reports late Thursday said Comcast is in talks to buy some of the assets of Rupert Murdoch's Fox. Shares in Fox jumped 6.6% to close at 30.48 on the stock market today, while Comcast shares slipped 2.5% to 36.16.

Walt Disney ( DIS) also has reportedly been in talks to buy parts of Fox, including its movie and TV studio as well as some cable TV channels.

Neither Disney nor Comcast can buy the Fox broadcast TV network because they already own ABC and NBC, respectively. Comcast tried to buy Disney in 2004. The Mouse-Peacock rivalry has grown since Comcast bought NBCU from General Electric ( GE) in 2011.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


Comcast is most interested in Fox's stake in satellite TV broadcaster Sky and Star India, say some reports. But if Comcast also aims to acquire Fox's U.S. entertainment assets it could invite regulatory trouble, says Jayant.

The DOJ's antitrust chief, Makan Delrahim, said at the American Bar Association on Thursday that the agency is not interested in placing "behavioral remedies" on the AT&T-Time Warner deal and is seeking structural solutions to competition issues.

"The AT&T and Time Warner deal is facing pushback due to concerns about vertical integration — an acquisition of material Fox assets by Comcast would face not only those concerns, but also horizontal merger concerns," added Jayant.

Verizon Communications ( VZ) has also approached Fox about some assets, but talks do not seem as serious as those involving Disney or Comcast, say reports.

RELATED:

Will iPhone X Promotions On Black Friday Renew Wireless Price War?

Telecom Stocks To Watch And Industry News

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting


44. Nvidia To Climb Higher On Data-Center, Gaming Demand: AnalystСб., 18 нояб.[−]

Graphics-chip maker Nvidia ( NVDA) late Thursday received a bullish report from a Wall Street analyst who thinks the company's stock could reach 300 under a bull-case scenario.

RBC Capital Markets analyst Mitch Steves reiterated his outperform rating on Nvidia and raised his base-case price target to 250 from 240.

Nvidia shares slipped 0.1% to close at 211.36 on the stock market today. Nvidia hit a record high of 218.67 on Nov. 10.

Steves has increased confidence in Nvidia's data center and gaming chip businesses. He noted that Facebook ( FB) has been a big buyer of Nvidia's DGX-1 chip sets for deep learning and artificial intelligence applications.


IBD'S TAKE: Nvidia is currently ranked No. 10 on the IBD 50 list of top-performing growth stocks.


Gaming chip sales are being driven by increased processing requirements for the latest ultrarealistic video games, he said. Nintendo ( NTDOY) Switch console demand and virtual-reality headsets also are likely to drive Nvidia chip sales, Steves said.

In his bull-case scenario, Steves believes Nvidia could hit 300 if it continues to see high growth in gaming and data center chip sales and gets a material boost from automotive chip sets for self-driving cars.

RELATED:

Nvidia Impresses Analysts At Supercomputing Conference


45. Electronic Arts Stock Falls As Company Caves To Gamer DemandsСб., 18 нояб.[−]

Shares of Electronic Arts ( EA) fell Friday after the video game publisher halted in-game purchases for its new game "Star Wars Battlefront 2" in response to customer complaints.

Gamers complained that EA's microtransactions in the title, released Friday, amounted to a "pay-to-win" scheme. Reviewers said it was difficult to advance in the game without paying for upgrades.

But analysts said EA's decision to pause in-game purchases while it figures out a new strategy likely will hurt the moneymaking potential of "Star Wars Battlefront 2."

EA shares dropped 2.5% to close at 108.82 on the stock market today. EA had been forming a flat base over the past 11 weeks, but undercut the prior low in that pattern.

Bank of America Merrill Lynch analyst Justin Post predicted that the "Star Wars" game will disappoint investors.

"The escalation of EA concessions over the past month are a potential negative indicator of preorder sales trends and overall unit confidence," Post said in a report Friday. Still, he reiterated his buy rating on EA with a price target of 137.


IBD'S TAKE: Electronic Arts has an IBD Composite Rating of 90 out of 99, but it ranks No. 6 out of 13 stocks in IBD's Computer Software-Gaming industry group. To see which companies lead the group, visit the IBD Stock Checkup.


In recent weeks, gamers have flooded social media and community sites with negative posts about the game. Many said it was unfair for EA to charge $60 for the game and then give some users an unfair advantage if they pay more to unlock capabilities.

EA is taking the right step in suspending in-game transactions for "Star Wars Battlefront 2," but it could pinch the company's bottom line, Baird analyst Colin Sebastian said in a report.

"We believe the postponement of microtransactions has the potential to limit upside from the game, in particular if the pause lingers late into the quarter, or EA substantially reduces the opportunities for microtransactions," he said. Sebastian kept his outperform rating on EA with a price target of 130.

RELATED:

Chinese Video Game Publisher NetEase Spikes To Record High

Take-Two Interactive Software Gets Price-Target Hike On Strong Outlook

Electronic Arts' Holiday-Quarter Sales Outlook Spooks Investors


46. Comcast, Verizon Reportedly Eyeing 21st Century Fox AssetsПт., 17 нояб.[−]

Comcast ( CMCSA) and Verizon ( VZ) are eyeing some of the assets of 21st Century Fox ( FOX) for a possible purchase, it was reported late Thursday.

XAutoplay: On | Off

CNBC said Comcast was looking to buy the same Fox assets that Walt Disney ( DIS) was considering when it looked at a possible purchase of its crosstown rival's assets.

Shares of Fox jumped more than 8% in after-hours trading on the stock market today. Comcast was up more than 1% while Verizon was flat. Dow Jones was reporting that Verizon was eyeing the assets.

Disney was looking at most of 21st Century Fox but was expected to run afoul of regulators over owning two broadcast networks at once. Disney owns ABC. But the same would be said of Comcast, which owns NBC.


47. Splunk Third-Quarter Results Beat Sales, Earnings EstimatesПт., 17 нояб.[−]

Big Data services provider Splunk ( SPLK) reported third-quarter results after the market close Thursday that beat estimates on the top and bottom lines, with a revenue forecast above expectations.

Splunk reported revenue of $328.7 million, up 34% year-over-year and beating the consensus estimate of $310 million. It reported adjusted earnings of 17 cents per share, beating the consensus estimate of 14 cents.

Splunk shares were up 7%, near 74.15 during after-hours trading in the stock market today.

Needham recently initiated coverage on Splunk with a buy rating and price target of 95, saying Splunk is an industry leader with strong products.

For the current quarter, Splunk estimated revenue will be in the range of $388 million to $390 million, above the consensus estimate of $383 million, as polled by Thomson Reuters. Adjusted operating margin is expected to be approximately 16%.

During the quarter Splunk said it signed up more than 450 new enterprise customers.

It expects total revenue in 2019 will be approximately $1.55 billion, in line with current estimates.

Splunk's software helps tech managers monitor and analyze the vast volumes of data that companies and other enterprises are fast accumulating in the digital age — a field called Big Data. Splunk software uses the data to provide businesses with operational intelligence for security and information technology.


48. This Dot-Com King's Stock Visits Levels Not Seen Since 2001Пт., 17 нояб.[−]

Cisco Systems ( CSCO) on Thursday surged to a high not seen since the end of the dot-com era, after the computer networking giant forecast revenue growth in the December quarter amid strong demand for a new line of switches.

XAutoplay: On | OffThe Dow component late Wednesday reported fiscal first-quarter adjusted earnings that topped expectations and forecast December quarter profit and revenue above views. It now looks as if the new network switches featuring advanced security technology, dubbed Catalyst 9000, could help Cisco reverse a tide of declining sales that have dropped year-over-year for seven straight quarters.

"This was a breakout quarter for Cisco," George Notter, a Jefferies analyst, said in a note to clients. "The print, guidance and the narrative around the business were significantly better than many investors expected. Impressively, they're now guiding for top-line growth in January."

Cisco jumped 5.2% to close at 35.88 on the stock market today, a level not seen since January 2001. That was right as the dot-com boom that Cisco helped perpetuate through its then-groundbreaking line of network systems was crashing.

A number of analysts hiked their price targets on Thursday. Among them was Deutsche Bank, which upped its target to 45.

Security continued to be a bright spot in the September quarter, analysts said. Cisco is shifting to software and services from its core business of selling network switches and routers.

Cisco's new Catalyst 9000 network switches feature a new management platform called "DNA Center" that feature software intelligence via automated security tools.

"The summer introduction of the new Catalyst seems to be faring well," Jeffrey Kvaal, a Nomura-Instinet analyst, said in his note. "This product launch is the catalyst for Cisco to convert its traditional book-and-ship business into a recurring subscription model."

Jason Ader, a William Blair analyst, wrote: "The improvement in campus switching is being driven by the introduction of the Catalyst 9000 switches, which grew to over 1,100 customers in the first three months since product launch (up from 200 last quarter), with a large majority of these customers adopting the most advanced subscription (contract)."


IBD'S TAKE: Prior to reporting earnings, Cisco had a so-so Composite Rating of 67 and ranked only No. 8 in the Computer Networking group, where Arista Networks in No. 1. Cisco pays a high dividend, though, and could get a boost from corporate tax reform. Learn more at IBD Stock Checkup.


Cisco said that fiscal Q1 adjusted earnings were 61 cents a share, flat vs. a year earlier, with revenue falling 2% to $12.1 billion. Analysts expected Cisco to report earnings of 60 cents on sales of $12.1 billion for the period ended Sept. 30.

In the December quarter, Cisco forecast earnings of 59 cents a share at its midpoint of guidance vs. estimates of 58 cents. Cisco said it expects revenue growth in a range of 1% to 3% vs. consensus estimates of 1% to $11.58 billion.

RELATED:

Wal-Mart Earnings Top As E-Commerce Sales Soar 50%

PayPal Builds On Acquisition War Chest With Consumer Credit Sale

Arista Networks Answers Pre-Earnings Sell-Off With Big Beat


49. PayPal Bolsters Acquisition War Chest With This MoveПт., 17 нояб.[−]

PayPal Holdings ( PYPL) has agreed to sell its U.S. consumer credit business to Synchrony Financial for $5.8 billion, freeing up cash for acquisitions or increased stock buybacks.

XAutoplay: On | OffThe online payment processor earlier this year told analysts it was planning to divest its consumer credit business, and it appears it managed to sell off the U.S. consumer credit receivables portfolio at a higher valuation than expected. Analysts had estimated a sale price of around $4 billion to $4.5 billion.

Synchrony Financial will fund future loans that PayPal makes to online shoppers, under terms of the deal. But PayPal will continue making loans to small businesses, the company said.

Shares in PayPal jumped 5.8% to close at 77.70 on the stock market today. PayPal has shot up more than 85% in 2017.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


PayPal already has $6 billion in cash on its balance sheet. Some analysts have speculated that PayPal could target Europe's Adyen as an acquisition or Square ( SQ), though its market cap is now around $11 billion. PayPal's market valuation tops $88 billion with this year's gains.

Since it was spun off from eBay ( EBAY) in 2015, PayPal has evolved from a payment button to a broad payments service provider, while expanding from online checkout to mobile payments.

RELATED:

PayPal A Buyer, Not Seller, And May Seek A Big Target: Analyst

Should PayPal Be Trading At A Higher Multiple Than Visa, Mastercard?

Is The Holy Grail Of Digital Payments Just One Click Away?P

PayPal Climbs On Upgrade, 'Never Going To Look Cheap Again'


50. T-Mobile Buyback Could Be Fallout From Sprint Deal CollapseПт., 17 нояб.[−]

T-Mobile US ( TMUS) stock popped Thursday after its chief financial officer said a stock buyback could be announced as soon as December following its failed merger talks with Sprint ( S).

XAutoplay: On | OffBraxton Carter, speaking at a Morgan Stanley conference in Barcelona, said T-Mobile's board of directors in late November will consider a "significant" share buyback. Carter previously signaled a possible stock buyback in September at a Goldman Sachs conference.

Parent Deutsche Telekom ( DTEGY) will not tender any of its shares, Carter added, according to a Reuters report. Deutsche Telekom owns 64% of T-Mobile.

"We estimate a buyback could be in the $5 billion range for 2018 and potentially even higher if Deutsche Telekom chooses to participate (thereby increasing its stake)," Jennifer Fritzsche, a Wells Fargo analyst, said in a note to clients.

"Given its expected ramp in free cash flow, we're not surprised that T-Mobile is pursuing a buyback, but it should be a catalyst to shares which have underperformed since the Sprint deal fell through," Fritzsche added.


IBD'S TAKE: With Thursday's gain, T-Mobile stock is up over 3% in 2017 but down from 67.50 on June 5 when merger speculation involving Sprint heated up. Learn more about T-Mobile and the telecom wireless group at IBD Stock Checkup.


T-Mobile stock jumped 5.5% to close at 59.80 on the stock market today.

T-Mobile has been gaining subscriber and market share from AT&T ( T) and Verizon Communications ( VZ) with its "Uncarrier"-branded marketing and price discounts.

RELATED:

Will iPhone X Promotions On Black Friday Renew Wireless Price War?

Telecom Stocks To Watch And Industry News

CenturyLink Quarterly Results Miss, Raise Worries Over Dividend

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting


51. How These Rivals Could Take A Chunk Of Medtronic's Heart-Unit SalesПт., 17 нояб.[−]

Medtronic ( MDT) will overcome Hurricane Maria's impact in fiscal 2018, but the maker of medical devices is expected to face growing competition from Abbott Laboratories ( ABT) and Boston Scientific ( BSX) in heart implants, an analyst said Thursday.

XAutoplay: On | OffIn September, Abbott caught up to Medtronic and Boston, gaining approval for an implantable cardioverter defibrillator, or ICD, that allows a patient to undergo an MRI scan if needed. These devices are implanted to help control abnormal heart rhythm.

Still, RBC analyst Glenn Novarro says the lower end of Medtronic's full-year forecast in August for 4%-5% sales growth on a constant basis remains realistic. He increased his view for fiscal 2018 to $29.55 billion in sales and adjusted income of $4.74 per share.

"The impact of MR-compliant ICDs from Abbott and Boston is another topic of interest as it relates to the second half of fiscal 2018 and fiscal 2019," he said. For Medtronic's fiscal 2019, Novarro forecasts the firm as managing 3% constant-currency growth.

Competitive concerns also extend to heart-valve replacements, Novarro said. In early 2018, he sees Boston re-entering the European market with its Lotus Edge product. Boston recalled the device, not approved in the U.S., due to problems with its locking mechanism.


IBD'S TAKE: Medtronic has an IBD Composite Rating of 57, meaning it performs in the top half of all stocks in terms of key growth metrics. But it still falls to No. 54 in the Medical-Products industry group in terms of rankings. Head to IBD Stock Checkup for a look at better-rated medtech players.


Despite the mounting competition for its cardiac and vascular group, Novarro sees Medtronic as capable of pulling off its full-year guidance.

"We expect management to reaffirm guidance for constant-currency revenue growth and refine guidance further on the (fiscal third-quarter) call," he said. "The only possible change in fiscal 2018 earnings per share guidance will be the impact from Hurricane Maria."

On Tuesday, Medtronic is slated to report its fiscal second-quarter earnings. The consensus expects Medtronic to report adjusted income of 99 cents per share on $6.93 billion in sales. The sales view is below the Medtronic pre-announcement on Nov. 8 for $7.05 billion.

Hurricane Maria, which battered Puerto Rico in September, is expected to have a $55 million to $65 million impact on Medtronic's second-quarter sales and to trim adjusted profit by 3 cents. The majority of the impact was on the company's minimally-invasive and restorative-therapies groups.

For that reason, Novarro shifted his segment views for Medtronic's second quarter. In the U.S., he sees the diabetes group diving 12% and minimally-invasive therapies losing 1%. He expects flat sales in restorative therapies, partly offset by 4% growth in cardiac and vascular.

Internationally, Novarro expects the cardiac and vascular and diabetes groups to grow 8% apiece. He sees the minimally-invasive and restorative-therapies groups growing a respective 6% and 5%. Only the pain-therapies group is expected to decline, by 5%.

Medtronic's diabetes group has been plagued recently by a shortage in glucose sensors. Growth in the latter half of fiscal 2018 will come on the backs of new products, Medtronic has said.

By the closing bell on the stock market today, Medtronic gained 0.7% to close at 79.26.

RELATED:

How Electricity Could Replace Opioids In Treating Chronic Pain

Edwards Lifesciences Crashes After Heart Valve Sales Miss Lofty Views

Dow Component J&J Pops After Topping Views On Pharma Strength


52. Tesla's Electric Truck Arrives Amid 'Production Hell,' Hot CompetitionПт., 17 нояб.[−]

The planned unveiling of an electric semi-trailer truck by Tesla ( TSLA) on Thursday evening is an event that Chief Executive Elon Musk in a tweet said "will blow your mind clear out of your skull and into an alternate dimension."

XAutoplay: On | OffThe event is scheduled to start at 8 p.m. PDT, to be broadcast live at Tesla.com and is Tesla's first major push into a market expected to get highly competitive. It also comes at a time when Tesla is struggling to get its new Model 3 out the door, during what Musk has called " production hell."

Tesla previously delayed the launch of its semi-truck to give it more time to work through production bottlenecks on its mass-market Model 3 sedan.

Musk has been having fun with the truck announcement. In a tweet on Wednesday, he said: "It can transform into a robot, fight aliens and make one hell of a latte."

But it won't be the first unveiling of an electric semi-truck.

The Japanese arm of German automotive giant Daimler ( DDAIF) stole some thunder from Tesla last month by introducing an all-electric, heavy duty truck in what is becoming an increasingly competitive market. Daimler said the new electric vehicle is part of a new product line dedicated to electric trucks and buses.

Volkswagen ( VLKAY) plans to roll out electric trucks and buses in a few years. Volkswagen and affiliated heavy-truck maker Navistar International ( NAV) are targeting the debut of a medium-duty electric truck in North America by late 2019 or early 2020. Volkswagen bought a stake in Navistar in 2016.

Nomura analyst Romit Shah in a research note to clients Thursday said he believes Tesla could reveal a new Autopilot technology at the truck unveiling "that may ease investor concerns that Tesla is lagging in self-driving." He said Tesla's Autopilot technology and other features inspire "a real fervor for the brand that will translate into significant revenue growth."

Shah has a buy rating on Tesla and a price target of 500.

Tesla shares ticked up 0.4% to close at 312.50 on the stock market today.


IBD'S TAKE: Despite skeptics and safety questions, the era of electric cars and trucks and self-driving vehicles is clearly underway. Automakers and tech companies are plowing billions of dollars into research and forging alliances in a rush for the inside lane on the automobile's most revolutionary track since the Model T.


Self-driving trucks are also being tested on roads or are under development by leading truck manufacturers. They're expected to maintain the same pace or perhaps take a faster track than cars.

General Motors ( GM) Chief Executive Mary Barra on Wednesday set out an aggressive new target to sell 1 million electric vehicles a year by 2026, as Tesla flounders with its own ambitious goal to produce half a million EVs next year. This year, GM is on pace to sell less than 50,000 EVs, with about 17,000 Bolts sold so far this year.

Daimler debuted its Freightliner Inspiration truck in May 2015, which it called the world's first licensed autonomous truck. It's licensed to operate on public highways in the state of Nevada, but with a licensed truck operator.

Volvo introduced its first autonomous truck, the Volvo FMX, early last year and conducted its first live demonstration at a mine in northern Sweden, with the idea that it can improve transport efficiency and productivity in mines, ports and other hard-to-access areas.

RELATED:

Tesla Third-Quarter Results Show A Big Miss As Model 3 Woes Persist

Automotive Industry News, Self-Driving Cars And Stocks To Watch


53. Best Buy Disappoints With Third-Quarter Results, Holiday GuidanceПт., 17 нояб.[−]

Consumer electronics retailer Best Buy ( BBY) on Thursday came up short of third-quarter targets and guided lower than Wall Street estimates for the holiday sales period, sending its shares lower.

XAutoplay: On | OffBest Buy shares fell 3.6% to close at 55.25 on the stock market today.

Richfield, Minn.-based Best Buy earned an adjusted 78 cents a share, up 30% year over year, on sales of $9.32 billion, up 4%, in its fiscal third quarter ended Oct. 28. Analysts expected 79 cents and $9.35 billion, according to Zacks Investment Research.

Same-store sales rose 4.4% in the quarter.

For the current quarter, Best Buy expects to earn $1.94 a share on sales of $14.35 billion, based on the midpoint of its guidance. Analysts were modeling for earnings of $2.03 a share on sales of $14.36 billion.


IBD'S TAKE: Best Buy stock has an IBD Composite Rating of 76, meaning it has outperformed 76% of stocks in key metrics over the past 12 months. For more analysis on Best Buy, visit the IBD Stock Checkup.


Best Buy's third-quarter results were impacted by the later-than-expected launch of Apple's ( AAPL) iPhone X smartphone as well as hurricanes in Texas and Florida, Best Buy Chief Executive Hubert Joly said in a news release.

The revenue impact from the launch of the iPhone X being pushed into the fourth quarter was more than $100 million, Joly said.

"Looking ahead, we are very excited about our plans for holiday, including a curated assortment of great new technology products, free shipping with no minimums, and a range of new capabilities such as our new in-home advisor program, an updated gift center, and same-day delivery in 40 cities," Joly said. "We believe we are well positioned for a successful season."


54. Apple Could Reach $1 Trillion Market Cap In 2018, Analyst SaysПт., 17 нояб.[−]

Apple ( AAPL) could become the first publicly traded company to reach a market capitalization of $1 trillion next year if several factors go in its favor, a Wall Street analyst said Thursday.

XAutoplay: On | OffGBH Insights analyst Daniel Ives laid out a "bull-case scenario" for Apple reaching the milestone, in a note to clients Thursday. Apple has a current market cap of about $881 billion.

"Apple shares, in a best-case/bull-case scenario, could be in the $210-$230 range over the next year in our opinion ... thus becoming the first member of the 'trillion-dollar market cap club,' " Ives said.

Ives reiterated his "highly attractive" rating on Apple stock with a price target of 205.

Apple shares climbed 1.2% to close at 171.10 on the stock market today.


IBD'S TAKE: Apple stock has an IBD Composite Rating of 91, meaning it has outperformed 91% of stocks in key metrics over the past 12 months. For more analysis on Apple, visit the IBD Stock Checkup.


Apple stock could appreciate on a major iPhone upgrade cycle, kicked off by the Nov. 3 launch of the iPhone X, and a host of other factors, Ives said. Those factors include a rise in average selling prices for iPhones as customers opt for more-premium models.

Other factors include a fast-growing services business, a renaissance of growth in China, and what Apple could do with its cash stockpile of more than $250 billion, most of it banked overseas.

Those foreign profits could be repatriated under U.S. tax code changes and be used for buybacks, dividends, and mergers and acquisitions, he said.

"It all comes down to the success and elongated demand trajectory of iPhone X over the coming quarters to determine if Apple finally ends up joining the elusive 'trillion dollar market cap club' in 2018 in our opinion," Ives said. "To this point, the first stage of the iPhone X launch is off to a great start."

RELATED:

Apple Stock Rated Neutral; Focus Shifts To What's Next After iPhone X

Apple To Launch Netflix Rival In 2018, Research Firm Predicts


55. China's NetEase Blasts Into Buy Zone On Strong EarningsПт., 17 нояб.[−]

Chinese video game publisher NetEase ( NTES) late Wednesday reported better-than-expected earnings for the third quarter, defying forecasts for a sharp decline.

XAutoplay: On | OffThe Beijing-based company earned an adjusted $3.43 per American depositary share vs. $3.42 a year earlier. Sales of $1.875 billion leapt 36% in the September quarter. Analysts expected EPS of $3.04 and revenue of $1.836 billion, according to Zacks Investment Research.

NetEase U.S. shares broke out of a cup-with-handle base with a 320.77 buy point on Thursday. The stock jumped 7.9% to close at 326.24 on the stock market today after hitting 332.20 intraday.

NetEase credited new hit games like "Onmyoji" and "Crusaders of Light" for its better-than-expected earnings in the third quarter. It also got a boost from increased popularity of several legacy games such as "Fantasy Westward Journey Online."

Online game services accounted for 64% of NetEase revenue in the September quarter, with advertising, e-commerce and other internet services making up the rest.

"We continue to amass one of China's pre-eminent mobile game portfolios while simultaneously advancing our advertising services and e-commerce business lines," NetEase Chief Executive William Ding said in a news release.

NetEase had rallied recently on plans to invest $11 billion in e-commerce.


IBD'S TAKE: For the latest news on U.S.-listed Chinese firms, check out the IBD page Best Chinese Stocks To Buy And Watch.


The company sees ample growth opportunities in China, but is expanding internationally as well, Ding said.

NetEase did not give guidance for the fourth quarter in its earnings news release. Analysts have been modeling NetEase to earn $3.22 per U.S. share on sales of $2.095 billion.

RELATED:

NetEase Beats Second-Quarter Views, But Shares Fall Late

Best Chinese Stocks To Buy And Watch


56. Cisco Profit, Revenue Outlook Above Estimates; Shares PopЧт., 16 нояб.[−]

Cisco Systems ( CSCO) reported fiscal first-quarter adjusted earnings that topped expectations by a penny and forecast December quarter profit and revenue above views, sending shares up in late trading.

XAutoplay: On | OffCisco said Wednesday that fiscal first-quarter adjusted earnings were 61 cents a share, flat vs. a year earlier, with revenue falling 2% to $12.1 billion. A year earlier, Cisco earned 61 cents a share on sales of $12.35 billion. Analysts expected Cisco to report earnings of 60 cents on sales of $12.1 billion for the period ended Sept. 30.

In the December quarter, Cisco forecast earnings of 59 cents a share at its midpoint of guidance vs. estimates of 58 cents. Cisco said it expects revenue growth in a range of 1% to 3%. Analysts had projected revenue growth of 1% to $11.58 billion.

Cisco reported earnings for the first time using new product categories: infrastructure platforms, applications, security, services and other amid its shift to recurring and subscription revenue models.


IBD'S TAKE: Cisco holds a Composite Rating of 67 and is ranked eighth in IBD's Computer-Networking Group. Tops in that group is Arista Networks ( ANET), with a best-possible rating of 99.


"Cisco is delivering more insights and intelligence as we help our customers build highly secure, intelligent platforms for digital business," Chief Executive Chuck Robbins said in a news release.

Cisco has stepped up acquisitions, most recently purchasing BroadSoft ( BSFT) and AppDynamics, to shift to software and services from its core business of selling network switches and routers.

Shares in the maker of computer networking gear rose 3.6% to 35.33 in after-hours trading on the stock market today.


57. Apple Stock Rated Neutral; Focus Shifts To What's Next After iPhone XЧт., 16 нояб.[−]

Excitement about Apple's ( AAPL) iPhone X drove the company's stock to record heights, but now the consumer electronics giant needs a new catalyst if shares are going to appreciate from here, a Wall Street analyst said late Wednesday.

Wells Fargo analyst Aaron Rakers initiated coverage of Apple with a market perform, or neutral, rating and a price target of 195.

Apple shares lost 1.3% to close at 169.08 on the stock market today.

Since hitting a record high of 176.24 on Nov. 8, Apple stock has fallen for five straight trading sessions.

Apple has entered the "What's next?" phase, Rakers said in a report.

"While we applaud Apple's execution and continual ecosystem buildout, the inevitable shift to what's next should once again surface (after) the iPhone 8/X cycle," he wrote. "We expect some investors to continually question Apple's rate of innovation (focus on Apple's significant R&D investments) for the iPhone as competitors offer similar features and cheaper smartphones."


IBD'S TAKE: Apple stock has an IBD Composite Rating of 93, meaning it has outperformed 93% of stocks in key metrics over the past 12 months. For more analysis on Apple, visit the IBD Stock Checkup.


Apple's stock has been driven by expectations for the company's 11th-generation smartphones, the iPhone 8 series and iPhone X, he said.

"We think the shares could now see increased volatility, with a focus on incremental derivative demand and (iPhone) mix data points over the coming months, supply vs. demand achievement (i.e., expectation of continued chasing demand into March 2018 quarter?), and upgrade and Android switcher rates," he wrote.

RELATED:

Apple To Launch Netflix Rival In 2018, Research Firm Predicts


58. Sunrun Overtakes Tesla's Solar City As Top Solar Lease FirmЧт., 16 нояб.[−]

Sunrun ( RUN) became the top residential solar leasing provider in the third quarter as rivals including Tesla's ( TSLA) SolarCity shifted their focus to cash sales.

XAutoplay: On | OffSunrun installed 80 megawatts through residential leases and other financing arrangements in the quarter, while SolarCity topped out at 59 megawatts, according to a report Wednesday from GTM Research.

SolarCity, which Tesla bought a year ago, held the largest share of the U.S. solar-leasing market in the first half with 31%, compared with Sunrun's 27%. Vivint Solar ( VSLR) was No. 3 with 15%, followed by closely held Sunnova Energy Corp. and SunPower ( SPWR).

For the second half of the year, GTM expects Sunrun to claim the top spot. The shift comes as SolarCity has changed its focus to cash sales over financing deals, a move that's aimed at boosting revenue but is also driving up customer acquisition costs, GTM said. Sunrun continues to focus on leasing and hasn't had the same issues, which is helping it expand sales.


IBD'S TAKE: Already heavily discounted, Sunrun shares are working on a cup base that started forming in August. That followed an eight-month consolidation that ended in June. With a Composite Rating of 69, it isn't ranked among other companies in IBD's Energy-Solar Group. Tops in that sector is Daqo New Energy ( DQ).


"As nearly every other large national installation company has struggled to grow this year, Sunrun is a standout as its growth has outpaced the market," Allison Mond, a GTM analyst, said in the report. "Unlike its largest competitors, Sunrun has seen customer acquisition costs come down in recent quarters."

But as nearly every other large national installation company has struggled to grow this year, Sunrun is a standout as its growth has outpaced the market.

Sunrun shares closed the regular trading day down 1.5% to 6.08. Tesla added 0.8% to 311.30.


59. Baidu Tech Conference To Push AI, Video Streaming Amid Stock SlumpЧт., 16 нояб.[−]

Baidu ( BIDU) stock has slumped ahead of its annual technology conference, where its push into artificial intelligence and its video streaming business, iQiyi.com, are expected to grab the spotlight.

The "Baidu World" tech conference kicks off Thursday. In a release, Baidu said its technology conference in Beijing will focus on the theme: "Bring AI to Life."

Baidu is pushing AI to fuel growth, with a special emphasis on self-driving cars. Baidu in July announced that it has more than 50 partners for its self-driving-car plans.

Yu Gong, founder and CEO of iQiyi, is expected to make a presentation at the tech conference as well.

Video streaming has been a growth driver for Baidu, similar to the boost Alphabet's ( GOOGL) Google has received from YouTube.

Baidu was off 0.3% to close at 234.21 on the stock market today.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


N.Y.-listed shares in Baidu are down 14% since the Chinese internet search leader reported third-quarter earnings in October. Baidu forecast December-quarter sales that were well below estimates. China's government restricted web activity and advertising during the Communist Party's National Congress in October, one of several recent regulatory events that have pressured China internet stocks.

Baidu is still up 42% in 2017, rebounding from last year when health-care-related search advertising dried up after regulatory probes into the death of a college student.

RELATED:

Sogou Rises In Debut After China Search-Engine IPO Prices High

China's Stock Leaders Break Down As Country Modifies Growth Plans

Best Chinese Stocks To Buy And Watch


60. Apple To Launch Netflix Rival In 2018, Research Firm PredictsЧт., 16 нояб.[−]

Apple ( AAPL) will launch a subscription video-on-demand service next year to take on Netflix ( NFLX) and others in the fast-growing sector, research firm CCS Insight predicted Wednesday.

At its annual year-ahead predictions event in London, CCS Insight said a streaming video offering would play into Apple's strategy to double its services revenue by 2020.

"Everyone is jostling for position and everyone is jumping in on the area of video," Paolo Pescatore, vice president of multiplay and media at CCS Insight, told CNBC. "When you look at Apple, it has a very strong hardware offering and their services business is on the march."

Original content will be the main battleground in the subscription video market and Apple is "well placed" to make an impact there, Pescatore said.

Apple has been quiet about its plans for streaming video, but Hollywood publications report that the company has been active in deal making. Apple reportedly has inked a deal with director-producer Steven Spielberg to relaunch his 1980s anthology series "Amazing Stories." Apple also is said to have won a bidding war for the rights to a drama about a TV morning news show starring Jennifer Aniston and Reese Witherspoon.


IBD'S TAKE: Apple stock has an IBD Composite Rating of 93, meaning it has outperformed 93% of stocks in key metrics over the past 12 months. For more analysis on Apple, visit the IBD Stock Checkup.


Apple also has acquired the rights to music documentaries and the series "Carpool Karaoke" for its Apple Music service.

Netflix is by far the leader in the subscription internet video market. Netflix ended the September quarter with 109.25 million streaming subscribers worldwide, including 52.77 million in the U.S. and 56.48 million in international markets.

But Netflix is facing increasing competition from the likes of Amazon.com ( AMZN), CBS ( CBS), Hulu and Time Warner's ( TWX) HBO. Walt Disney ( DIS) plans to join the fray in late 2019 with a service featuring its catalog of hit movies as well as original programming such as a live-action "Star Wars" series.

On Monday, Amazon announced plans to make a TV series based on "The Lord of the Rings" fantasy novels by J.R.R. Tolkien for its Prime Video service.

Apple shares ended the regular trading session down 1.3% to 169.08 on the stock market today. Netflix shares fell 1.8% to finish at 192.12.

RELATED:

Netflix Stock Retreats On Disney Competitive Threat

Disney Vows To Launch Netflix Rival 'Aggressively'


61. Acorda Nose-Dives To 5-Month Low On Deaths In Parkinson's StudiesЧт., 16 нояб.[−]

Acorda Therapeutics ( ACOR) lost more than a third of its value Wednesday after announcing five patients died in late-stage Parkinson's disease drug trials and that it would stop adding new patients to those studies.

XAutoplay: On | OffBy the closing bell on the stock market today, Acorda crumbled, falling 39.7% to end the regular trading day at 17.

The company said some patients developed a condition in which a severely lowered white blood cell count makes it difficult to fight infection. These were possibly associated with use of Acorda's drug called tozadenant, the firm said in a news release.

In total, seven patients in the studies developed sepsis, all of which were treated with tozadenant. Of those cases, five were fatal. Four were associated with a low white blood cell count, two had no counts available and one had a high count.

The company paused enrollment in the long-term safety studies pending discussion with the Food and Drug Administration and the Data Safety Monitoring Board. It also upped blood cell count monitoring to weekly in the ongoing Phase 3 program.

Acorda expects to release top-line data in the first quarter, contingent upon discussions with regulators.


IBD'S TAKE: Acorda has an IBD Composite Rating of 89, meaning it outperforms nearly nine in 10 stocks in terms of key growth metrics. For more on Acorda, get an IBD Stock Checkup. To understand how a strong CR plays into making smart investments, head to IBD Data Stories.


Acorda shares gapped down to a low last seen in mid-June. The broader biotech group dipped nearly 1% after closing down 1.9% on Tuesday.

Leerink analyst Paul Matteis expects most investors to have removed most or all of their credit for tozadenant from their valuations on Acorda. His prior model assumed a 50% chance of success for the drug in Phase 3, though a 70% probability of approval.

"These assumptions now seem overly optimistic," he said in a note to clients. But he kept his market perform rating on Acorda.

The safety update complicates matters for tozadenant, Matteis said. Even if approved, tozadenant only offers a modest clinical benefit over other Parkinson's disease drugs and the mortality signal is likely to scare off an elderly patient population.

"The drug is not disease-modifying and will be targeted toward an already fragile elderly population," he said. "Thus, we not surprisingly believe investors will hold a more distressed view of the drug's odds of success and commercial potential."

Acorda has struggled this year. In April, it put four programs on the back-burner after a judge tossed key patents protecting multiple sclerosis drug Ampyra. It planned to focus solely on tozadenant and a drug called Inbrija, an inhaled Parkinson's disease treatment.

But in late August, the FDA rejected Acorda's application for Inbrija, citing issues at its manufacturing plant.

RELATED:

Biotechs Sell Off In Droves — Are Investors Seeking Mergers?

This Biotech Is Feeling The Pain After FDA Sets Panel On Anesthetic

Acorda Dives On Merger Talk As Investor Tries To Urge A Sale


62. Tencent Third-Quarter Results Top Estimates For Sales, ProfitsЧт., 16 нояб.[−]

Tencent Holdings ( TCEHY) reported third-quarter results before the market open Wednesday that beat estimates on the top and bottom line, fueled by strong growth in mobile gaming and video-related subscription services.

Tencent reported revenue of $9.8 billion, beating the lone estimate on Zacks Investment Research of $9.39 billion and up 61% from the year-ago period.

The company said adjusted earnings were 27 cents per share, beating the estimate of 26 cents and up 42%.

Net profit for the third quarter rose 67% from the year-ago period to 18 billion yuan, or $2.72 billion. That beat the consensus estimates of 15.18 billion yuan, or $2.29 billion from six analysts polled by Thomson Reuters.

Tencent shares gained 2.2% to close at 50.17 on the stock market today. The shares have doubled in price this year.

"Tencent had an outstanding quarter as all cylinders were driving: online/mobile gaming, social networks and online advertising," wrote Brendan Ahern, chief investment officer at Krane Funds Advisors, in an email to clients.

Tencent is China's leading provider of messaging and mobile gaming services, and owner of the popular WeChat app. It ended the quarter with 980 million WeChat users, an addition of 17 million users from the previous quarter and up 16% from the year-ago period.


IBD'S TAKE: Tencent is among the best Chinese stocks to buy and watch. When you're looking to get a broader idea on top tech stocks, check out IBD's Tech Leaders feature.


Revenue from smartphone games grew by 84% to $2.74 billion.

Tencent said revenue form digital content "continued to record rapid growth, driven by video subscriptions and by live broadcast revenue." It said Tencent Video has exceeded 43 million fee-based subscriptions, "which we believe represents the largest video streaming services subscriber base in China."

Tencent follows the third-quarter report of e-commerce company JD.com ( JD) early Monday that topped estimates and sent the stock soaring. JD.com reported revenue of $12.58 billion, beating the consensus estimate of $12.25 billion and up 39% from the year-ago quarter. Tencent owns a stake in JD.com.

Tencent last week bought a 12% stake in Snapchat operator Snap ( SNAP). The announcement came when Snap reported third quarter results that missed estimates on many metrics, sending shares tumbling.

RELATED:

YY Reports Third-Quarter Results That Smash Analyst Estimates


63. Square Rises On Bitcoin Buy And Sell Option For Mobile App UsersЧт., 16 нояб.[−]

Shares of Square ( SQ) rose on Wednesday after the digital payment processor said it's adding a Bitcoin cryptocurrency buying option to its money-transfer service.

XAutoplay: On | OffShares in Square climbed 2.3% to close at 40.66 on the stock market today. Square's move could place it "in an early-mover position as a mainstream fintech company providing cryptocurrency services," Credit Suisse analyst Paul Condra said in a note to clients.

"We believe Square is aggregating the bitcoin of its users rather than creating individual private bitcoin addresses per user. This is similar to how the popular app Coinbase works," Condra said. "As of November, Coinbase reported having almost 12 million users, up from 7 million in June. Coinbase charges roughly 1.5% per bitcoin purchase.

Square Cash lets users send money to friends or family members via emails. Square Cash competes with Apple's ( AAPL) new person-to-person payment service and PayPal Holding's ( PYPL) Venmo service. Normally Square Cash users link a bank or credit card account to the smartphone app.


IBD'S TAKE: Square stock has nearly tripled in 2017 and is no longer in a buy zone, having shot past a buy point of 28.07. Learn more at IBD's Stock Checkup.


Bitcoin's digital currency is created and held electronically. Square told website Tech Crunch late Tuesday that it's letting Square Cash app users buy and sell Bitcoin via an exchange. Square Cash users cannot send the digital currency to other users of the money-transfer service.

San Francisco-based Square makes credit-card readers that plug into mobile phones and tablets. While Square's primary customers are small businesses, it's attracting bigger customers, analysts say. Square has expanded into providing financing and bank loans to small businesses.

RELATED:

Before You Buy Bitcoin, Read This

Is The Holy Grail Of Digital Payments Just One Click Away?

The GOP Just Bet Everything On A 20% Corporate Tax Rate

Square Snares Sellers With Sticky Services In Financial Tech

Bitcoin Jesus' Makes This Prophecy On The Digital Currency


64. Tesla (TSLA) Stock Quotes, Company News And Chart AnalysisСр., 15 нояб.[−]

XAutoplay: On | Off


View TSLA Stock Quote Page
| View TSLA Ratings

Tesla Stock News & Analysis

Tesla Could Rocket To New Highs, Then Collapse: Morgan StanleyExpect Tesla shares to be extremely volatile in 2018, as shares could hit a record high of 400 before facing headwinds and collapsing, a Morgan Stanley analyst said Tuesday. In a note... Read More
Stocks Up Big As Apple Leads Dow; Is It Time To Buy This Top Internet Play?Apple paced a hearty gain for the Dow Jones industrial average at midday Tuesday, rising more than 2% to 173.49, amid a broad stock market rally. Apple is now extended past a... Read More
Tesla Shares Up On Semi Truck Unveiling, But Model 3 Problems SmolderShares of Tesla rose Friday following the splashy debut Thursday evening of a futuristic big-rig truck and a zippy new sports car, at a time when the company is burning cash and... Read More
S&P 500 Dips Amid Big News On Wal-Mart, Cisco, Tesla, General Electric, China Internets, Taxes: Weekly ReviewThe S&P 500 index was slightly lower for the week even as Dow components Wal-Mart and Cisco Systems skyrocketed on strong earnings and hopes that the titans will continue to transition into... Read More
Truck Stocks Slammed As Wal-Mart Orders 15 Tesla Semi TrucksTesla, now a truck maker, is denting truck-making stocks as its newest vehicle snaps up interest from the biggest U.S. retailer and a long-haul transporter. Cummins, Paccar and Navistar tumbled Friday after the big... Read More

More Technology Stocks Coverage

Latest FANG Stocks News: Facebook, Amazon, Netflix, Google

Apple (AAPL) Stock Quotes And Company News

View More Tech Stocks


65. Netflix (NFLX) Stock Quotes, Company News And Chart AnalysisСр., 15 нояб.[−]

XAutoplay: On | Off


View NFLX Stock Quote Page
| View NFLX Ratings

Netflix Stock News & Analysis

Are Netflix Shares Dormant Or Holding Up Well?Like other FANG stocks, Netflix has been trending sideways since it broke out of its most recent base. While shares are in buy range, their progress has stalled. Yet there are no... Read More
Apple To Launch Netflix Rival In 2018, Research Firm PredictsApple will launch a subscription video-on-demand service next year to take on Netflix and others in the fast-growing sector, research firm CCS Insight predicted Wednesday. At its annual year-ahead predictions event in... Read More
S&P 500 Futures Fall Amid GE, China Internet News; FANGs Are Still BuysS&P 500 futures fell modestly Monday morning as Chinese internet giants rallied on earnings and the 11.11 sales event, while General Electric slashed its dividend in half. Meanwhile, Facebook, Amazon, Netflix and Google-parent Alphabet... Read More
Disney Vows To Launch Netflix Rival 'Aggressively'Walt Disney's answer to Netflix won't have as much content, but it will be priced "substantially below" the streaming entertainment service, and that — in combination with a few other major announcements Thursday —... Read More
Netflix Stock Retreats On Disney Competitive ThreatInternet television network Netflix saw its stock retreat to its 50-day moving average on Friday after one-time friend — and now future competitor — Walt Disney provided tantalizing details on its upcoming rival... Read More

More Technology Stocks Coverage

FANG Stocks News: Facebook, Amazon, Netflix, Google

Apple (AAPL) Stock Quotes And Company News

Tesla (TSLA) Stock Quotes And Company News

View More Tech Stocks


66. Apple (AAPL) Stock Quotes, Company News And Chart AnalysisСр., 15 нояб.[−]

XAutoplay: On | Off


View AAPL Stock Quote Page
| View AAPL Ratings

Apple Stock News & Analysis

Apple's Self-Driving Bet Pits It Against Tesla, With Big AutoApple is working on using a light-based technology to make it easier for self-driving cars to identify pedestrians and cyclists, putting it in the camp of several big-name proponents of the tech but... Read More
Amazon, Google, Wal-Mart Fight For The Key To Your Smart HomeThe hottest smart-home purchase this holiday season is likely to be a smart video doorbell. As many as 14% of U.S. households with broadband access say they're pretty likely to buy the... Read More
Stocks Down, Banks Break Out; Will Apple's Growth Moderate In The Future?Major stock indexes were slightly lower near midday Wednesday on the eve of the Thanksgiving holiday, but Apple continued to warm investors' hearts as it recouped more of its moderate losses seen over... Read More
Apple iPhone X Supply Catching Up With Demand; Some Balk At PriceApple's production of the iPhone X smartphone is starting to catch up with demand — as evidenced by shorter delivery wait times — but the high price of the premium handset also could... Read More
Santa Claus Rally Comes Early; These Top Stocks Stood OutThe stock marked turned in another bullish performance Tuesday, with the Dow Jones industrial average, S&P 500 Nasdaq composite and Russell 2000 hitting new highs. Apple was a solid gainer in the... Read More

More Technology Stocks Coverage

FANG Stocks News: Facebook, Amazon, Netflix, Google

Tesla (TSLA) Stock Quotes And Company News

View More Tech Stocks


67. Apple Is Subject Of Trade Commission Probe Over PatentsСр., 15 нояб.[−]

Apple ( AAPL) has become the subject of an investigation by the U.S. International Trade Commission for patent infringement that could block the import of several key devices made by the technology giant, a report issued late Tuesday said.

XAutoplay: On | Off

MarketWatch reported that Apple Mac computers, iPhones, iPads, iPods and Apple TVs could be subject to a temporary exclusion order, according to a complaint from two companies: Aqua Connect and Strategic Technology Partners. The two entities lodged their complaint Oct. 10, but it was not clear exactly which Apple devices would be targeted by the commission's probe.

Apple shares slipped 1.5% to close at 171.34 Tuesday.

RELATED:

Apple's iPhone X Screen Is Giving Some Users Headaches


68. Roku Stock Downgraded On Valuation After Spiking To Record HighСр., 15 нояб.[−]

Shares of recent IPO Roku ( ROKU) spiked to a third record high in as many days on Tuesday, but one Wall Street firm thinks the rally is overdone.

Oppenheimer analyst Jason Helfstein lowered his rating on Roku to underperform from perform, or neutral, and set a 12- to 18-month price target on the stock of 28.

"While Roku has established itself as the leading independent OTT (over-the-top TV) streaming platform though a device and software strategy, the stock is now the most expensive publicly traded internet-based company, on the basis of platform revenue or platform gross profit," Helfstein said in a report.

Roku shares lost 13.5% to close at 36.95 on the stock market today. Earlier in the session, Roku hit an all-time high of 48.80.

The Los Gatos, Calif.-based company went public on Sept. 28 at 14 a share. Roku stock went on a tear after posting better-than-expected third-quarter results.


IBD'S TAKE: For a look at top-performing recent initial public offerings, visit the IBD stock list page on IPO Leaders.


Roku makes hardware and software for accessing internet video services like Netflix ( NFLX), Hulu and Amazon ( AMZN) Prime Video. It sells set-top boxes and dongles and provides software for smart TVs. It also gets revenue from selling advertising on its home screen and takes a share of pay-per-view movie sales and subscriptions sold through its platform.

"In our view, the stock is trading on nonfundamental factors, driven by a limited float (9% of non-GAAP shares) and high short interest (likely over 46% of float, as data are delayed)," Helfstein said.

RELATED:

Roku Stock Rises Sharply On Markets For Third Straight Day


69. Nvidia Impresses Analysts At Supercomputing ConferenceСр., 15 нояб.[−]

Graphics-chip maker Nvidia ( NVDA) earned high marks from Wall Street analysts for its presentations at the SC17 supercomputing conference in Denver this week.

In a report, RBC Capital Markets analyst Mitch Steves said he is "incrementally more bullish" on Nvidia's prospects in the data center, gaming and automotive markets after the chipmaker's investor update at the show. He reiterated his outperform rating on Nvidia stock and price target of 240.

Nvidia shares added 0.7% to close at 214.18 on the stock market today.

At SC17, Nvidia said its Tesla V100 graphics processing unit, based on the company's Volta architecture, has been chosen by every major cloud computing company for artificial intelligence and high-performance computing applications.

"Volta is the world's most powerful platform for AI and HPC, and will allow the world's top minds in scientific research to push the limit on what's possible in areas like drug discovery, alternative fuel sources and predicting natural disasters," Nvidia Chief Executive Jensen Huang said in a news release. "With Volta now in data centers and clouds around the world, a new wave of innovation is underway that will have an incredible impact across society."

Cloud computing providers such as Alibaba ( BABA) Cloud, Amazon ( AMZN) Web Services, Baidu ( BIDU) Cloud, Microsoft ( MSFT) Azure, Oracle ( ORCL) Cloud and Tencent ( TCEHY) Cloud have announced Volta-based cloud services, Nvidia said.


IBD'S TAKE: Nvidia is currently ranked No. 8 on the IBD 50 list of top-performing growth stocks.


B. Riley FBR analyst Craig Ellis said he is left more confident in Nvidia's data center growth after the company's presentations. Nvidia estimates the total addressable market in data center chips to be worth $30 billion.

In a note to clients, Ellis maintained his buy rating on Nvidia and stock price target of 270.

Rosenblatt Securities analyst Hans Mosesmann also came away from the show with a good feeling about Nvidia. He reiterated his buy rating on the stock.

"GPU (graphics processing unit) acceleration trends in AI/HPC and data center are secular, powerful and devastating for CPU (central processing unit) incumbents," Mosesmann said in a report. "Volta is at the early stages of an inflection point with broad implications for the industry and investors."

RELATED:

Nvidia Upgraded As Analyst Admits Being Wrong On The Stock


70. This Biotech Is Feeling The Pain After FDA Sets Panel On AnestheticСр., 15 нояб.[−]

Pacira Pharmaceuticals ( PCRX) was down nearly 7% at the close Tuesday after the Food and Drug Administration said an advisory committee would review the benefits of Pacira's drug Exparel as a regional anesthetic before potential approval in April.

XAutoplay: On | OffThe Anesthetic and Analgesic Drug Products Advisory Committee is set to discuss expanding Exparel's label in mid-February. An expansion to the label would allow physicians to use Exparel to block nerves in a region from feeling pain during surgical procedures.

Advisory committees use independent advise from outside experts to vote on whether to recommend a drug for approval. These committees aren't assigned to every drug before approval and the FDA doesn't have to follow the recommendation.

Exparel is approved as a local anesthetic. Pacira filed to have it approved as a regional anesthetic in 2015 based on a successful trial of lower-extremity surgeries. But the FDA required Pacira to run additional trials in upper extremities and to look at the impact through 120 hours post-surgery.

Results in July were mixed. The upper-extremity trial in shoulder surgery hit its main goals, but the study testing Exparel as a regional anesthetic in lower-extremity surgery missed. Pacira filed a new application in the third quarter.


IBD'S TAKE: Pacira has an IBD Composite Rating of 43 out of a best-possible 99, meaning it underperforms about six in 10 stocks in terms of key growth metrics. Head to IBD Stock Checkup for a look at better-rated leaders in the biotech group.


Needham analyst Serge Belanger was surprised by the need for an advisory committee in this instance.

"The convening of the FDA (advisory committee) panel for the Exparel label expansion is somewhat of a surprise since (advisory committee) reviews have typically been reserved for new chemical entities and novel indications," he said. "Neither Exparel or nerve block regional anesthesia tick those boxes."

He noted in a report to clients that the FDA and Pacira have tussled over this expansion in the past. Exparel has been on the market as a local anesthetic since 2012. Plus, nerve block anesthesia is well understood and the original application as a regional anesthetic wasn't subject to an advisory panel.

"While somewhat of a surprise, we don't view the (advisory committee) as a negative since it will allow Pacira to address any specific issue the FDA may have by laying out the clinical data package supporting the (application) and making the case for an Exparel nerve block expansion," he said.

Belanger kept his buy rating and 52 price target on Pacira.

Still, in afternoon trading on the stock market today, Pacira toppled 6.6% to finish at 39.93. The biotech group widely sold off Tuesday, diving a collective 2.9%.

RELATED:

This Cancer Biotech Is Falling On Its $1.55 Billion Bayer Deal

Why This Biotech Still Gets Hit Despite Promising Cancer Data

This Biotech Just Neared A 17-Year High On Strong Cancer Regimen


71. Western Digital Hits Buy Zone On Report That Toshiba Deal Is NearСр., 15 нояб.[−]

Western Digital ( WDC) shares rose Tuesday, following a report from a Japanese newspaper late Monday saying the company is in active discussions to settle a dispute with Toshiba about their joint venture in a chip-manufacturing plant.

XAutoplay: On | OffA report from Japanese newspaper Yomiuri Shimbun said the two companies were striving to reach an agreement by the end of this month over the control of Toshiba's portion of the joint venture with Western Digital.

Western Digital shares rose 3.6% to close at 91.58 on the stock market today, just above a 91.33 buy point.

The Toshiba unit makes a popular computer memory chip known as Nand flash, which is used in a wide variety of consumer electronics and in chip-based data storage systems. Toshiba is under heavy pressure to sell the chip unit, in order to cover massive losses from its nuclear division and avoid having its stock delisted from Japan's stock exchanges.

Western Digital lost out in an attempt to buy Toshiba Memory to a group led by Korean chipmaker SK Hynix and Bain Capital, but has continued to pursue arbitration in an international court. Western Digital had also bid on the chip unit as part of a group that includes KKR ( KKR).

Western Digital acquired a stake in Toshiba Memory resulting from its $15.8 billion SanDisk acquisition, giving it certain contractual rights. It's those rights that are in dispute and which Western Digital continues to leverage for its benefit by trying to nix any deal without its approval.


IBD'S TAKE: Western Digital holds a strong IBD Composite Rating of 90 out of a possible 99 and is trading above its 50-day moving average. When you're looking to get a broader idea on top tech stocks, IBD's Tech Leaders feature is worth reviewing.


The Yomiuri Shimbun report said that Western Digital would receive better terms in its joint venture, in addition to supply guarantees, in return for dropping its arbitration process.

Western Digital on Oct. 26 reported quarterly results that topped estimates on the top and bottom lines.

Western Digital reported revenue of $5.18 billion for its fiscal first quarter ended Sept. 29, beating the consensus estimate of $5.1 billion and up 10% from the year-ago period. In addition to its strong presence in the memory-chip market, Western Digital is also the largest provider of disk drives.

RELATED:

Toshiba Tells Western Digital To Back Off On Quashing Chip Deal


72. Biotechs Sell Off In Droves — Are Investors Seeking Mergers?Ср., 15 нояб.[−]

Loxo Oncology's ( LOXO) deal with Bayer ( BAYRY) had a bigger impact on the biotech sector than you'd expect, an industry observer told Investor's Business Daily on Tuesday as key exchange traded funds fell out of flat bases.

XAutoplay: On | OffEarly Tuesday, Loxo announced a deal with Bayer to co-develop two of its cancer drugs in an agreement that could pay Loxo up to $1.55 billion. Under the terms of the deal, Loxo and Bayer will split profits equally on drugs known as larotrectinib and LOXO-195 in the U.S.

But the sector was hoping for an outright buyout, said Brad Loncar, portfolio manager for Loncar Investments, in an interview with IBD. The Loncar Cancer Immunotherapy ETF ( CNCR) toppled alongside its fellow ETF peers, falling 3.4% to 23.30.

"(Loxo) has been one of, if not the, most successful small biotech companies this year," he said. "Some people were hoping for an outright buyout, and even if they weren't hoping for a buyout they gave pretty clear guidance they were going to hold on to those rights."

Loxo stock was up 159% for the year as of Monday's close, easily outperforming IBD's 458-company biotech industry group, which has climbed 25% year to date. On the stock market today, Loxo toppled 4.1% to close at 79.84, though shares were down as much as 12.8% earlier in the day.

Collectively, the biotech group dove 2.6% and neared a three-month low after hitting its highest point since December 2015 in October. But the third-quarter earnings season was rough for a number of players like Celgene ( CELG) and Gilead Sciences ( GILD), which weighed heavily on the group.

Biotech-centric ETFs also took pitfalls. The S&P Biotech ETF ( XBI) fell out of its flat base with a buy point at 89.08, diving 2%. The iShares Nasdaq Biotechnology ETF ( IBB) had been forming a flat base with an entry at 342.60, but fell 1.6%. ProShares Ultra Nasdaq Biotechnology ETF ( BIB) dove 3.3%.


IBD'S TAKE: Loxo has an IBD Composite Rating of 51 out of a best-possible 99, meaning it performs in the middle of all stocks in terms of key growth metrics. Head to IBD Stock Checkup for a look at better-rated players in the biotech group.


Loncar says mergers and acquisitions could really help the biotech group.

"If (Loxo) had been bought out today, everybody would be saying, 'What's the next smaller company that's going to be bought out?' and they would probably be bidding up all of the stocks," he said.

The fact Loxo was willing to give away 50% of its profits on these two drugs, both of which work to target gene fusions in cancer, suggests the biotech's negotiating was a bit weaker than expected, Loncar said. This "revaluation" is hurting the sector.

He puts Tesaro ( TSRO) and Clovis Oncology ( CLVS) into the same bucket. Both have approved drugs, known as PARP inhibitors, that target ovarian cancer. Loxo's larotrectinib isn't yet approved.

Big pharmas, which struggled in the quarter, need to buy revenue growth, Loncar says. But it's possible "the market (has) pushed their valuations so high that an outright buyout doesn't make sense" for the likes of Loxo, Tesaro and Clovis, he added.

Biotech Group Dives

The biotech industry group is now ranked No. 19 out of 197 groups tracked by IBD, down from first just a month ago. Gilead's acquisition of Kite Pharma — announced in August and completed in October — helped spike the group to a nearly two-year high.

Since then, the group has pulled back. Investors either reacted harshly or surprisingly to news out of the group, Loncar said. Five Prime Therapeutics ( FPRX) dove nearly 41% on Nov. 7 after unveiling the abstracts for its immuno-oncology combination with Bristol-Myers Squibb ( BMY) for pancreatic cancer.

Overall, 13% of patients responded to the combination of Five Prime's cabiralizumab and Bristol's Opdivo. Pancreatic cancer is particularly hard to treat. Typically, doctors would have expected no response from the combination. Now, the duo has time to refine its treatment regimen.

"We Wall Street people demand instant gratification and instant success out of drugs," Loncar said. "It would be disappointing if this was a big Phase 3 trial at the end of the road. But this is literally the first in-human trial."

Dynavax Technologies ( DVAX) also has suffered following the Food and Drug Administration's approval of its drug dubbed Heplisav-B to treat hepatitis B. The stock fell 9.4% on Monday. Loncar says investors are looking for Dynavax to either be bought or find a partner.

"I think they probably will find a deal like that," he said. "But you can't expect it literally the day after the approval. So between now and the first quarter when they're actually launching the drug, I think there's a chance for some good news there."

He added: "A lot of investors expected a big pop, and as soon as there wasn't they ran for the exits. I don't think that's reflective of the quality of the company."

RELATED:

This Biotech Just Neared A 17-Year High On Strong Cancer Regimen

Why Tesaro's $2 Million Cancer-Drug Miss Prompted Its Rivals To Topple

This Biotech Just Rose By A Third On Its Earnings — But Is It In Trouble?


73. Apple's iPhone X Screen Is Giving Some Users HeadachesСр., 15 нояб.[−]

A growing number of Apple ( AAPL) iPhone X customers have reported eye fatigue and headaches from using the new premium handset and are taking to online forums to share their concerns.

XAutoplay: On | Off"Ever since Thursday I have been experiencing headaches every time I'm on my phone for around 10 minutes-plus," one iPhone X user said in a MacRumors forum on Saturday. "This has never happened to me before on any of my other devices."

Another iPhone X user replied, "Same thing, got really sore eyes since two days (really painful), the X is the culprit for sure. I don't know what to do."

Some tech-savvy forum members on MacRumors suggested that the eye strain is the result of Apple's use of pulse-width modulation to dim the brightness of the OLED display. They noted that some people are more sensitive to the flicker effect than others.

The number of iPhone X owners complaining about the display issue is hard to quantify at this point.

One user in Los Angeles told IBD that he experienced eye strain from the iPhone X and decided to trade the device in for an iPhone 8 Plus, which has an LCD screen. The user said he didn't know if it was the OLED display technology itself that was giving his eyes problems or the lack of a display zoom option in combination with the narrower screen width on the iPhone X.

Apple did not respond to a request for comment by the time this article was posted.

Apple shares were down 1.5% to close at 171.34 on the stock market today.


IBD'S TAKE: Apple stock has an IBD Composite Rating of 94, meaning it has outperformed 94% of stocks in key metrics over the past 12 months. For more analysis on Apple, visit the IBD Stock Checkup.


New iPhone designs like the iPhone X tend to have more technical issues than established form factors.

On Friday, MacRumors reported that a limited but increasing number of iPhone X owners have encountered a green line appearing on the smartphone's display.

On Sunday, 9to5Mac reported that some iPhone X users are experiencing crackling and buzzing sounds from the handset's earpiece speaker.

RELATED:

Apple Readying Augmented-Reality Glasses For 2020 Launch: Report

Apple Stores Run Out Of iPhone X's In First Weekend Of Sales


74. This Cancer Biotech Is Falling On Its $1.55 Billion Bayer DealСр., 15 нояб.[−]

Loxo Oncology ( LOXO) toppled Tuesday after agreeing to codevelop two cancer therapies with drug firm Bayer ( BAYRY) in a deal that could be worth up to $1.55 billion in total payments for Loxo.

XAutoplay: On | OffThe two drugs focus on what's called tropomyosin receptor kinase, or TRK, inhibition. Evidence suggests the NTRK genes, which encode for the TRKs, can become abnormally fused to other genes, prompting growth signals that can lead to cancer.

Loxo's drug, larotrectinib, targets these gene fusions to treat cancer. The other drug in Loxo's agreement with Bayer is known as LOXO-195. This drug is being developed for patients whose cancer begins to resist treatment with TRK inhibitors like larotrectinib.

Loxo will lead global development and U.S. regulatory activities, while Bayer will lead outside the U.S. in regulatory and commercial activities. Globally, the firms will split development costs. In the U.S., where they will co-promote the drugs, the two will share costs and profits equally.

By the closing bell on the stock market today, though, Loxo fell 4.1% to finish at 79.84. Shares had been consolidating with a buy point at 96.02. Bayer lifted less than 1%, near 32.

It was not immediately apparent why Loxo shares were tumbling, although the fact it is sharing profits on what is considered a promising technology with Bayer may have factored into investors' thinking.

Under the terms of the deal, Loxo will receive $400 million upfront. It is eligible to receive $450 million in milestone payments for larotrectinib and an additional $200 million in milestones for LOXO-195.


IBD'S TAKE: Need some help getting your feet wet in the stock market? A good place to start is IBD's Stock Lists page, which helps highlight top-rated equities on the IBD 50, IPO Leaders, IBD Big Cap 20, Sector Leaders and Stock Spotlight.


Bayer will pay Loxo $25 million upon hitting a specific U.S. net sales threshold. Outside the U.S., Bayer will pay Loxo a tiered, double-digit royalty on net sales and milestones up to $475 million. But Bayer will book revenue worldwide.

Investors have keyed in on larotrectinib as an important drug for Loxo. Shares jumped 43.2% on June 5 on Phase 1 and Phase 2 data for the drug. On Sept. 13, the stock flew 15.3% when the firm said it would have thyroid, colon and solid-tumor cancer data the following month.

Year-to-date, Loxo shares are up 159%. Outside its TRK drugs, Loxo is working on a Phase 1 drug known as LOXO-292, which targets different gene fusions in lung, thyroid, colon and other cancers. It also has two other preclinical cancer programs in its pipeline.

RELATED:

Loxo Oncology Fights Cancer With 'Tumor Agnostic' Approach

6 Top Biotech Companies In Innovation Earn Recognition In New Awards

Buying And Selling Stocks Right Are Keys To This Top Mutual Fund's Success


75. Stratasys Beats Views On Third-Quarter Earnings, Raises GuidanceСр., 15 нояб.[−]

Stratasys ( SSYS) reported third-quarter earnings before the market open Tuesday that beat on the bottom line as the company raised guidance for the current quarter, and shares soared after the opening bell.

XAutoplay: On | OffStratasys shares jumped nearly 11% right after the open, and settled back for a closing gain of 4.3% to 20.98 on the stock market today.

The manufacturer of 3D printers reported adjusted earnings of 8 cents per share, vs. 1 cent in the year-ago period and beating the consensus estimate of four cents, as polled by Zacks Investment Research.

Stratasys reported revenue of $155.9 million, down 1% from the year-ago period and missing the consensus estimate of $162 million. Stratasys said revenue for the third quarter was partially impacted by several large, multisystem orders that were deferred until October.

But Stratasys raised full-year guidance by $10 million to a range of $655 million to $670 million. It raised guidance on adjusted earnings to a range of 40 cents to 48 cents, up from 19 cents to 37 cents.

"We achieved significant improvements in operating profit during the third quarter compared to the prior year," said Stratasys Chief Executive Ilan Levin, which he attributed partly to "developing high-value applications within our key vertical markets."

RELATED:

Competition In 3D Printer Field Mounts As 3D Systems Rated Sell


76. This Top Chip-Gear Maker Soars 20% On Strong EarningsСр., 15 нояб.[−]

Semiconductor-equipment maker Kulicke & Soffa Industries ( KLIC) beat Wall Street's expectations for fiscal fourth-quarter sales and earnings, and its shares catapulted by more than 20% Tuesday.

XAutoplay: On | OffKulicke & Soffa shares ended the day 20.4% to 28.52 by the closing bell on the stock market today. Kulicke & Soffa stock broke out of a 27-week consolidation period at a buy point of 23.10 on Nov. 6.

Singapore-based Kulicke & Soffa reported earnings per share of 51 cents, up 240% year over year, on sales of $215.9 million, up 48%, in its fiscal fourth quarter ended Sept. 30. Analysts expected earnings of 35 cents a share on sales of $208.7 million.

For the current quarter, it expects sales of $190 million, up 27%, based on the midpoint of its guidance. It did not give a target for earnings per share. Wall Street was modeling earnings per share of 17 cents on sales of $160.7 million.

"We continue to seek out meaningful new growth opportunities while extending existing market positions," Kulicke & Soffa Chief Executive Fusen Chen said in a news release.


IBD'S TAKE: Kulicke & Soffa has an IBD Composite Rating of 94, meaning it has outperformed 94% of stocks in key metrics over the past 12 months. But it ranks No. 22 out of 34 stocks in IBD's Electronics-Semiconductor Equipment industry group. To see which companies lead the group, visit the IBD Stock Checkup.


Kulicke & Soffa makes semiconductor packaging and electronic assembly systems for automotive, computing, communications and other markets.

Semiconductor unit production, a proxy for equipment demand, is expected to grow at 11.8% year over year in calendar 2017, the company said. Kulicke & Soffa expects semiconductor unit production to grow at a compound annual growth rate of 8.9% through calendar 2021, materially higher than the 3.4% rate of the previous four-year period.

Kulicke & Soffa said its products are aligned with several fast-growing markets including sensors and Nand flash memory.

RELATED:

Ichor Holdings Falls On In-Line Q3 Earnings Report

Top-Rated Brooks Automation Beats September-Quarter Targets, Guides Higher

This Top-Rated Laser Maker Is Blasting Past A Buy Point On Earnings, Guidance


77. Will iPhone X Promotions On Black Friday Renew Wireless Price War?Вт., 14 нояб.[−]

Hot deals for Apple's ( AAPL) iPhone X starting around Black Friday could bring back wireless price wars as T-Mobile US ( TMUS) and Sprint ( S) renew aggressive marketing after failed merger talks.

"We suspect the need to maintain net (subscriber) add momentum will drive Sprint and T-Mobile to offer aggressive promotions starting around Black Friday (Nov. 24 following Thanksgiving)," Jeffrey Kvaal, a Nomura-Instinet analyst, said in a note to clients.

T-Mobile and Sprint broke off merger talks on Nov. 4.

Verizon Communications ( VZ) and AT&T ( T) will likely match promotional offers from T-Mobile and Sprint, analysts say. AT&T and Verizon reintroduced unlimited wireless data plans in early 2017 amid market share gains by T-Mobile and Sprint.

"We believe competition will heat up after the recent abnormal lull as the holiday selling season begins, the iPhone X becomes available and cable enters the mix," UBS analyst John Hodulik said in his note.

Apple's new flagship smartphone, the iPhone X, hit store shelves on Nov. 3 after production delays. The iPhone X is expected to be in tight supply throughout the holidays. Delivery dates for online orders have improved from 5-6 weeks to 3-4 weeks.

"The iPhone X cycle stands out as the best chance in years to entice subscribers to shift carriers," added Kvaal in a report. "We expect both T-Mobile and Sprint to offer aggressive promos for Black Friday."

Apple rolled out the iPhone 8 and the higher-priced iPhone X in mid-September.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


AT&T, Sprint, T-Mobile and Verizon all reported that subscribers upgraded to new smartphones, including the iPhone 8, at a slower rate in the September quarter than a year earlier.

In the September quarter, T-Mobile again led the industry in "postpaid" phone subscriber additions. T-Mobile added 595,000 higher spending postpaid subscribers, while Sprint claimed 279,000 more and Verizon tacked on 274,000. AT&T said it lost 97,000 postpaid phone subscribers.

RELATED:

Telecom Stocks To Watch And Industry News

CenturyLink Quarterly Results Miss, Raise Worries Over Dividend

AT&T Likely Would Win Court Fight Over Time Warner, Analysts Say

Cable TV's Hail Mary: Hike Broadband Prices Amid Cord-Cutting


78. Facebook (FB) Stock Quotes, Company News And Chart AnalysisВт., 14 нояб.[−]

XAutoplay: On | Off


View FB Stock Quote Page
| View FB Ratings

Facebook Stock News & Analysis

New Facebook Portal Will Tell If You Were Misinformed By RussiansFacebook, under congressional scrutiny for the role its social network played in the 2016 U.S. election, took a step Wednesday to inform users if they were fooled by misinformation from Russian operatives.... Read More
The Most Timely Stock In This Elite ScreenGoing into Monday's session, the Sector Leaders screen was up a stunning 55.6% year to date. This is a bullish sign for the market for two reasons. First, the Sector Leaders list... Read More
Nvidia To Climb Higher On Data-Center, Gaming Demand: AnalystGraphics-chip maker Nvidia late Thursday received a bullish report from a Wall Street analyst who thinks the company's stock could reach 300 under a bull-case scenario. RBC Capital Markets analyst Mitch Steves... Read More
Creativity Helps Yelp Defend Against Facebook, Google OnslaughtLooking to avoid the competitive wrath of Facebook and Alphabet that target its core market with various ventures, Yelp has been busy adjusting business models and creating new ones to boost growth.... Read More
S&P 500 Futures Fall Amid GE, China Internet News; FANGs Are Still BuysS&P 500 futures fell modestly Monday morning as Chinese internet giants rallied on earnings and the 11.11 sales event, while General Electric slashed its dividend in half. Meanwhile, Facebook, Amazon, Netflix and Google-parent Alphabet... Read More

More Technology Stocks Coverage

FANG Stocks News: Facebook, Amazon, Netflix, Google

Apple (AAPL) Stock Quotes And Company News

Tesla (TSLA) Stock Quotes And Company News

View More Tech Stocks


79. Roku Stock Rises Sharply On Markets For Third Straight DayВт., 14 нояб.[−]

Shares of streaming video firm Roku ( ROKU) continued their impressive climb on Monday amid investor enthusiasm following the company's third-quarter earnings report late Wednesday.

Roku rose 28.5% to 42.71 on the stock market today. During the regular session, Roku hit an all-time high of 47.49. It was the third straight day of big gains for the recent IPO. Roku rose 55% on Thursday and 13.9% on Friday. Since posting better-than-expected September-quarter results, Roku stock has rocketed nearly 127%.

The Los Gatos, Calif.-based company went public on Sept. 28 at $14 a share. On Friday, Roku broke out of an IPO base with a buy point of 29.90 in heavy trading.


IBD'S TAKE: For a look at top-performing recent initial public offerings, visit the IBD stock list page on IPO Leaders.


On Friday, Roku disclosed that it purchased Denmark-based multiroom audio startup Dynastrom in September for $3.5 million. The news is seen as evidence that Roku is working on a smart speaker or will add new audio functions to future set-top boxes, Variety reported.

Roku makes hardware and software for accessing internet video services like Netflix ( NFLX), Hulu and Amazon.com's ( AMZN) Prime Video. It sells set-top boxes and dongles and provides software for smart TVs. It also gets revenue from selling advertising on its home screen and takes a share of pay-per-view movie sales and subscriptions sold through its platform.

RELATED:

Roku Stock Breaks Out On Post-Earnings-Report Fervor


80. Qualcomm Rejects Broadcom's Buyout Offer, Says It's UndervaluedВт., 14 нояб.[−]

Wireless-chip maker Qualcomm ( QCOM) on Monday rejected an unsolicited acquisition offer by Broadcom ( AVGO), saying the proposed $130 billion deal undervalues the company, but Broadcom insists it plans to continue pursuing the merger.

XAutoplay: On | OffIn a news release, Qualcomm said its board of directors unanimously rejected the Nov. 6 proposal and said it was not in the best interests of shareholders.

"It is the board's unanimous belief that Broadcom's proposal significantly undervalues Qualcomm relative to the company's leadership position in mobile technology and our future growth prospects," Qualcomm Chairman Paul Jacobs said in the release.

The board also believes Broadcom's proposal comes with "significant regulatory uncertainty," meaning it might not pass muster with antitrust authorities.

Broadcom responded with its own statement on Monday, saying it remains fully committed to the deal.

"We continue to believe our proposal represents the most attractive, value-enhancing alternative available to Qualcomm stockholders and we are encouraged by their reaction," Broadcom Chief Executive Hock Tan said in the statement. "Many have expressed to us their desire that Qualcomm meet with us to discuss our proposal. It remains our strong preference to engage cooperatively with Qualcomm's board of directors and management team."

Qualcomm shares were up 3% to close at 66.49 on the stock market today. Broadcom ticked up 5 cents to 265.01, still in buy range.


IBD'S TAKE: Broadcom stock has a best-possible IBD Composite Rating of 99. For more analysis on Broadcom and its peers, visit the IBD Stock Checkup.


Qualcomm Chief Executive Steve Mollenkopf said the company's prospects remain bright.

"No company is better positioned in mobile, IoT (internet of things), automotive, edge computing and networking within the semiconductor industry," Mollenkopf said in the release. "We are confident in our ability to create significant additional value for our stockholders as we continue our growth in these attractive segments and lead the transition to 5G (wireless technology)."

Broadcom offered to pay $70 in cash and stock for each share of Qualcomm. The deal would consist of $60 in cash and $10 per share in Broadcom shares. The proposed transaction value of $130 billion includes $25 billion of net debt.

Broadcom Might Have To Sweeten Deal

Broadcom might have to raise the acquisition offer to make it more palatable to Qualcomm shareholders, analysts say.

If Broadcom can pull off the acquisition, it would be the largest ever tech deal, dwarfing Dell's $67 billion acquisition of EMC in 2015.

The combination of Broadcom and Qualcomm would create the world's third-largest semiconductor maker, behind Intel ( INTC) and Samsung.

William Blair analyst Anil Doradla said he expects the back-and-forth between Qualcomm and Broadcom to last for a number of months.

"We are still in the very early stages of a potential deal, and even if the companies are able to agree on terms, it could be well over a year before the deal receives regulatory approval," Doradla said in a note to clients Monday.

Regulatory issues are the main sticking point in the deal moving forward, Doradla said.

"Qualcomm is clearly using the prospect of regulatory uncertainty to drive a higher offer price," he said.

RBC Capital Markets analyst Amit Daryanani reiterated his "top pick" buy rating on Broadcom with a price target of 300. He said Broadcom is committed to its dividend strategy even with its bid to acquire Qualcomm.

Qualcomm's rejection of Broadcom's offer sets the stage for a proxy battle that will be decided by shareholders, Daryanani said in a report Monday.

"In a proxy fight we believe the debate would be: Can Qualcomm management that has overseen severe underperformance and been unable to resolve key disputes turn the ship or do shareholders put faith in Hock and take the exit? At the right price ($80?) we think investors would choose the Broadcom option," Daryanani said. He maintained his outperform rating on Qualcomm with a price target of 70.

Qualcomm's recent performance has been hindered by a legal dispute with major customer Apple ( AAPL) over patent royalty terms.

Canaccord Genuity analyst Michael Walkley reiterated his buy rating on Qualcomm and raised his price target to 83 from 76, based on the expectation for a higher buyout price.

RELATED:

Broadcom Offers To Buy Qualcomm For $130 Billion In Largest Tech Deal Ever


81. Take-Two Interactive Software Gets Price-Target Hike On Strong OutlookВт., 14 нояб.[−]

Video game publisher Take-Two Interactive Software ( TTWO) received a bullish report from a Wall Street firm on Monday, based on the company's strong outlook for the rest of this year and next.

BMO Capital Markets analyst Gerrick Johnson reiterated his outperform rating on Take-Two and lifted his price target to 135 from 125.

Take-Two shares climbed 2.2% to finish at 118.26 on the stock market today.

"Of the video game companies we cover, we think Take-Two stands to benefit the most from positive video game industry tailwinds, including the transition to digital distribution offering higher margins and the opportunity for incremental add-on sales and multiplayer online services," Johnson said in a note to clients.

The most important aspect of the digital transition for Take-Two has been that it has allowed the company to smooth out its once highly volatile earnings stream by monetizing hit game franchises like "Grand Theft Auto" and "NBA 2K" well beyond their initial releases, he said.


IBD'S TAKE: Take-Two Interactive Software stock has an IBD Composite Rating of 96, meaning it has outperformed 96% of stocks in key metrics over the past 12 months. For more analysis on Take-Two and its peers, visit IBD Stock Checkup.


"In the past, the knock against the company had always been that it was overly reliant on just a few games, most notably 'Grand Theft Auto,' creating a lumpy, unpredictable, and risky earnings stream," Johnson said.

"But in the digital era this is a competitive advantage," he added. "By having some of the highest-quality games, and periodically dropping additional content, Take-Two can keep its players engaged and spending in its games without having to reinvent the wheel every 3-5 years. The company's earnings stream is now predictable, reliable, and much less risky."

RELATED:

'Grand Theft Auto' Game Maker Crushes Views; Stock Seen As A Steal


82. Why This Biotech Still Gets Hit Despite Promising Cancer DataВт., 14 нояб.[−]

Five Prime Therapeutics ( FPRX) continued taking hits Monday after presenting data from a Phase 1 trial of its drug combined with Bristol-Myers Squibb's ( BMY) Opdivo in pancreatic cancer patients.

XAutoplay: On | OffBut at least one analyst says the data have been taken out of context. The combination of Five Prime's cabiralizumab with Bristol's Opdivo resulted in a 13% overall response rate and led to durable responses in patients out to one year.

Pancreatic cancer is particularly hard to treat using a drug like Opdivo, which belongs to a class of checkpoint inhibitors that target an interaction involving the PD-1 protein in the immune system to treat cancer, Instinet analyst Christopher Marai said in a note to clients.

Marai classified the combination as "compelling and could become more so on top of chemo." The presenter "highlighted the rarity of seeing an (immuno-oncology) combo work in pancreatic cancer, noting thousands of patients have received treatment inside and outside trials with checkpoint inhibitors and have not seen benefit," he said.

The data were presented at the Society for Immunotherapy of Cancer annual meeting. Five Prime first released the abstracts on Nov. 7.

Five Prime has taken a beating since releasing the abstracts. By the closing bell on the stock market today, Five Prime sank 10% to close at 25.96. The stock has lost more than a third of its value since releasing the data.

Investors are keying in on adverse event data, analysts say. Five Prime and Bristol tested the regimen across multiple tumor types. Across all patients, grade 3-5 adverse events attributed to cabiralizumab occurred in 43%, leading 13% to discontinue treatment.


IBD'S TAKE: Could this top-ranking medical stock pop higher on earnings in early December as its shares near a buy point? Head to IBD Stock Analysis for more.


But in pancreatic cancer patients, 7% and 13% on the combination and on cabiralizumab alone, respectively, discontinued treatment due to adverse events. Broad safety data were in line with what one would expect from treatment with Opdivo, Marai said.

Cabiralizumab has been previously tested in rheumatoid arthritis and a joint disease. The drug proved safe and well-tolerated in those trials, he wrote.

Some investors have expressed concern that Five Prime and Bristol only released efficiency data from the regimen in pancreatic cancer, Marai said. But he noted the first segment of the trial to complete enrollment and have mature data was pancreatic cancer.

This is "logical given the high unmet need and poor response to general therapies," he said. "We believe limited disclosure is more a result of the highly competitive nature of the (immuno-oncology) space and Bristol's strategic position, than a lack of positive data."

RELATED:

Why This Biotech Crashed Despite Topping Breast Cancer Drug Sales

This Biotech Just Rose By A Third On Its Earnings — But Is It In Trouble?

Why Tesaro's $2 Million Cancer-Drug Miss Prompted Its Rivals To Topple


83. Morgan Stanley Sees Amazon Reaching $1 Trillion Market CapitalizationВт., 14 нояб.[−]

Morgan Stanley on Monday presented a bull-case scenario for Amazon.com ( AMZN) that sees the e-commerce leader nearly doubling to a market capitalization of $1 trillion and a share price of 2,000 by the end of 2018.

XAutoplay: On | OffMorgan Stanley analyst Brian Nowak used a "sum of the parts methodology" that looks out to 2022 for five segments of Amazon. Those parts are Amazon's first- and third-party retail businesses; its cloud computing unit, Amazon Web Services; Prime membership subscriptions; and the general category of advertising/other.

"Amazon's high-margin revenue disclosure speaks to the $1 trillion ($2,000/share) sum-of-parts bull case," Nowak wrote in a note to clients Sunday.

"The valuations apply multiples based on what we view are appropriate peer groups, factoring in relative growth rates and margin profiles," Nowak wrote. "We discount each segment back to year-end 2018 to arrive at a $2,000/share value or (about a) $1 trillion bull case."

Amazon's current market capitalization is near $546 billion. Amazon shares ticked up 0.3% to close at 1,129.17 on the stock market today. Nowak currently has an overweight rating on Amazon with a price target of 1,250.

Nowak estimates that Amazon's first- and third-party core retail business will be worth $600 billion. Amazon Web Services will be worth $270 billion, with its Prime subscription revenue business worth $70 billion and Amazon's ad business worth $55 billion.


IBD'S TAKE: Amazon is on the exclusive list of IBD Leaderboard stocks, which says the stock is holding near highs as it sits in buy range from a 1,083.41 buy point. The latest breakout was from a late-stage base.


Amazon shares hit a record high after reporting better-than-expected third-quarter results on Oct. 26 that smashed estimates and subsequently received multiple price-target hikes.

Amazon reported revenue of $43.7 billion, up 34% from the year-ago quarter and beating the consensus estimate of $42 billion. It reported adjusted earnings of 52 cents, smashing the consensus estimate of 1 cent, as polled by Zacks Investment Research.

RELATED:

Amazon Stock Quotes, Company News And Chart Analysis

FANG Stocks News: Facebook, Amazon, Netflix, Google


84. 58.com Shares Jump As Third-Quarter Results Top EstimatesВт., 14 нояб.[−]

Shares soared Monday for China internet company 58.com ( WUBA), the so-called Craigslist of China, after it reported third-quarter results that topped estimates.

XAutoplay: On | Off58.com reported revenue of $410.2 million, beating the consensus estimate of $385.6 million and up 33% from the year-ago period. It reported adjusted earnings of 49 cents per share, beating the consensus estimate of 28 cents and up from a 2-cent loss in the year-ago period.

58.com is China's largest online market place for classifieds. Revenue from membership rose 27% to $149.8 million.

58.com shares jumped 6% to close at 73 on the stock market today.


IBD'S TAKE: The IBD SmartSelect Composite Rating for 58.com is 97, up from 94 last week. The new rating shows the stock is outpacing 97% of all stocks when it comes to the most important stock-picking criteria.


"We continued to drive traffic growth and expand user engagement by deploying new and innovative technologies, particularly on our mobile applications," said 58.com Chief Executive Michael Yao, in prepared remarks with the earnings release. "We continue to see enormous market opportunities."

Another China-based company reporting third-quarter results Monday was e-commerce company JD.com ( JD), which beat estimates. JD.com, the largest internet company in China by revenue, reported quarterly revenue of $12.58 billion, up 39% from the year-ago period. JD.com was up 3.5% to finish at 41.34.

RELATED:

Retail Industry News And Stocks To Watch


85. JD.com Stock Jumps As Quarterly Earnings Beat EstimatesВт., 14 нояб.[−]

China e-commerce company JD.com ( JD) reported third-quarter results before the market open Monday that topped estimates and sent the stock soaring.

XAutoplay: On | OffJD.com, the largest internet company in China by revenue, reported revenue of $12.58 billion, beating the consensus estimate of $12.25 billion and up 39% from the year-ago quarter. It reported adjusted earnings of 23 cents vs. 3 cents in the same period a year ago, beating the consensus estimate of 10 cents, as polled by Zacks Investment Research.

JD.com shares ended the regular trading session up 3.5% to close at 41.34 on the stock market today. The company said annual active customer accounts rose 34% to 266.3 million, up from 198.7 million in the year-ago period.

"We are achieving our mission of bringing China's consumers the widest selection of top brands and, by far, the highest quality e-commerce experience," JD.com Chief Executive Richard Liu said in prepared remarks with the earnings release.

JD.com has an e-commerce business model similar to Amazon.com ( AMZN) and competes most directly in China against Alibaba ( BABA). JD and Alibaba are among the best Chinese stocks to buy and watch.


IBD'S TAKE: JD.com shares on Monday jumped above its 50 day moving average, which is a positive indicator. The stock has an IBD Composite Rating of 75 out of a possible 99. Check out IBD's Tech Leaders feature to get a broader idea on top tech stock.


Alibaba, on Nov. 11, held its annual one-day sales event, the largest shopping day globally, known as the 11.11 Global Shopping Festival. Alibaba reported gross merchandise volume of $25.4 billion, up 39% vs. a year earlier. But JD.com racked up $19.1 billion.

Alibaba, on Nov. 2, reported revenue of $8.29 billion for its fiscal second quarter, up 61% from the year-ago period and topping estimates. Alibaba shares lost 1% to close at 184.54.

JD.com has a strategic alliance with messaging and gaming giant Tencent ( TCEHY), which owns a big stake in the e-commerce firm. Tencent will report third-quarter results early Wednesday.

In October, JD.com and Tencent expanded their partnership with the launch of a retail marketing platform. JD.com also has an alliance with Wal-Mart ( WMT), which sold its Chinese e-commerce operation to JD.com last year. Wal-Mart took a stake in JD.com as part of the transaction.

RELATED:

Chinese, Retail Leaders Plus GE's Future: Investing Action Plan

Looking For The Best Stocks To Buy? Start Here


86. This Biotech Just Neared A 17-Year High On Strong Cancer RegimenВт., 14 нояб.[−]

Nektar Therapeutics ( NKTR) launched to a nearly 17-year high Monday on strong combination data for its immuno-oncology drug combined with Bristol-Myers Squibb's ( BMY) Opdivo in skin, kidney and lung cancers.

XAutoplay: On | OffBy the closing bell on the stock market today, Nektar soared by more than 14% to close at 37.10, after earlier rising as much as 27.2% to touch a high last seen in January 2001. Meanwhile, Bristol ticked up 0.2% to close at 60.99.

The data were presented at the 2017 Society for Immunotherapy of Cancer annual meeting. Nektar's drug, NKTR-214, is designed to grow specific cancer-killing immune system cells and natural killer cell populations in the body to fight cancer.

Opdivo is what's known as a PD-1 checkpoint inhibitor, which works to block specific interactions in the immune system that would prevent an immune response. It competes closely against Dow's Merck ( MRK), which makes a rival drug called Keytruda.

A total of 38 patients were enrolled in the dose-escalation phase of the trial, dubbed Pivot.


IBD'S TAKE: Keep tabs on the earnings season by bookmarking IBD's Investing Action Plan.


As of Nov. 2, 63% of never-before-treated patients with advanced melanoma responded to the treatment. Of those, all signs of cancer disappeared in two patients and five had partial responses to the treatment.

In never-before-treated kidney cancer patients with at least one baseline scan, responses were seen in 46%, including one complete response and five partial responses. For patients with two or more prior scans, 60% responded to the combination.

Among advanced kidney cancer patients who'd already received at least two rounds of prior therapy, a partial response was observed in one of seven.

Three of four advanced lung cancer patients responded to the regimen. All signs of cancer disappeared in one patient. The other two patients had partial responses.

The most common side effects were low grade — including fatigue, flulike symptoms, rash and itching. There were no grade three or worse side effects at the dose recommended for testing in the continuing Phase 2 trial, Nektar said in a news release.

"In the dose-escalation stage of the Pivot trial, we've observed important response rates across all three tumor types," said Mary Tagliaferri, senior vice president of clinical development at Nektar. "All patients with responses in the trial continue on treatment."

Canaccord analyst Arlinda Lee boosted her price target on Nektar to 50 from 35 and kept her buy rating. She expects Nektar to target additional types of cancer using NKTR-214.

"In 2018, we expect clinical data for NKTR-214 plus Opdivo in renal cell carcinoma and sarcoma and other solid tumors, as well as potentially NKTR-214 in combination with (Roche's ( RHHBY)) Tecentriq and/or Keytruda," she said in a note to clients.

RELATED:

Nektar, Acadia Pop On Street-Crushing Quarters, But Tesaro Dips

Nektar Rockets To 16-Year High As Analyst Pegs It For Success

Nektar Therapeutics Earns Relative Strength Rating Update; Hits Key Benchmark


87. Nvidia Upgraded As Analyst Admits Being Wrong On The StockВт., 14 нояб.[−]

Graphics chip maker Nvidia ( NVDA) on Monday received a stock rating upgrade from a Wall Street analyst who admits to being wrongheaded on the company.

XAutoplay: On | OffAfter missing out on Nvidia's epic run over the past two years, BMO Capital Markets analyst Ambrish Srivastava issued a mea culpa. But he still can't rate Nvidia stock a buy.

He upgraded Nvidia to market perform, or neutral, from underperform. He raised his price target to 200 from 135.

Nvidia shares lost 1.6% to close at 212.63 on the stock market today.

"We have had calls in the past that have not worked out and we are likely going to have calls in the future that may not necessarily work out," Srivastava said in a report. "We have been reluctant to change our view, but now recognize that our underperform call did not work out, either. Nvidia has demonstrated a far stronger data-center business than we had been forecasting and the leverage in the model is far greater than what we had anticipated."

In 2016, Nvidia stock rose 224% in value. So far in 2017, Nvidia shares are up 102% as of Friday's close. Nvidia hit an all-time high of 218.67 on Friday.

BMO rated Nvidia as market perform throughout 2016. It lowered its rating to underperform on Feb. 23.


IBD'S TAKE: Nvidia is currently ranked No. 8 on the IBD 50 list of top-performing growth stocks.


"Our negative stance to date was based largely on our view that the gaming (chip) business would see a marked deceleration in calendar 2017 vs. 2016," Srivastava said. "However, the diversity in the business with wins at Nintendo ( NTDOY), and help from the cryptocurrency market, has enabled the business to sustain at a higher level than what we were modeling."

Nvidia's data-center chip business also has been stronger than expected, capitalizing on the market for artificial-intelligence applications, he said.

Also Monday, KeyBanc Capital Markets named Nvidia to its AI "all-star" list of 20 stocks. Others on the list include Amazon.com ( AMZN), Microsoft ( MSFT) and Alphabet ( GOOGL).

RELATED:

This Artificial Intelligence All-Star List Has Surprising Names

Nvidia Muscles Higher On Third-Quarter Beat, Price-Target Hikes


88. This Artificial Intelligence All-Star List Has A Few SurprisesВт., 14 нояб.[−]

KeyBanc Capital Markets is out with its first-ever, artificial intelligence "All-Star" stock rankings, with some surprising names such as Yext ( YEXT) and Alteryx ( AYX) joining staples led by Nvidia ( NVDA), Salesforce.com ( CRM) and Amazon.com ( AMZN).

XAutoplay: On | OffChipmaker Nvidia stock has doubled in 2017, owing to growth in the internet data center market as well as forecasts for AI hardware built into self-driving cars.

With its AI All-Star listing, KeyBanc aimed to identify stalwarts such as Nvidia and Alphabet's ( GOOGL) Google as well as lesser-known small caps.

"We have identified 9 of the 20 AI All-Stars in our report that still have 30% or more upside potential to our bull-case scenarios," said the KeyBanc report.

Yext and Alteryx are recent initial public offerings. New York-based Yext offers businesses online data and mapping services. Alteryx provides self-service data analytics software.

Also on KeyBanc's list of companies with 30% or more potential upside are: Wix.com ( WIX), Facebook ( FB), Square ( SQ), Shopify ( SHOP), Microsoft ( MSFT) and New Relic ( NEWR).

At a basic level, artificial intelligence is the use of computer algorithms to attempt to replicate the human ability to learn, reason and make decisions.


IBD'S TAKE: Read IBD's The Big Picture column each day to stay on top of the market direction, a key indicator that lets you know when you can be aggressive and when you should move to the sidelines.


Customers of tech companies — spanning banks and finance, health care, energy, retail, agriculture and other sectors — are spending on AI tools to gain a competitive edge, analysts say.

Also included in the KeyBanc AI All-Stars are Adobe Systems ( ADBE), chipmaker Xilinx ( XLNX), Accenture ( ACN), ASML ( ASML), Splunk ( SPLK), Grubhub ( GRUB), Aspen Technology ( AZPN) and Ambarella ( AMBA).

RELATED:

Why Artificial Intelligence Could Boost Demand For Chipmaking Gear

Where Are The Early Investing Hot Spots In Artificial Intelligence?

Chip Stocks To Watch And Semiconductor Industry News

Nvidia Gets Price-Target Hike On Artificial Intelligence View


89. Roku, Snap, Sogou: 3 Different IPOs, One Investing StrategyВс., 12 нояб.[−]

Roku ( ROKU), Snapchat parent Snap ( SNAP) and Sogou ( SOGO) are all 2017 IPOs, but with different chart action. Roku skyrocketed 70% last week on its first-ever quarterly report since coming public. Snap crashed on yet another disappointing quarter as it struggles vs. much-larger Facebook ( FB). Sogou, a Chinese search engine from Sohu ( SOHU), had a solid first two days after pricing at the high end of its IPO last week.

XAutoplay: On | Off But you should use the same investing strategy for all three new stocks, and recent initial public offerings generally. Wait for a newly public company to prove itself by setting up in a proper base and breaking out.

Roku

Roku came public at $14 a share in late September, and on its second day of trading hit an intraday peak of 29.80. But then shares pulled back to 18.35 on Oct. 25. Shares closed at 18.84 last Wednesday.

But late Wednesday Roku reported an adjusted loss of just 10 cents a share as revenue swelled 40% to $124.8 million. Analysts expected a 28-cent loss on sales of $110.50 million. Growth in users and revenue per user was strong.

Shares shot up 55% to 29.19 on Thursday. Then on Friday, Roku leapt 13.9% to 33.25 in Friday's stock market trading, clearing a 29.90 buy point.

Why not buy when Roku first came public, or right ahead of earnings. Anyone who did that would up a lot more than those that waited for Roku to hit 29.90 buy point. But investors had no way of knowing that the stock would ultimately rebound. If Roku had reported weak results or guidance, the stock could be trading at all-time lows.

Snap

The Snapchat operator shows the downside of buying early. Like Roku, Snap rallied for its first two days, then began retreating. Unlike Roku, Snap continued to fall as it has now reported three quarters of disappointing results. Late Tuesday, Snap fell well short of third-quarter revenue and user growth levels. Snap CEO Evan Spiegel, who earlier this year had laughed at the idea that Facebook was a serious threat, admitted that many people found the Snapchat "hard to use."

Snap fell 14.6% on Wednesday, even with Chinese internet giant Tencent ( TCEHY) taking a big stake. Snap closing the week at 12.76. While not a record low, shares are well below the IPO price of 17 and the all-time high of 29.44.

As for Facebook, the FANG stock is in buy range from a recent breakout. But the social media giant had a disastrous IPO start. After hitting 45 soon after trading opened in May 2012, shares closed that day right around the 38 IPO price. Facebook hit a record-low 17.55 in September, and didn't set a new high until September 2013.

Sogou

The Chinese search engine rival to Baidu ( BIDU) priced its IPO at 13, the high end of its expected range. Shares rose to 13.50 in Thursday's debut and then to 13.81 on Friday. That's a solid start, but as Roku and Snap show, you have no real idea how Sogou will perform after just two days.

On the upside, Sogou is profitable and has shown accelerating revenue growth in recent quarters. Sohu is the main shareholder, but Tencent also has a big stake.

IPOs will go in different directions, but you should stick to the same path. Wait for the dust to settle and only consider investing when the stock presents a sound buying opportunity.

RELATED:

IPO Stock News And Analysis: Find Today's Top New Issues

Snap's Three Lessons

IPO Leaders: See Today's Top-Performing IPO Stocks

A Tale Of 4 IPOs: Facebook, Alibaba, Snap And Square

What Are Today's Fastest-Growing Companies?

Looking For The Best Stocks To Buy? Start Here


90. This Chinese E-Commerce Giant Had A Huge '11.11' — And So Did AlibabaСб., 11 нояб.[−]

Alibaba ( BABA) racked up another huge take from its "11.11 Global Shopping Festival," but JD.com ( JD) also enjoyed a sales windfall.

XAutoplay: On | OffAlibaba had a 24-hour take of $25.4 billion, up 39% vs. a year earlier. Alibaba created the 11.11 event as "Singles Day" back in 2009.

But JD.com, reporting 11.11 figures for the first time, generated 127.1 billion RMB in revenue, or $19.14 billion.

Alibaba offers an e-commerce marketplace, while JD.com has a more vertical operation like Amazon ( AMZN).

JD.com reports earnings before Monday's open. Adjusted earnings should rise 233% to 10 cents a share while revenue swells 36% to $12.25 billion.

JD is in a consolidation with a 49.09 buy point, closing Friday at 39.94. The stock is finding resistance at its 50-day moving average.

JD benefits from a strategic alliance with messaging and gaming internet giant Tencent ( TCEHY), which owns a big stake. JD has an alliance with Wal-Mart ( WMT), which sold its Chinese e-commerce operation to JD last year. Wal-Mart took a stake in JD as part of the transaction. JD also as well as a partnership with search giant Baidu ( BIDU).

Tencent will report its third-quarter results early Wednesday.

RELATED:

Chinese, Retail Leaders Plus GE's Future: Investing Action Plan

Best Chinese Stocks To Buy And Watch

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Looking For The Best Stocks To Buy? Start Here


91. Netflix Stock Retreats On Disney Competitive ThreatСб., 11 нояб.[−]

Internet television network Netflix ( NFLX) saw its stock retreat to its 50-day moving average on Friday after one-time friend — and now future competitor — Walt Disney ( DIS) provided tantalizing details on its upcoming rival streaming video service.

XAutoplay: On | OffDisney late Thursday said it intends to price its over-the-top television service "substantially below" the monthly rates Netflix charges.

Disney Chief Executive Bob Iger said his company's new streaming video service to rival Netflix will launch in late 2019 with thousands of hours of movies and TV show content. Disney is developing a live-action "Star Wars" TV series for the service as well as new shows based on the Pixar Monsters franchise, High School Musical films and a Marvel adaptation, Iger said on a conference call with analysts.

"There's been a lot written about whether this is aimed at being a Netflix killer," Iger said. "Our goal here is be a viable player in the direct-to-consumer space, a space that we all know is a very, very compelling space to be in."

The new streaming service will offer the latest Disney, Pixar, Marvel and "Star Wars" feature films in the first pay TV window. Plus, Disney plans to produce four or five movies a year exclusively for the service, Iger said.

Netflix shares were down 1% to close at 192.02 on the stock market today. In intraday trading, it fell as low as 189.50, briefly undercutting a 190.05 buy point. Netflix stock peaked at 204.38 on Oct. 17, a day after posting better-than-expected third-quarter results.

Disney stock climbed 2.1% to finish the regular trading session at 104.78.


IBD'S TAKE: The FANG group of closely watched internet stocks is made up of Facebook, Amazon, Netflix and Google-parent Alphabet. For the latest news on the group, visit IBD's page on FANG stocks.


Disney plans to price its streaming service below what Netflix charges based on the fact that it will have less content initially, Iger said.

"Our plan on the Disney side is to price this substantially below where Netflix is," Iger said. "It'll have a lot of high-quality content because of the brands and the franchises that will be on it that we've talked about. But it'll simply launch with less volume, and the price will reflect that. It is our goal to attract as many (subscribers) as possible starting out."

Netflix's streaming service starts at $7.99 a month for standard-definition video to one device at a time. Its most popular plan, which allows high-definition video streaming on two devices at a time, costs $10.99 a month. It also offers a premium plan for $13.99 a month, which allows ultra-high definition streaming on up to four screens at the same time.

Netflix is by far the leader in the subscription internet video market. Netflix ended the September quarter with 109.25 million streaming subscribers worldwide, including 52.77 million in the U.S. and 56.48 million in international markets.

But Netflix already faces a lot of competitors, including Amazon.com ( AMZN), Hulu and CBS ( CBS). Soon, Disney and Apple ( AAPL) will join the fray.

Earlier this week, Apple won a bidding war for a new TV series starring Jennifer Aniston and Reese Witherspoon, the Hollywood Reporter said. Apple committed to a two-season order of 20 episodes total of the untitled series that will center on the lives of morning TV news stars.

The drama is the second big series Apple has secured for its fledgling streaming service, joining the Steven Spielberg-produced "Amazing Stories" series.

RELATED:

Roku Stock Breaks Out On Post-Earnings-Report Fervor

Disney Vows To Launch Netflix Rival 'Aggressively'

Netflix Stock Falls Despite Third-Quarter Subscriber Beat


92. This Biotech Just Rose By A Third On Its Earnings — But Is It In Trouble?Сб., 11 нояб.[−]

Biotechnology company Omeros ( OMER) rocketed higher by more than a quarter of its value Friday after revenue from eye-surgery drug Omidria beat its typical summertime sales weakness and topped expectations on double-digit growth vs. the year-earlier period.

XAutoplay: On | OffBut one analyst noted that the sales trajectory for Omidria is unclear as its status at the Centers for Medicare and Medicaid Services is set to change next month.

Omidria is a drug added to an irrigation solution and used during cataract surgery or intraocular lens replacement. It currently has pass-through reimbursement status, meaning it is paid separately by the CMS when used in ambulatory surgery centers or in hospital outpatient departments.

Pass-through status is meant to last no more than two years. Omidria was granted that status in October 2014. It is set to expire on Dec. 31. How Omidria is reimbursed after that will be key to its future trajectory, Needham analyst Serge Belanger said in a note to clients.

"If no CMS reimbursement is extended, Omidria would be reimbursed as part of a procedure bundling payment," he said. "It's unclear what the impact would be on Omidria pricing (likely lower) and volume (potentially higher)."


IBD'S TAKE: Omeros isn't the only stock to enjoy a major gap-up following its third-quarter earnings report. Head to IBD's Stock Spotlight for a look at how shares of a company that provides private label and branded credit cards reacted to earnings.


By the closing bell on the stock market today, Omeros popped 29% to close at 18.17 in high volume after earlier lifting as much as 42.1%. Omeros led IBD's 457-company Biotech industry group, which dipped a collective fraction.

For the third quarter, sales of Omidria came in at $21.7 million, up 92% year over year, and beating expectations for $17.4 million, Belanger wrote. Belanger kept his buy rating and 28 price target on Omeros.

"Omeros' third-quarter financials surpassed expectations as Omidria shook off its usual summer weakness," he said. "Based on early fourth-quarter sales trends, Omidria is annualizing in the $90 million-range."

Omeros also offered an update on its drug, known as OMS721, which is enrolling a late-stage trial in patients with a rare blood disease known as atypical hemolytic uremic syndrome. The trial will be used for potential approval in the U.S. and Europe.

The firm is also looking at OMS721 in a kidney disease known as IgA nephropathy. For approval the Food and Drug Administration will require a single successful Phase 3 trial showing a reduction in proteinuria, the result of overproduction of proteins by the body.

Belanger notes that this trial could start before year-end.

In other financial news, Omeros reported losses of 16 cents per share, which also topped Belanger's expectations for a 34-cent per share loss. In the year-earlier period, Omeros reported a 34-cent loss per share.

RELATED:

Sage Therapeutics Hits Record On Potential $600 Million Depression Drug

Tesaro Takes Swipe At AstraZeneca's Ovarian Cancer Drug Sales

Why This Biotech Crashed Despite Topping Breast Cancer Drug Sales


93. Here's What To Expect When China Internet Giant JD.com Reports EarningsСб., 11 нояб.[−]

China's largest internet company by revenue, JD.com ( JD), is set to report third-quarter results before the market open Monday, with expectations of continued double-digit growth.

XAutoplay: On | OffJD.com has an e-commerce business model similar to Amazon.com ( AMZN), and competes most directly in China against Alibaba ( BABA).

The consensus estimate looks for JD.com to report revenue of $12.25 billion, up 36% from the year-ago period, and maintain a string of double-digit growth per quarter going back more than four years. The consensus estimate on adjusted earnings is 10 cents per share, vs. 3 cents in the year-ago period.

"We anticipate JD will likely post revenue results in line with the guidance range," KeyBanc Capital Markets analyst Hans Chung said in a recent note to clients. He has an overweight rating on JD.com and a price target of 49.

"Along with a positive read-through of Alibaba's results, we remain buyers ahead of the earnings," Chung wrote.

Alibaba reported revenue of $8.29 billion for its fiscal second quarter, up 61% from the year-ago period. Adjusted earnings rose 63% to $1.29 cents per share.


IBD'S TAKE: U.S.-listed China-based firms, particularly those that cater to China's booming internet population, aren't suffering from lack of growth. Bookmark this page to stay on top of the latest movers and shakers in China.


When JD.com reported second-quarter results three months ago, adjusted earnings topped forecasts, but its net loss was wider than expected as marketing expenses swelled, causing shares to fall.

As JD.com prepares to report quarterly results, Alibaba on Friday kicked off its 24-hour " 11.11 global Shopping Festival." The event is expected to reach total sales, or gross merchandise volume, of about $24 billion this year, up from $17.8 billion on the same day last year.

Amazon appeared to take notice of Alibaba's one-day shopping event and created one of its own. In 2015 it launched Amazon Prime Day, also a 24-hour shopping event loaded with specials and promotions.

JD.com shares were up 0.4% to close at 39.96 on the stock market today. Alibaba ticked up 0.7% to finish at 186.41, while Amazon was down 0.3% to close at 1,125.35.

RELATED:

Alibaba Scores Another Price Target Hike On Quarterly Results

Best Chinese Stocks To Buy And Watch


94. Roku Stock Breaks Out On Post-Earnings-Report FervorСб., 11 нояб.[−]

Shares of streaming video specialist Roku ( ROKU) roared higher on Friday as investors continued to respond positively to the company's upbeat third-quarter earnings report.

XAutoplay: On | OffRoku shares soared another 13.9% to close at 33.25 on the stock market today. Intraday, the stock hit a record high of 36.65. On Thursday, Roku rocketed 55% to 29.19.

Roku broke out of an IPO base with a buy point of 29.90 in heavy trading. The company went public on Sept. 28 at $14 a share. It notched its previous record high of 29.80 on its second day of trading.

Roku makes hardware and software for accessing internet video services like Netflix ( NFLX), Hulu and Amazon.com's ( AMZN) Prime Video. It sells set-top boxes and dongles and provides software for smart TVs. It also gets revenue from selling advertising on its home screen and takes a share of pay-per-view movie sales and subscriptions sold through its platform.


IBD'S TAKE: For a look at top-performing recent initial public offerings, visit the IBD stock list page on IPO Leaders.


Late Wednesday, Roku reported an adjusted loss of 10 cents a share in the third quarter, compared with a loss of 17 cents a share in the year-earlier period. Revenue rose 40% to $124.8 million. Analysts expected a loss of 28 cents a share on sales of $110.5 million in the September quarter.

Roku ended the third quarter with 16.7 million active users, up 48% year over year. Its average revenue per user grew 37% year over year to $12.68.

RELATED:

Roku Blasts Off On Third-Quarter Beat-And-Raise Report


95. Nvidia Muscles Higher On Third-Quarter Beat, Price-Target HikesСб., 11 нояб.[−]

Graphics-chip maker Nvidia ( NVDA) saw its stock surge to a record high Friday after delivering much better-than-expected third-quarter results and offering rosy guidance.

XAutoplay: On | OffNvidia shares jumped 5.3% to close at 216.14 on the stock market today. Intraday, the stock hit a record-high of 218.67.

Nvidia late Thursday said it earned $1.33 a share, up 60% year over year, on sales of $2.64 billion, up 32%, in its quarter ended Oct. 29. Analysts expected earnings of 94 cents on sales of $2.36 billion.

For the current quarter, Nvidia expects sales to rise 22% year over year to $2.65 billion, topping views. It did not give a target for earnings per share. Wall Street was modeling earnings per share of 97 cents, down 2%, on sales of $2.43 billion, up 12%.

Nvidia received at least 18 price-target increases from Wall Street firms. Of those, 10 rate Nvidia stock as buy, seven are neutral and one is at underperform.

The most bullish of the crowd is B. Riley FBR analyst Craig Ellis. He reiterated his buy rating on Nvidia and raised his price target to 270 from 250.

Nvidia deserves a higher valuation because of its "superior growth and robust competitive position in four secularly strong areas": advanced driver assistance systems and autopilot, artificial intelligence, data center acceleration, and gaming, he said.


IBD'S TAKE: Nvidia is currently ranked No. 7 on the IBD 50 list of top-performing growth stocks.


Nvidia is best known for making graphics processors for PCs and gaming consoles, but has a fast-growing business selling processors for cloud data centers, artificial intelligence applications and self-driving cars.

Nvidia is at an inflection point as data center customers switch to graphics processing units from central processing units, Rosenblatt Securities analyst Hans Mosesmann said in a report.

"We believe in the next couple of years we will witness a data center disruption as cloud players accelerate their move to GPU compute for both training and inferencing, at the expense of CPUs," Mosesmann said.

Nvidia's new Volta GPU is just starting to ramp up sales and "is likely to be the most successful product in the company's history," Mosesmann said. "Management indicated that the Volta pipeline is deep as customers are realizing that a single Volta can replace 100s of server CPUs in deep learning environments."

BMO Capital Markets analyst Ambrish Srivastava thinks Nvidia stock is overvalued. He reiterated his underperform rating on the stock, but raised his price target to 135 from 90.

"We have to give credit to Nvidia," Srivastava said in a report. "The quarter was very strong, and the company delivered on very strong expectations on pretty much all fronts."

Morgan Stanley analyst Joseph Moore said he likes the Nvidia growth story, but the stock's rich valuation is keeping him on the sidelines.

In a report, Moore reiterated his equal-weight rating on Nvidia, but upped his price target to 222 from 210.

Microsemi Delivers Slight Beat

Elsewhere in the chip sector, Microsemi ( MSCC) shares were flat Friday after the company posted slightly better-than-expected fiscal fourth-quarter results and guided in line with views for the current quarter.

Microsemi was up a fraction, near 52.90, in morning trading.

Late Thursday, Microsemi reported adjusted earnings per share of $1.09, up 20% year over year, on sales of $475.3 million, up 6%, in the quarter ended Oct. 1. Analysts expected $1.08 and $475 million.

For the current quarter, the Aliso Viejo, Calif.-based chipmaker expects adjusted earnings per share of $1.01 on sales of $460 million. Wall Street was modeling $1.01 and $460.4 million.

RELATED:

Nvidia Trounces Third-Quarter Views, Guides Sales Targets Higher

Chipmaker Diodes Beats Third-Quarter Sales, Earnings Goals


96. OLED Stock Displays Continued Strength, Hits Record HighСб., 11 нояб.[−]

Universal Display ( OLED), a maker of technology and materials for organic light-emitting diode (OLED) displays and lighting, saw its stock surge to a record high Friday in its seventh straight day of gains.

XAutoplay: On | OffUniversal Display shares climbed 3.7% to close at 175.90 on the stock market today.

The Ewing, N.J.-based company is riding high since it delivered much-better-than-expected third-quarter results and guidance on Nov. 2.

Universal Display is benefiting from smartphone makers like Samsung and Apple ( AAPL) shifting to OLED screens from liquid crystal displays. OLED displays are seen as superior to LCD screens in color reproduction, refresh rate and power consumption. OLED screens are also being adopted for wearables, televisions and automotive displays.


IBD'S TAKE: Universal Display is currently ranked No. 1 on the IBD 50 list of top-performing growth stocks.


Cowen analyst Robert Stone on Friday reiterated his outperform rating on Universal Display stock and raised his price target to 195 from 155.

"We believe Universal Display is poised for another strong year in 2018," Stone said in a report. He cited multiple catalysts for the stock, including a new multiyear deal with major customer Samsung and the continued ramp up of Apple's iPhone X, and perhaps new OLED iPhones.

Plus, Universal Display could get a boost from sampling new blue phosphorescent OLED emitter materials and a partnership to make Organic Vapor Jet Printing equipment, Stone said.

RELATED:

Universal Display Hits Record High After Analyst Day

Universal Display Surges After Obliterating Third-Quarter Targets


97. Why This Biotech Crashed Despite Topping Breast Cancer Drug SalesСб., 11 нояб.[−]

Puma Biotechnology ( PBYI) crashed to a two-month low Friday after sales of its breast cancer drug crushed the third-quarter consensus but failed to live up to more bullish buy-side expectations, analysts said.

XAutoplay: On | OffBy the closing bell on the stock market today, Puma plummeted by 19% to close at 103.

Puma's Nerlynx was approved in July as a maintenance treatment to reduce the risk of breast cancer returning in a specific population of patients. The drug was "soft" launched in July with a full commercial rollout in September.

For the quarter, Nerlynx pulled in $6.1 million in sales, above consensus views between $3 million and $4 million, according to various analyst reports. But that could have lagged more bullish buy-side expectations, analysts said Friday.

"Headed into (earnings), we sense that buy-side expectations around the launch were likely higher," RBC analyst Matthew Eckler wrote in a note to clients. He views the launch as still in its infancy.

Through October, Nerlynx has achieved an estimated $11.6 million in sales, Eckler said. He projects Nerlynx pulling in $20 million in the fourth quarter and $26 million in 2017, up from his prior model for $13 million and $17 million, respectively.

In total, 779 patients have been enrolled in Puma's specialty pharma network through October, accounting for 567 patients on the commercial drug and 443 total prescriptions in October.


IBD'S TAKE: A slew of biotechs have already reported earnings, but the season is still ongoing. Keep tabs on what's up next by visiting IBD's Investing Action Plan.


Nearly nine in 10, or 86%, of patients receive the drug in 20 days or less and the discontinuation rate is running at 11% thus far, Eckler wrote. He boosted his price target on Puma to 108 from 92, though kept his sector perform rating.

Leerink analyst Michael Schmidt says all the launch metrics "point in the right direction." October sales of $5.5 million suggest Puma is capable of meeting fourth-quarter and 2018 sell-side views for $16.3 million and $191 million, respectively.

"Despite that, shares are down after the market close (Thursday) offering a buying opportunity in our opinion," he wrote in a note to clients. Puma is still trading two times below its peers as investors discount estimates for Nerlynx.

Schmidt reiterated his outperform rating and 140 price target on Puma. He noted the majority of patients receive insurance approval within 10 days or less with no denials thus far. And only $1 million of the quarterly sales figure was inventory, he added.

Credit Suisse analyst Alethia Young increased her price target to 142 from 136, and maintained her outperform rating.

"Expectations were high, and we think that launch is living up to high expectations," she wrote in a note to clients. "The stock was weak due to high expectations into the quarter."

Investors are pegging between $25 million and $30 million in the fourth quarter. The October $5.5 million sales figure represents an almost 100% growth rate from September to October and indicates the range is "very achievable," she said.

RELATED:

Puma Biotechnology Flops Despite Topping Sales, Loss Expectations

Tesaro Takes A Swipe At AstraZeneca's Ovarian Cancer Drug Sales

Sage Therapeutics Hits Record On Potential $600 Million Depression Drug


98. Two Bulls Stand Firm As The Trade Desk Buckles On GuidanceСб., 11 нояб.[−]

A disappointing fourth-quarter outlook from The Trade Desk ( TTD) smacked its shares Friday as two bulls raised price targets nonetheless and touted overseas investments as a growth driver.

The Trade Desk tumbled 14% to 51 on the stock market today. With the fall, shares are still up 90% in 2017 but down from 66 on Oct. 31.

Bullish Mark Mahaney, an analyst at RBC Capital, raised his price target to 67 from 65.

"Shares traded down in the aftermarket as (a fourth-quarter) guide was raised by less than (Wall Street) expectations," Mahaney said in a note to clients. "The Trade Desk continues to invest in growth opportunities such as international and is executing better than expected."

Brent Thill, analyst at Jefferies, raised his price target to 63 from 60.

"Expectations were running up ahead of the (third-quarter) print given (Trade Desk's) history of large beats, but we see continued fundamental execution and a beat-and-raise wasn't enough to satisfy investors after hours," Thill wrote in his morning note. "Fundamentals remain solid for one of our top small-cap picks benefiting from one of the largest secular shifts (programmatic advertising) in our coverage."

The digital-ad placement company late Thursday reported adjusted third-quarter earnings and revenue above expectations. But, The Trade Desk forecast December-quarter revenue and EBITDA (earnings before interest, taxes, depreciation and amortization) below views.


IBD'S TAKE: Buying or holding a stock can be risky heading into an earnings report. Here's an earnings options strategy that can help you cash in on post-earnings stock gains, while minimizing the risk from a weak quarter.


Trade Desk enables agencies and other ad buyers to purchase online advertising through its self-service platform. Trade Desk competes with Google parent Alphabet ( GOOGL), as well as smaller companies such as AppNexus.

The company has touted China as a growth market.

Desk said adjusted third-quarter earnings were 35 cents a share, up 46% from a year ago, with revenue rising nearly 50% to $79.4 million, topping consensus estimates. Analysts expected Trade Desk to report earnings of 26 cents on sales of $77 million for the period ended Sept. 30.

In the December quarter, Trade Desk forecast revenue of $101 million vs. estimates of $102 million and EBITDA of $34 million vs. estimates of $37 million.

RELATED:

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

This Cloud Company Took On Cisco And Citrix, Now Eyes Salesforce

Nvidia Trounces Third-Quarter Views, Guides Sales Targets Higher

Sogou Rises In Debut After China Search-Engine IPO Prices High


99. Ichor Holdings Falls On In-Line Q3 Earnings ReportСб., 11 нояб.[−]

Chip-gear supplier Ichor Holdings ( ICHR) saw its stock fall Friday after reporting in-line earnings with sales a hair below views for the third quarter.

XAutoplay: On | OffFremont, Calif.-based Ichor earned an adjusted 62 cents a share, up 82% year over year, on sales of $164.5 million, up 56%, in the quarter ended Sept. 29. Analysts expected EPS of 62 cents and sales of $165.2 million.

For the current quarter, Ichor expects to earn an adjusted 68 cents a share on sales of $180 million, based on the midpoint of its guidance. Wall Street was modeling 66 cents and $173.2 million.

In a news release, Ichor Chief Executive Tom Rohrs said the company's revenue guidance shows that it expects accelerating growth.

Ichor shares fell 6.2% to close at 27.98 on the stock market today. Ichor hit a record high of 35.51 on Oct. 20.


IBD'S TAKE: Ichor is one of eight chip-industry players on the IBD 50 list of top-performing growth stocks.


Cowen analyst Karl Ackerman reiterated his outperform rating on Ichor and raised his price target to 40 from 38.

"This remains an incredibly inexpensive way to play the myriad of positive drivers for semiconductor production equipment," he said in a report.

Ichor late Thursday also announced an acquisition to expand its prospects in the semiconductor-equipment market.

Ichor agreed to pay $130 million to buy Talon Innovations, a maker of high-precision machined parts used in leading-edge semiconductor tools. Ichor is financing the acquisition with $10 million of cash on hand and $120 million of incremental borrowing.

"Talon brings to Ichor the capability to deliver complex precision components to mission critical areas of semiconductor manufacturing," Rohrs said in a statement. "It will enable Ichor to extend our fluid delivery product portfolio and deepen our collaboration with our customers' design teams."

Ichor makes gas- and chemical-delivery subsystems for chipmaking equipment.

RELATED:

IBD 50 Chip-Gear Stock Ichor Hits Record High On Bullish Report


100. Biotech Stocks To Watch And Pharma Industry NewsПт., 10 нояб.[−]

One minute Dow Jones industrial average component Merck ( MRK) might be doing battle with fellow drugmaker Bristol-Myers Squibb ( BMY) over drugs that can ward off cancer.

The next, biotech giants like Amgen ( AMGN) and Sanofi ( SNY) are tussling in court over the fate of cholesterol-busting drugs. Meanwhile, a company like Gilead Sciences ( GILD) might be raked over the coals in Congress for charging $1,000 a day to treat hepatitis.

It's a brave – and contentious – new world for pharmaceutical and biotechnology companies. It's a realm where science is trying to develop landmark medicines that cure cancer, hepatitis and other life-threatening illnesses.

All the while it does a delicate dance with Wall Street and regulators – balancing public health issues with the demands of shareholders. Investors will find it tricky to navigate the sector, as companies can rise and fall at the drop of a hat.

Bookmark this page to stay on top of the latest news in the biopharma sector.

Biotech And Pharma News

Why This Biotech Could Prosper On Back Of Roche Cancer TrialFive Prime Therapeutics could benefit from Roche's recent lung cancer trial, an analyst suggested Wednesday — about two weeks after Five Prime lost nearly 41% of its value on a pancreatic cancer study.... Read More
Sage Therapeutics Shows Rising Price Performance With Jump To 91 RS RatingOn Wednesday, Sage Therapeutics reached an important technical milestone, with its Relative Strength (RS) Rating jumping into the 90-plus percentile with an improvement to 91, an increase from 87 the day before.... Read More
Zynerba Pharmaceuticals Joins Rank Of Stocks With RS Ratings Over 90On Wednesday, Zynerba Pharmaceuticals got an upgrade to its Relative Strength (RS) Rating, from 90 to 94. IBD's proprietary RS Rating tracks technical performance by using a 1 (worst) to 99 (best)... Read More
Biotech Spikes After Settling Debate Over Its Seizure MedicineGW Pharmaceuticals settled a debate Tuesday on whether its cannabinoid seizure drug, Epidiolex, is only effective in a combination — prodding shares to an eight-month high on successful data. By the closing bell... Read More
Medtronic Surges After Topping Quarterly Earnings ViewsMedtronic surged to a three-month high Tuesday after the No. 1 medical devices-maker topped fiscal second-quarter earnings views and reported revenue from heart valve replacements grew by more than a third. By... Read More
Stocks Flashing Renewed Technical Strength: Intra-Cellular TherapiesIntra-Cellular Therapies saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 89 to 92. IBD's proprietary RS Rating measures technical performance by showing how a... Read More
Galapagos Pops To Vertex's Detriment — But Can It Compete?Galapagos stock popped Monday to Vertex Pharmaceuticals' detriment after it figured out "one piece of its triple-combination puzzle" in treating cystic fibrosis, an analyst said. Still, Galapagos still has a long road... Read More

View More Biotech And Pharma Stock News

RELATED:

Best Stocks To Buy And Watch



 
Каталог RSS-каналов (лент) — RSSfeedReader
Всего заголовков: 100
По категориям:
Все заголовки
AAPL (20)
ABBV (1)
ABT (1)
ACN (1)
ACOR (1)
ADBE (2)
ADI (2)
Amazon Stock News (5)
AMBA (1)
AMGN (1)
AMZN (18)
ANET (1)
Apple Stock News (9)
Artificial Intelligence (3)
ASML (1)
Auto Industry News & Stocks To Watch (1)
AVGO (4)
AYX (1)
AZPN (1)
BABA (6)
BAYRY (2)
BBY (1)
BIB (1)
BIDU (4)
Biotech And Pharma Stock News (15)
BITA (1)
Bitcoin And Cryptocurrency (1)
BMY (5)
BSFT (1)
BSX (2)
BZUN (1)
CAVM (1)
CBS (2)
CELG (1)
Chinese Stocks To Watch (12)
Chip Stocks Semiconductor Industry News (12)
CHKP (1)
CHTR (2)
Click (11)
CLVS (1)
CMCSA (7)
CNCR (1)
CRM (3)
CSCO (5)
DDAIF (2)
DIS (6)
DISCA (1)
DISH (2)
Dow Jones Industrial Average Stock News (1)
DQ (1)
DTEGY (1)
DVAX (1)
DVMT (1)
DXC (1)
EA (1)
Earnings (29)
EBAY (2)
Energy News: Oil Gas Solar Coal (1)
EPAM (1)
EW (1)
EXEL (1)
EXPE (1)
F (1)
Facebook Stock News (3)
FANG Stocks: Facebook Amazon Netflix Google (6)
FB (5)
FOX (1)
FOXA (3)
FPRX (3)
FTNT (1)
GE (2)
GILD (2)
GLPG (1)
GM (2)
GOOGL (10)
Google Stock News (1)
GRUB (1)
GWPH (1)
HPE (1)
HPQ (2)
IBB (1)
IBM (1)
ICHR (1)
Industry Trends And Stock News (9)
INTC (2)
INTU (1)
IPO News (4)
JASO (1)
JBHY (1)
JD (6)
KKR (1)
KLIC (1)
LLY (1)
LOXO (2)
MCHP (2)
MDT (2)
MRK (3)
MRVL (1)
MSCC (1)
MSFT (4)
NAV (2)
NBIX (1)
Netflix Stock News (3)
NEWR (1)
NFLX (7)
NKTR (1)
NTDOY (2)
NTES (1)
NVDA (6)
OLED (1)
OMER (1)
ORCL (1)
PANW (1)
PBYI (1)
PCRX (1)
PPDF (1)
PYPL (2)
QCOM (4)
QD (1)
QRVO (1)
Retail And E-Commerce Stocks And Industry News (1)
RHHBY (3)
ROKU (4)
RS (2)
RUN (1)
S (3)
SAIL (1)
SEND (1)
SHOP (1)
SNAP (2)
SNY (1)
SOGO (1)
SOHU (1)
SPLK (2)
SPWR (1)
SQ (3)
SSYS (1)
T (8)
TCEHY (6)
Tech Earnings (29)
Technology (89)
Telecom Stocks To Watch And Industry News (9)
Tesla Stock News (3)
TMUS (3)
TSLA (10)
TSM (1)
TSRO (1)
TTD (1)
TTWO (1)
TWTR (1)
TWX (5)
TXN (1)
VLKAY (2)
VRTX (1)
VSLR (1)
VZ (7)
WDC (1)
WIX (1)
WMT (3)
WUBA (1)
XBI (1)
XLNX (1)
XRF (1)
YEXT (1)
YRD (1)
По датам:
Все заголовки
2017-11-23, Чт. (7)
2017-11-22, Ср. (16)
2017-11-21, Вт. (12)
2017-11-20, Пн. (3)
2017-11-18, Сб. (7)
2017-11-17, Пт. (10)
2017-11-16, Чт. (8)
2017-11-15, Ср. (13)
2017-11-14, Вт. (12)
2017-11-12, Вс. (1)
2017-11-11, Сб. (10)
2017-11-10, Пт. (1)
По авторам:
Все заголовки
ALLISON GATLIN (14)
APARNA NARAYANAN (1)
BRIAN DEAGON (19)
ED CARSON (2)
IBD STAFF (9)
PATRICK SEITZ (31)
REINHARDT KRAUSE (20)
RUSS BRITT (4)